Cell cycle heterogeneity as a regulator of epithelial bending during neural tube closure by Danielsen, KE
  
1 
 
 
Cell cycle heterogeneity as a regulator of 
epithelial bending during neural tube closure 
 
Katrin Eivindardottir Danielsen 
 
Thesis submitted to University College London for the degree of 
Doctor of Philosophy 
 
2016 
 
Newlife Birth Defects Research Centre 
UCL Institute of Child Health 
London   
  
2 
 
Declaration 
I, Katrin Eivindardottir Danielsen confirm that the work presented in this thesis is 
my own. Where information has been derived from other sources, I confirm that 
this has been indicated in the thesis. 
  
  
3 
Abstract  
During neurulation, the neural plate bends around the median hinge point (MHP), 
overlying the notochord. MHP cells spend more time in G1/S-phase of the cell cycle 
than lateral cells, and this is associated with adoption of a wedged cell shape due to 
interruption of interkinetic nuclear migration. Clustering of wedge shaped cells in 
the MHP is suggested to drive midline bending. To determine the mechanism 
underlying the prolonged cell cycle in the MHP, I examined the mRNA expression of 
cell cycle inhibitors, and found the cyclin-dependent-kinase-inhibitors (CDKIs), p21, 
p27 and p57, to be expressed in midline cells. p21-/- mice, which exhibit MHPs, show 
upregulation of p57 mRNA in midline cells, supporting the hypothesis of a 
redundant relationship between p21 and p57 during neural plate bending. Detailed 
cell cycle analysis was performed in p21-/- and p21+/+ embryos by sequential 
injections of two thymidine analogues, IdU and BrdU. p21-/- MHP cells spend 
significantly less time in S-phase compared to wild-type littermates, suggesting that 
p21 is responsible for the prolonged S-phase in the MHP. In the absence of p21, S-
phase length in the MHP and lateral cells is equivalent. Overexpression of CIP/KIP 
genes in the midline of cultured embryos did not increase the proportion of basal 
nuclei, a measure of wedge shaped cells. Electroporation of p57 siRNA abolished 
p57 mRNA from the neural plate and notochord of p21-/- embryos but did not 
prevent MHP formation. Collectively, the results indicate that p21 is responsible for 
the prolongation of S-phase in the MHP but is not necessary for MHP formation. 
There is possible redundancy between p21 and p57 in the MHP. However, loss of 
both p21 and p57 is not sufficient to prevent MHP formation. Furthermore, a 
prolonged S-phase in the midline cells of the neural plate is not necessary for MHP 
formation.  
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Chapter 1 – General introduction 
1.1 Neurulation 
Neurulation is the process whereby the future brain and spinal cord are formed in 
the first 3-4 weeks after fertilisation in humans (Copp et al., 2013; Greene and 
Copp, 2009). Neural tube defects (NTDs) are a severe group of congenital disorders 
that arise when neurulation fails and affects approximately 1:1000 established 
pregnancies worldwide (Copp et al., 2003b; Mitchell, 2005). Neurulation in mice 
and humans is very similar at the embryonic level (Greene et al., 2009; Greene and 
Copp, 2009) and as NTD associated genes are discovered in humans, the number of 
genetic NTD mouse models grows rapidly. To date over 250 genetic mouse mutants 
have been described (Harris and Juriloff, 2010) in the attempt to find candidate 
genes for better treatment of NTDs and to improve genetic counselling of people 
with affected NTD pregnancies.  
Neurulation is divided into primary neurulation, which in mice takes place around 
E8-E10, and secondary neurulation that forms the neural tube at the most caudal 
region of the spinal cord (Copp et al., 2013). Primary neurulation can further be 
divided into three distinct morphogenetic events: neural plate shaping, neural fold 
elevation and neural fold fusion.  
1.1.1 Generation of the neural plate 
During gastrulation, the embryo transforms from a single layer of pluripotent 
epithelium to a structure composed of ectoderm, mesoderm and endoderm with 
the axial organisation of the future embryo (Tzouanacou et al., 2009). In amniote 
embryos the epiblast comprised of the pluripotent epithelium (Gardner and 
Rossant, 1979) forms mesoderm and endoderm via ingression through the primitive 
streak, while surface ectoderm and neurectoderm is formed by cells remaining in 
the epiblast (Tam and Behringer, 1997). The head and most anterior trunk 
structures are formed during gastrulation while the embryo continues to elongate 
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during organogenesis from cells supplied by the posterior neuropore, and later, the 
tail bud at the caudal end of the embryo (Stern et al., 2006). 
The primitive streak (PS) (Figure 1.1, A; white box) in mouse and chick embryos 
orchestrates much of the early patterning of the embryo during gastrulation 
(Wilson et al., 2009). Cells of the node streak border (NSB) (Figure 1.1, A; red area), 
a region comprising the caudal end of the node (Figure 1.1, A; green area) and the 
rostral 5-10% of the primitive streak (Figure 1.1, A; white box), contribute to the 
neural tube, somites, and notochord (Cambray and Wilson, 2007) while the neural 
tube ventral midline is produced by the dorsal part of the node exclusively (Charrier 
et al., 1999; Selleck and Stern, 1991). Progenitors of the lateral and dorsal neural 
tube and some somatic tissue are found on either side of the primitive streak in a 
region known as the caudal lateral epiblast (CLE) (Figure 1.1, A; white circle) (Wilson 
et al., 2009) with a rostral limit at the NSB, extending caudally to approximately 80% 
of the primitive streak length in the mouse at the 2-6 somite stage (Cambray and 
Wilson, 2007). The derivative of the NSB, with a minor contribution from the CLE, is 
known as the chordo-neural hinge (Figure 1.1, B; CNH) located in the later forming 
tail bud (TB) rostral to the tail bud mesoderm (TBM) at the junction between 
notochord (NC) and neural tube (NT). The CNH contains progenitors for the ventral 
neural tube, somites and notochord (Figure 1.1, B) (Cambray and Wilson, 2007; 
Wilson et al., 2009). The CNH is continuous with the newly formed neural tube and 
notochord while somites are produced from the tissue immediately caudal to the 
CNH (McGrew et al., 2008; Wilson et al., 2009). 
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Figure 1.1 - Generation of the neural plate 
In the early mouse embryo with 5 somites, the node streak border (red) and caudal lateral epiblast 
(CLE; white circle) contribute to the spinal cord and the paraxial mesoderm of the extending body 
axis. The node is shown by the green region and the primitive streak (PS) as the white box (A). At 
E10.5, the chordo-neural hinge (CNH) has formed with contributions of cells from the NSB and CLE 
(B). The CNH is situated in the tailbud (TB) rostral to the tail bud mesenchyme (TBM), between the 
neural tube (NT) and notochord (NC). The CNH contains precursors for the ventral midline from the 
hindbrain to the tail and the notochord (Henrique et al., 2015; Tzouanacou et al., 2009; Wilson et al., 
2009). Figure B is taken from (Wilson et al., 2009). Scale bar = 50 μm. 
1.1.2 Neural plate shaping 
The first step in primary neurulation is the formation of the neural plate which 
differentiates from the dorsal midline ectoderm into neuroepithelium. This event is 
induced by BMP antagonists emanating from the primitive node, underlying the 
prospective neural plate (Bassuk and Kibar, 2009). Secondly, the neural plate is 
shaped as it lengthens and narrows. The mechanism behind the shaping is likely to 
be a combination of the rostro-caudal growth of the embryo and convergent 
extension movements of cells in the neural plate as they intercalate at the midline, 
causing the neural plate to converge and extend (Greene and Copp, 2009; Keller, 
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2002). Convergent extension relies on the planar cell polarity (PCP) pathway 
(Mlodzik, 2002; Zohn et al., 2003) and its importance is highlighted by the severe 
neural tube defects that arise as a result of the wide neural plate which prevents 
neural tube closure in several PCP mouse mutants (reviewed by (Greene and Copp, 
2009). 
1.1.3 Neural fold elevation 
The elongated and narrow neural plate undergoes bending as a midline furrow 
known as the median hinge point (MHP) appears along the rostro-caudal axis in 
close proximity to the notochord (Figure 1.2). During early neurulation from E8.5 to 
E9 this is the only point at which the neural plate bends, resulting in the 
characteristic V-shaped appearance of the neural plate at rostral levels of open 
neural tube (Figure 1.2 and Figure 1.3, B) while at caudal levels the forming MHP is 
relatively flat (Figure 1.3, A). At E9, paired dorsolateral hinge points (DLHPs) appear 
at spinal levels (Figure 1.2; arrowheads) and the neural plate bends around all three 
hinge points. At the last stage of primary spinal neurulation the MHP is lost and the 
neural plate bends solely at the DLHPs (Copp et al., 2003b; Greene and Copp, 2009; 
Shum and Copp, 1996). DLHPs seem necessary for spinal neurulation as mouse 
embryos with a null mutation in the zinc finger protein Zic2 do not form DLHPs 
(Ybot-Gonzalez et al., 2007a) and consequently develop fully penetrant and 
extensive spina bifida (Elms et al., 2003; Nagai et al., 2000). On the other hand, 
neural tube closure seems to be able to proceed in the absence of MHPs, at least in 
some mouse models (Greene and Copp, 2009). 
In the cranial region, neural plate bending has a slightly different mechanism. 
During early neurulation the neural folds bend around the MHP as shown in Figure 
1.2, but the neural folds then adopt a biconvex appearance where the neural folds 
face away from the midline before coming together in a biconcave shape in the 
midline to fuse (Morriss-Kay et al., 1994; Morriss-Kay, 1981). It has been proposed 
that the convex neural fold elevation is supported by mesenchyme expansion 
(Morriss-Kay et al., 1986) whereas spinal neural fold elevation is able to proceed in 
the absence of paraxial mesoderm (Ybot-Gonzalez et al., 2002). 
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Figure 1.2 - Primary neurulation in the mouse embryo 
At E8.5 the neural plate bends around the MHP only (arrows). Later, at E9, paired dorsolateral hinge 
points (DLHPs; arrowheads) appear and bending occurs at the three hinge points. At the latest stages 
of primary neurulation the MHP is lost and the neural plate bends solely at the DLHPs. The 
notochord (nc) is shown in dark grey underlying the MHP. 
 
 
Figure 1.3 - The MHP is flat caudally and sharpens more rostrally 
Diagram of transverse sections through the PNP of an embryo at E8.5. At caudal levels the neural 
plate and the MHP is wide (A). At more rostral levels the MHP is sharp and the neural plate has a V-
shaped appearance (B). The notochord (nc) is shown in dark grey. 
1.1.4 Neural fold fusion 
The last step of primary neurulation is fusion of the neural folds at the dorsal 
midline. This step seems to depend on cellular protrusions similar to filopodia that 
extend from the neural fold tips and seem to interdigitate to bring the neural folds 
into close apposition enabling cell adhesion, remodelling of the epithelia and fusion 
(Greene and Copp, 2009; Pai et al., 2012; Pyrgaki et al., 2010). 
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1.1.5 Secondary neurulation 
In the tail bud in the caudal region of the embryo, secondary neurulation takes 
place once primary neurulation is complete. The tail bud hosts a population of stem 
cells that condense into cell masses and these masses in the dorsal region undergo 
canalisation whereby the solid neural precursor population is converted into a 
hollow structure, continuous with the lumen created by primary neurulation 
(Schoenwolf, 1984). Secondary neurulation thereby creates the lowest part of the 
spinal cord (Copp et al., 2003b; Copp et al., 2013). 
1.1.6 Neural tube closure is a discontinuous event 
In the mouse, the first neural tube closure site is observed at the 6-7 somite stage 
(embryonic day E8.5) at the hindbrain-cervical boundary (closure 1) from where 
closure propagates bidirectionally to the future brain and spinal cord (Figure 1.4, b) 
(Copp et al., 2003b; Copp et al., 2013). A second closure is initiated at the forebrain-
midbrain boundary (closure 2) approximately 12 hours later and runs in a 
bidirectional manner, followed by a third closure site (closure 3) which is initiated at 
the rostral forebrain and proceeds in a caudal direction towards closure 2 (Figure 
1.4, c-d) (Copp et al., 2003b; Copp et al., 2013). The open area of elevated neural 
folds between closures 2 and 3 is called the anterior neuropore and closes up within 
a few hours, and the open area posterior to closure 1 is called the posterior 
neuropore (PNP) and has completed closure approximately 48 hours after 
neurulation has started. Primary neurulation is complete around E10 in the mouse 
(Copp et al., 2013).  
Neurulation in humans is very similar to mouse neurulation (O'Rahilly and Muller, 
2002). In the human embryo, neural plate bending is initiated approximately 18 
days post-fertilisation at a closure site analogous to closure 1 in mice, although it 
has been suggested that closure 1 in human embryos is slightly more rostral 
(Greene and Copp, 2009; O'Rahilly and Muller, 2002). Closure 3 in humans seems to 
be similar to that of mouse but the presence of a closure 2 site in humans is 
controversial. Some studies suggest that it exists in humans (Van Allen et al., 1993) 
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while others do not (O'Rahilly and Muller, 2002). Human cranial neural tube closure 
is completed by day 25 and PNP closure 26-28 day after fertilisation (Greene and 
Copp, 2009). 
 
Figure 1.4 - Closure sites during mouse neurulation 
Scanning electron micrograph showing the three closure sites in a mouse embryo at E8.5. Closure is 
initiated at the hindbrain-cervical boundary (b, closure 1) from where closure proceeds 
bidirectionally. Closure 2 is at the future forebrain-midbrain boundary (c) and closure 3 is observed 
last at the rostral limit of the future forebrain (d). The posterior neuropore (PNP) is the open region 
in the caudal embryo (b, PNP). Adapted from (Copp et al., 1990). Scale bars = 250 μm. 
1.2 Neural tube defects 
Neural tube defects (NTDs) are the second most common birth defects (Copp et al., 
2003b; Mitchell, 2005; Stoll et al., 2011). In humans, NTDs occur between three and 
four weeks after fertilisation and are the result of failure of all or part of the neural 
tube to close (Bassuk and Kibar, 2009; Copp, 2005; Copp et al., 2013). Numerous 
types of NTDs have been described and these can be grouped according to the 
stage of neurulation that fails. 
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1.2.1 Closure 1  
The most severe NTD, craniorachischisis, results from failure of the neural folds to 
fuse at closure 1 resulting in an entirely open neural tube from the midbrain to the 
lower spine (Copp et al., 1994). In mouse mutants with craniorachischisis, closures 2 
and 3 are generally unaffected (Greene et al., 1998; Murdoch et al., 2003). This is 
similar to what is seen in human cases and suggests that craniorachischisis in mice 
closely resembles the condition in humans (Greene and Copp, 2009). 
Craniorachischisis is not commonly observed in mice as most embryos with NTDs 
undergo closure 1 successfully with subsequent failure of neurulation in the cranial 
or rostral region (Copp et al., 2013; Harris and Juriloff, 2010). In fact, from the 
approximately 250 mouse mutant strains that develop NTDs, only 14 have been 
reported to develop craniorachischisis (Harris and Juriloff, 2010), suggesting that 
closure 1 might be a relatively robust event. 
Failure of closure 1 to proceed caudally in the spinal region leads to open spina 
bifida. The two main forms are myelomeningocele where the neural tissue is 
covered by a meninges-sac, and myelocele where the neural tissue is exposed to 
the amniotic fluid (Greene and Copp, 2009). Spina bifida is generally compatible 
with postnatal survival and the severity depends on the axial level at which 
neurulation stops. Spina bifida can lead to neurological impairment below the 
lesion, including inability to walk, incontinence, and lack of sensation (Copp et al., 
2013). Furthermore, spina bifida is associated with secondary disorders such as 
hydrocephalus, vertebral deformities and genitourinary and gastrointestinal 
disorders (Copp et al., 2013). 
1.2.2 Closures 2 and 3 
Failure of the neural tube to close in the cranial region at closure 2, or failure in the 
rostral zippering leads to exencephaly where the neural folds remain open and 
exposed to the amniotic environment. Exencephaly progresses into anencephaly as 
gestation proceeds and the neural tissue is degenerated by amniotic fluid due to 
failure of the skull vault to form (Copp et al., 2003b; Greene and Copp, 2009). 
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Closure defects in the rostral forebrain (closure 3) lead to forebrain anencephaly 
which is often accompanied by a split phase phenotype (Copp et al., 2003b). 
1.2.3 Secondary neurulation defects 
NTDs can also arise as a result of incomplete secondary neurulation in the form of 
closed spina bifida. In this case the neural tube fails to separate from surrounding 
tissues in the tail bud, leading to tethering of the spinal cord and possible neural 
damage as the body axis elongates at a different rate than the spinal cord (Greene 
and Copp, 2009). 
1.2.4 Aetiology of NTDs 
The aetiology of NTDs is complex and multifactorial. Several genes have been 
identified that are associated with NTDs and over 250 genetic NTD mouse models 
are available (Harris and Juriloff, 2010). Among these mouse mutants roughly 80% 
exhibit cranial defects and only 20% spina bifida (Harris and Juriloff, 2010), 
suggesting that cranial neurulation is more sensitive to insults compared to the 
spinal region. This could reflect the more complex mode of closure.  
In support of a genetic aspect of NTDs, humans have an increased recurrence risk 
for siblings: 2-5% compared to 0.1% for the general population. Furthermore, 
women who have had two or more affected pregnancies have a recurrence risk of 
approximately 10% (Copp et al., 2013). Environmental factors associated with NTDs 
include valproic acid, which when taken in pregnancy increases the risk of NTDs 
(Lammer et al., 1987), maternal diabetes, maternal obesity and a high temperature 
during pregnancy (reviewed by Copp et al., 2013). 
1.3 MHP formation 
During neurulation, the early neural plate midline and MHP is formed by cells 
originating from the node region in the caudal region of the embryo (Patten et al., 
2003; Placzek and Briscoe, 2005) and is in close proximity to the underlying 
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notochord. Although spinal neural tube closure can proceed in the absence of MHPs 
in some notochord ablated embryos (Ybot-Gonzalez et al., 2002) and at the latest 
stages of spinal neurulation by bending at DLHPs, the MHP has been shown to be 
important for cranial neural tube closure in the chick (Eom et al., 2011) and for the 
positioning of the midline and in establishing a normal morphology of the neural 
tube (Schoenwolf, 1988; Smith et al., 1994).  
The MHP is distinct from the lateral non-bending regions by its cell shape 
composition. Cells of the MHP are mainly wedge shaped, i.e. are wide at their base, 
compared to lateral regions of the neural plate where three main cell shapes are 
found at roughly equal ratios: wedge shaped, spindle shaped (widest in the middle) 
and inverted wedge shaped (widest at the apex) (Figure 1.5, nuclei in blue) 
(McShane et al., 2015; Schoenwolf and Franks, 1984). In the flat neural plate, the 
cell shape composition of the prospective MHP is indistinguishable from the lateral 
neural plate and the increase in the proportion of wedge shaped cells coincides 
with midline bending (McShane et al., 2015; Schoenwolf and Franks, 1984; Smith et 
al., 1994). It has been shown that the position of the nucleus is responsible for the 
shape of a neuroepithelial cell (Schoenwolf and Franks, 1984). This was originally 
shown by measuring the greatest diameter of neuroepithelial cells from scanning 
electron micrographs and comparing it to the diameter of neuroepithelial nuclei 
from light micrographs. The only place in the cell that was wide enough to 
accommodate the nucleus was the bulbous part (Schoenwolf and Franks, 1984). 
Today, this can be easily visualised on transverse sections through the neural plate 
stained with anti-β-catenin, a marker of neuroepithelial cell membranes, and a 
nuclear stain. 
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Figure 1.5 - Cell shape composition in the neuroepithelium 
In the MHP, the majority of the cells are wedge shaped with basal nuclei (blue) while in the lateral 
neural folds three cell shapes are found at roughly equal ratios: inverted wedge shaped cells with 
apical nuclei, spindle shaped cells with nuclei in the centre region of the neuroepithelium, and 
wedge shaped cells. The notochord (nc) is indicated in dark grey. 
It has long been speculated that the cell shape changes in the MHP are important 
for bending at the neural plate midline and the idea that bending was driven by 
changes in cell shape was first proposed by Glaser in 1914 (Schoenwolf and Franks, 
1984). The question has, however, always been whether MHP cell wedging is an 
intrinsic process due to apical constriction or basal expansion, or whether it 
depends on extrinsic forces such as surrounding tissues. Furthermore, are the shape 
changes the result of neural plate bending, or do the cells change shape in order to 
cause bending?  
1.3.1 Intrinsic forces 
1.3.2 Apical constriction 
Apical constriction of MHP cells is a popular theory regarding how the cells become 
wedge shaped. The theory is based on findings by Baker and Schroeder in 1967 
(Schoenwolf and Smith, 1990). By transmission electron microscopy, they showed 
that circumferential microfilament bands were present in the apices of Hyla regilla 
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and Xenopus laevis during neural plate bending (Schoenwolf and Smith, 1990). 
Similar findings were later reported by many other groups in amphibians, birds, 
mammals, and in the cells of developing systems with similarities to neural tube 
formation, e.g. optic vesicle and pancreatic bud (reviewed by Schoenwolf and 
Smith, 1990). The microfilaments found were considered to be contractile, thereby 
providing force for the bending of the neural plate. Some of the research supporting 
the theory included the findings that circular bands of apical microfilaments were 
dense during neural plate bending (Burnside, 1971), that the apical microfilaments 
were able to bind heavy meromyosin, thereby suggesting actin similar properties 
(Nagele and Lee, 1980), that active forms of actin, myosin and other contractile 
proteins were found apically in neuroepithelial cells (Lee et al., 1983; Nagele and 
Lee, 1980; Sadler et al., 1982), and the fact that calcium, which is required for 
microfilament contractility, was found in vesicles in the apices of neuroepithelial 
cells which was released during neurulation (Moran, 1976; Nagele et al., 1981). 
Furthermore, preventing the release of calcium using papaverine inhibited neural 
plate bending, while A23187 induced stimulation of calcium transport and release, 
and accelerated neural plate bending (Moran and Rice, 1976). Later it was shown 
that Cytochalasin D, which disrupts actin polymerisation, led to neural tube defects 
in the chick (Schoenwolf et al., 1988). In chick, actin and myosin has been found to 
be most intense in regions with the highest degree of bending, i.e in the MHP, 
which coincides with dense packing of microfilaments and highly constricted cell 
apices (Lee and Nagele, 1985). The intense staining of actin and myosin was seen to 
decline after neural tube closure (Lee and Nagele, 1985). In the chick midbrain it has 
more recently been shown that Rho, which regulates actomyosin constriction and 
cytoskeletal reorganisation, generally accumulates in apices of ectodermal cells 
where a sheet of columnar cells is bending or invaginating, that actin and activated 
myosin are slightly more intense in the MHP, and that Blebbistatin, Y27632 and 
Cytochalasin D all disrupt midline bending of the neural plate (Kinoshita et al., 
2008). Mouse embryos treated with the same inhibitors do, however, show normal 
midline bending during early neurulation (Escuin et al., 2015). 
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Importantly, cells of the MHP become, and remain, wedge shaped in the absence of 
microfilaments, and furrowing and bending at the midline proceeds as usual while 
dorsolateral wedging, furrowing, and neural fold convergence are blocked 
(Schoenwolf et al., 1988; Ybot-Gonzalez and Copp, 1999). Combined, these studies 
suggest that there might be a role for microfilaments in neural fold elevation and 
fusion, while the first events of neurulation: cell wedging, furrowing and bending 
are independent of microfilaments.  
1.3.3 Basal expansion 
Basal expansion of neuroepithelial cells is an equally old theory. It was originally 
thought that the basal expansion observed in neuroepithelial cells resulted from 
increased water uptake by their bases (Glaser, 1914). Proving this theory was 
unsuccessful, and when the apical constriction theory came along, the basal 
expansion theory took a backseat for some decades (Schoenwolf and Smith, 1990). 
In 1935 Sauer proposed that the pseudostratified epithelium of the neural plate 
undergoes interkinetic nuclear migration (Sauer, 1935). That is, nuclei migrate to 
the basal site during S-phase of the cell cycle and migrate to the apical site during 
M-phase. This was later confirmed by others (Fujita, 1962; Martin and Langman, 
1965; Sauer and Walker, 1959; Sidman et al., 1959). Due to IKNM, cells undergoing 
S-phase adopt a wedged cell shape as the nuclei are situated at the basal surface. It 
was later shown that MHP cells are transformed from spindle shaped cells to wedge 
shaped cells immediately prior to furrowing and bending of the neural plate 
(Schoenwolf and Franks, 1984). It was proposed that basal expansion occurred in 
orchestration with the cell cycle due to IKNM as the cell cycle phase determines the 
shape of the cell (Schoenwolf and Franks, 1984). Thus, it was thought that wedge 
shaped cells could be generated by cell cycle alterations.  
Indeed, Smith and Schoenwolf found that a prolongation of the MHP cell cycle 
coincided with an increase in the number of wedge shaped cells during neural plate 
bending in the chick embryo (Smith and Schoenwolf, 1987). The prolonged S-phase 
was not observed in cells of the lateral regions or in the flat prospective MHP in 
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younger embryos (Smith and Schoenwolf, 1987). Furthermore, all phases of the cell 
cycle except M-phase, when nuclei are apical and cells inverted wedge shaped, 
were prolonged in the MHP (Smith and Schoenwolf, 1988). In fact, the length of M-
phase in the MHP shortened as bending proceeded. It has been suggested that 
nuclei of all regions are apical during M-phase (inverted wedge shaped), apical or 
central during the transition from G1- to S-phase and during late G2-phase (spindle 
shaped), and basal during S- and most of G2-phase (wedge shaped). It was 
therefore predicted that the non-S-phase part of the cell cycle that is prolonged in 
the MHP is G2 phase, when cells are mostly wedge shaped (Smith and Schoenwolf, 
1987; Smith and Schoenwolf, 1988). 
The mechanisms behind the altered cell cycle in the MHP are still unknown. A 
suggested mechanism is that the underlying notochord induces cells to prolong S-
phase (and possibly G2). In support of this theory, the proportion of wedge shaped 
cells in the MHP does not increase following notochord ablation and, as a 
consequence, furrowing and bending at the MHP is lost (Smith and Schoenwolf, 
1989). On the other hand, notochordal fragments transplanted into the lateral 
region of the neural tube are able to convert overlying (lateral) neuroepithelial cells 
to ‘MHP-like’ cells (Smith and Schoenwolf, 1989). Further evidence for this theory 
comes from work showing that notochordal transplants in the lateral region of the 
neural tube leads to a reduction in the mitotic index of the cells in contact with the 
notochord compared to a control region in the opposite neural fold (van Straaten et 
al., 1988). The authors conclude that the notochord induces floor plate like 
structures and diminishes proliferation in the overlying neural plate (van Straaten et 
al., 1988). 
1.3.4 Extrinsic forces 
1.3.5 Surrounding tissues 
MHP cells that have been surgically separated from lateral tissues become wedge 
shaped and form a MHP indicating that wedging is not secondary to neural plate 
bending due to extrinsic forces (Alvarez and Schoenwolf, 1992; Schoenwolf, 1988). 
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Similarly, in mouse embryos, PNP closure proceeds in isolated neural tubes and 
plates that have been separated from lateral tissues that could otherwise exert 
extrinsic forces on neural plate bending and elevation (van Straaten et al., 1993). 
Interestingly, surgical removal of the lateral neural fold region on one side of the 
prospective MHP does not change the position of the MHP. That is, cell wedging 
and bending occurs in the original MHP which is off centre due to loss of one of the 
lateral regions (Schoenwolf, 1988). Furthermore, the side of the neuroepithelium 
that is still intact elevates and bends around the original furrow, even though the 
apposing neural fold is missing (Schoenwolf, 1988). This suggests that an important 
role for the MHP is to determine the site at which bending and elevation will occur, 
ensuring that the neural tube forms with the right morphology. 
It is difficult to dissect wedge shaping and furrowing from each other as they take 
place simultaneously. However, the fact that furrowing occurs when midline cells 
have been separated from all lateral tissues that could have exerted extrinsic forces 
to cause bending (Schoenwolf, 1988) suggests that the intrinsic, active event of cell 
shape changes in the MHP causes initial furrowing. Furthermore, furrowing occurs 
roughly 4 hours prior to neural fold elevation in the chick embryo (Schoenwolf and 
Franks, 1984), suggesting that cell wedging is not a secondary effect of bending and 
cell crowding. 
1.3.6 Molecular mechanisms of MHP formation 
BMP inhibition has in recent years been suggested to be important for MHP 
formation in the chick midbrain (Eom et al., 2012). pSmad1,5,8 which is a readout of 
canonical BMP signalling, is found at low levels in the chick midline due to the 
expression of the BMP antagonists Chordin and Noggin (Eom et al., 2012). 
Electroporation of overexpressing Noggin-, or dominant negative BMP receptor-
constructs into the midline exacerbated the MHP, while overexpression in the 
lateral neural folds in some cases led to indentation of the neural plate, or an 
ectopic hinge point (Eom et al., 2012). Moreover, electroporation of a constitutively 
active BMP receptor led to a flat neural plate, i.e. abolished MHP formation and 
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resulted in failure of the neural folds to elevate and fuse, suggesting that BMP 
antagonist mediated MHP formation is necessary and sufficient for neural tube 
closure (Eom et al., 2012). BMP blockade also led to an increase in apical 
constriction and an overall trend towards more basal nuclei in the MHP due to a 
reduction in the levels of apical tight junction proteins and an increase in the apical 
levels of basolateral proteins (Eom et al., 2012). 
BMP inhibition was previously shown to be important for DLHP formation in the 
mouse embryo (Ybot-Gonzalez et al., 2007a). BMP signalling is both necessary and 
sufficient for the inhibition of DLHPs while BMP antagonism, in the form of Noggin, 
is necessary and sufficient to induce DLHPs (Ybot-Gonzalez et al., 2007a). At rostral 
levels DLHPs do not form as Shh signalling from the notochord inhibits Noggin in the 
dorsal neural folds. Caudally, however, Shh signalling from the notochord is weaker 
and unable to inhibit Noggin, leading to DLHP formation (Ybot-Gonzalez et al., 
2007a). 
1.3.7 Notochordal role in MHP formation 
Notochordless chick embryos do not form a MHP and cell wedging, apico-basal cell 
shortening and midline furrowing is abolished (Smith and Schoenwolf, 1989). 
Furthermore, the increase in the proportion of wedge shaped cells and the 
prolongation of the cell cycle in the MHP is only observed after the notochord has 
formed and established contact with the chick MHP (Smith and Schoenwolf, 1989). 
In some notochordless embryos the neural folds elevate but do not fuse, and the 
cross section is U-shaped rather than V-shaped. In other embryos closure occurs but 
the cross sectional morphology is abnormal with a broad ventral midline region and 
a small lumen (Smith and Schoenwolf, 1989). Thus, it seems that the notochord and 
MHP are dispensable for neural fold elevation and fusion, but are important for the 
spatial regulation of bending, and the proper cross sectional V-shaped morphology 
(Smith and Schoenwolf, 1989). 
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1.3.7.1 Notochordal factors 
As described above, BMP antagonists have been implicated in MHP formation in the 
chick. Noggin and Chordin are BMP antagonists that bind to several BMPs including 
BMP2 and BMP7 (McMahon et al., 1998) that are expressed in the dorsal neural 
tube in the mouse (Ybot-Gonzalez et al., 2007a). In the mouse embryo, Noggin is 
expressed in the node at E7.5 and is later expressed along the rostro-caudal length 
of the notochord underlying the MHP (McMahon et al., 1998; Ybot-Gonzalez et al., 
2007a). In agreement with a role in BMP antagonism, Noggin mutants have ectopic 
BMP4 expression in the MHP compared to Noggin heterozygous mice but the MHP 
seems to be normal (McMahon et al., 1998). Thus, the phenotype of BMP 
overexpressing chick embryos (Eom et al., 2012) is not reproduced in a Noggin 
mouse mutant (McMahon et al., 1998). 
Chordin is expressed in the node and notochord underlying the MHP in the mouse 
(Bachiller et al., 2000; Ybot-Gonzalez et al., 2007a). Unlike Noggin mutants, Chordin 
mutants develop normally (Bachiller et al., 2000) while Noggin-Chordin double 
mutants exhibit holoprosencephaly, a single nasal pit and a cyclopic eye; 
phenotypes that resemble those observed for Shh null mice (Bachiller et al., 2000). 
Furthermore, Noggin-Chordin double mutant mice lack Shh in the rostral midline 
similarly to Shh mutants (Bachiller et al., 2000; Chiang et al., 1996) and develop a 
notochord which is degenerated after E8.5, suggesting that Noggin and Chordin are 
required for the maintenance of the notochord (Bachiller et al., 2000).   
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1.4 Interkinetic nuclear migration  
Interkinetic nuclear migration (IKNM) was first identified in the chick and pig 
neuroepithelium by Sauer in 1935 (Sauer, 1935) and is characteristic of all 
pseudostratified epithelia (Lee and Norden, 2013). During IKNM, nuclei migrate 
between the apical and the basal side of the epithelium depending on the phase of 
the cell cycle, undergoing mitosis at the apex and DNA synthesis basally (Figure 1.6) 
(Spear and Erickson, 2012b). IKNM has been suggested to be important for shaping 
of epithelia (Spear and Erickson, 2012b) and in several pseudostratified epithelia 
IKNM is associated with shape changes (Table 1.1). IKNM has also been suggested 
to be important for the balance between neurogenesis and maintenance of 
progenitor pools by regulating the amount of neurogenic and proliferative signals a 
progenitor cell receives as it traverses through apical and basal expression domains 
(Del et al., 2008). A third theory is that it allows more progenitor cells to be packed 
within a limited surface area (Spear and Erickson, 2012b). Pseudostratified epithelia 
allow for a greater density of cells and are associated with highly proliferating 
tissues (Lee and Norden, 2013). Accordingly, pseudostratified epithelium has been 
described in a congenital tumour of the ciliary epithelium (Saunders and Margo, 
2012). Abnormal pseudostratification has also been implicated in developmental 
defects of the brain, such as microcephaly, suggesting that it is important for 
normal brain development (Ge et al., 2010). 
The molecular mechanisms underlying IKNM are controversial and likely to be 
different from system to system. In liver buds, for example, the transcription factor 
Hex is required for the transition from a columnar to a pseudostratified epithelium 
but deletion of Hex affects only the liver bud, and not the neuroepithelium (Bort et 
al., 2006). Some studies conclude that IKNM is a process driven by microtubules and 
the minus-end-directed microtubule motor protein Dynein, while other studies find 
IKNM to be dependent on actomyosin forces (reviewed by Spear and Erickson, 
2012b). Examples of different systems and IKNM requirements are shown in Table 
1.2. 
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Figure 1.6 - Interkinetic nuclear migration in the neural plate 
Nuclei of neuroepithelial cells migrate between the basal surface where they undergo DNA synthesis 
(S-phase), and the apical surface for mitosis. Cells in the MHP have mainly basal nuclei due to the 
prolonged time spent in ‘basal cell cycle phases’.  
 
Table 1.1 - IKNM in vertebrate embryos is associated with shape change 
The lens placode invaginates, and the lung buds, liver bud and pancreatic buds evaginate from the 
endoderm (Bort et al., 2006; Zwaan et al., 1969).  
Tissue Reference 
Lens placode (Zwaan et al., 1969) 
Liver, lung buds and pancreatic bud (Bort et al., 2006) 
Mouse intestine E12.5-14.5 (Grosse et al., 2011) 
Chick somite (Langman and Nelson, 1968) 
Mesonephros (Sauer, 1935) 
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System IKNM dependent on: Reference 
Zebrafish retina 
MTs and motor proteins play minor roles 
while most movement is generated by 
actomyosin activity 
(Norden et al., 
2009) 
Mouse cortex 
E13.5 
Basal to apical regulated by Tpx2. Apical 
to basal is passive, non-autonomous 
displacement due to nuclear movement 
in the opposite direction 
(Kosodo et al., 
2011) 
Chicken neural 
tube slice culture 
Apical migration during G2 microtubule-
dependent and cell rounding during 
mitosis actin-dependent 
(Spear and 
Erickson, 2012a) 
Table 1.2 - Requirements for IKNM 
Summary of some of the mechanisms proposed for IKNM in the zebrafish retina, the mouse cortex, 
and in chick slice cultures. MT; microtubules. 
1.4.1 Microtubule dependent IKNM 
The microtubule-based cytoplasmic motors Dynein and Kinesin have been 
implicated in IKNM in many systems such as fungi, fruit flies and algae (Baye and 
Link, 2008). The Dynein motor is referred to as a minus-end directed motor and 
Kinesin as a plus-end directed motor as they carry cargo in opposite directions: 
Dynein basal to apical, and Kinesin apical to basal (Figure 1.7) (Baye and Link, 2008). 
In the mouse and rat cerebral cortex, several studies find a necessary role for 
microtubules and dynein in IKNM (reviewed by Spear and Erickson, 2012b): Lis1 
knock-down (a regulator of Dynein) prevents apical migration and mitosis, and low 
levels of Lis1 lead to ectopic mitosis away from the apex. NudC (which also 
regulates Dynein), Cep120 and TACCs (two proteins important for the integrity of 
the microtubule cytoskeleton), Hook3 and PCM1 (important for the anchoring of 
microtubules to the centrosomes) and TPX2 (a microtubule associated protein) have 
all been shown to be essential for IKNM (Spear and Erickson, 2012b). Furthermore, 
KASH and SUN nuclear membrane proteins, specifically Syne-2 and SUN1 and 2, 
have been shown to link nuclei of photoreceptor cells to microtubules in the mouse 
retina, thereby attaching the nuclei to the microtubule motors (Yu et al., 2011). 
KASH proteins also contain actin-binding sites and could therefore be important in 
actin and myosin mediated IKNM as well (Baye and Link, 2008). 
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Figure 1.7 - The Dynein and Kinesin motors in IKNM 
The microtubule-based cytoplasmic motors Dynein and Kinesin carry cargo in opposite directions: 
Dynein basal to apical, and Kinesin apical to basal. Taken from Baye and Link, 2008. 
1.4.2 Actomyosin dependent IKNM 
Other evidence suggests roles for actin and myosin in IKNM. Myosin localises to the 
basal side of the nucleus during nuclear migration in zebrafish neuroepithelium, 
seemingly contracting behind the nucleus to push it towards the apex (Leung et al., 
2011). Inhibition of non-muscle myosin with Blebbistatin perturbs apical nuclear 
migration in the zebrafish retina (Norden et al., 2009), Cytochalasin B mediated 
inhibition of actin polymerisation disrupts IKNM (Murciano et al., 2002) and 
regulators of the actin cytoskeleton and myosin, including Rho GTPase and Rho 
kinase (ROCK) affect IKNM (Liu et al., 2010; Meyer et al., 2011; Minobe et al., 2009). 
In Drosophila, inhibition of ROCK disrupts apical migration, suggesting that ROCK 
might be an upstream activator of actomyosin contraction during IKNM (Meyer et 
al., 2011). Furthermore, it has been shown that microtubule depolymerisation in 
the zebrafish retina does not perturb IKNM (Norden et al., 2009). 
  
37 
It is possible that the different outcomes of the studies are linked to morphological 
differences, as the mouse and rat cortices are vastly wider than the zebrafish retina 
(Lee and Norden, 2013). Thus, it is possible that over longer distances, as in the 
rodent developing brain, microtubule motors are required for the steady and 
directed migration of nuclei to the apex, whereas actin and myosin are sufficient to 
‘push’ nuclei over shorter distances. It remains to be found which system drives 
IKNM in the mouse neural plate which in width is similar to the zebrafish retina. An 
alternate theory is that microtubules and actin are both required as suggested by 
Spear and Erickson in chicken neural tube slice cultures (Spear and Erickson, 2012a). 
They find that apical migration during G2-phase is microtubule dependent but entry 
into mitosis occurs some distance away from the apex after which the cell rounds 
up in an actin dependent manner which is responsible for getting the nucleus the 
rest of the way to the apical surface (Spear and Erickson, 2012a). Accordingly, 
colcemide-induced depolymerisation of microtubules prevents apical migration but 
not mitosis or apical movement of mitotic cells, whereas Cytochalasin B mediated 
actin depolymerisation prevents mitotic cell rounding and results in ectopic mitoses 
some distance away from the apex (Spear and Erickson, 2012a). 
The apical to basal migration has received less attention and has been suggested to 
be passive and random for cells in G1- and S-phase in mouse neocortex, zebrafish 
retina, and zebrafish hindbrain (Kosodo et al., 2011; Leung et al., 2011; Norden et 
al., 2009). Other studies have found that it depends on actin and myosin (Schenk et 
al., 2009) or the plus-end directed microtubule motor Kinesin-3 (Tsai et al., 2010).  
1.4.3 IKNM is regulated by the cell cycle 
IKNM is tightly linked to cell cycle progression in the developing mouse brain but 
IKNM is not required for cell cycle progression (Kosodo et al., 2011; Murciano et al., 
2002; Schenk et al., 2009; Ueno et al., 2006). Through cell cycle block in G2/M-
phase or S-phase using the chemical inhibitors 5-azacytidine or cyclophosphamide, 
respectively, Ueno et al. showed that nuclei fail to undergo IKNM when the cell 
cycle is blocked (Ueno et al., 2006). Overexpression of the CDK inhibitor p18INK4c 
has also been used to block the cell cycle at G1-phase and inhibit the apical 
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migration of nuclei (Kosodo et al., 2011). Moreover, inhibition of IKNM by 
Cytochalasin B treatment, which inhibits actin polymerisation and disrupts 
contractile microfilaments, does not affect cell cycle progression (Murciano et al., 
2002). 
It is not known what triggers apical migration and at what point in the cell cycle this 
is triggered. In the zebrafish neuroepithelium, using PCNA-GFP constructs, Leung et 
al found that nuclei in S-phase where found broadly distributed across the centre of 
the neuroepithelium, and that the apico-basal level of S- to G2-transition varied 
(Leung et al., 2011). Once nuclei reached G2-phase, apical migration was rapid and 
directed (Leung et al., 2011). Using a fluorescently tagged myosin together with 
PCNA-GFP, the group showed that nuclei in G1- and S-phase are surrounded by 
symmetric myosin which then accumulates at the base of the nucleus once it goes 
into G2-phase (Leung et al., 2011). The basal myosin then seems to push the nuclei 
to the apex for mitosis. Finally, Cdk1, which is required for S- to G2-phase transition, 
was shown to be necessary for apical nuclear migration (Leung et al., 2011). 
Interestingly, Cdk1 has also been shown to phosphorylate the kinesin microtubule 
motor, Kif11, and this phosphorylation modulates its interaction with dynactin-1 
(Blangy et al., 1997). Another link between the cell cycle and apical migration is 
through the microtubule binding protein TPX2 that reorganises the microtubule 
cytoskeleton (Kosodo et al., 2011). TPX2 is contained within the nucleus but 
relocates to the apical process during G2-phase and could be important for apical 
migration (Kosodo et al., 2011).  
1.5 The cell cycle 
The cell cycle is an important regulator of cell behaviour during embryonic 
development. During neurogenesis the progenitors of neurons undergo G1-phase 
lengthening which is sufficient to induce neuroepithelial cell differentiation, linking 
cell fate to the length of the cell cycle (Calegari and Huttner, 2003). Furthermore, 
alterations of the cell cycle due to loss of negative cell cycle regulators affects cell 
cycle exit and differentiation in the lens and pituitary during development, leading 
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to inappropriate proliferation (Bilodeau et al., 2009; Zhang et al., 1998). Moreover, 
a mouse model with a null mutation in the cyclin-dependent kinase inhibitor, p27, 
has a neuronal density 30% higher than that of wild-type littermates (Fero et al., 
1996) highlighting how de-regulation of the cell cycle can have significant biological 
implications in development. 
The cell cycle is regulated by cyclins and cyclin-dependent kinases (CDK) that form 
complexes. Cyclins are synthesised and destroyed in a cell cycle dependent manner, 
thereby regulating kinase activity and ensuring that the cell cycle proceeds in a 
sequential and orderly fashion (reviewed by Malumbres and Barbacid, 2009). The 
CDKs that drive the cell cycle consist of three interphase CDKs, namely CDK2, CDK4 
and CDK6, and one mitotic CKD, CDK1 (Malumbres and Barbacid, 2009). In addition 
there are ten different cyclins belonging to four different classes, i.e. A, B, D and E 
cyclins (Malumbres and Barbacid, 2009). Cell cycle progression is monitored by 
checkpoints that ensure that DNA replication and chromosome segregation occurs 
without errors. 
Mitogenic signals lead to expression of the D-type cyclins (D1, D2 and D3) that bind 
and activate CDKs in G1-phase, preferentially CDK4 and CDK6. The cyclin D-
CDK4/CDK6 complexes cause partial inactivation of the pocket proteins Rb, RBL1 
and RBL2, permitting expression of the E-type cyclins (E1 and E2) which in turn bind 
and activate CDK2 (Figure 1.8). The cyclin E-CDK2 complexes further phosphorylate 
and complete inactivation of Rb (reviewed by Malumbres and Barbacid, 2009). 
Availability of E-type cyclins is under tight regulation and is only permissive during 
the early stage of DNA synthesis (Malumbres and Barbacid, 2009). During late 
stages of DNA synthesis, CDK2 is activated by cyclin-A2 to drive transition from S-
phase to G2-phase. Lastly, it is thought that CDK1 is activated by A-type cyclins at 
the end of interphase to allow entry into M-phase. After nuclear envelope 
breakdown the A-type cyclins are degraded, permitting the formation of cyclin B - 
CDK1 complexes that drive the cell through Mitosis (Figure 1.8) (reviewed by 
Malumbres and Barbacid, 2009).  
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Figure 1.8 - The cell cycle 
In mid G1-phase, mitogenic signals induce the transcription of cyclins D which bind and activate 
CDK4/6, phosphorylating retinoblastoma protein (Rb) to partially inactivate it and release 
transcription factors from its inhibition. This allows transcription of genes required for G1-S-phase 
transition including cyclins E which bind and activate CDK2, further inactivating Rb. The availability of 
cyclins E is limited to early S-phase. In late S-phase, cyclin A activates CDK2 to drive the cell cycle into 
G2-phase, and at the end of G2-phase, cyclin A activates CDK1 to facilitate the onset of mitosis (M-
phase). Once the nuclear envelope has broken down, cyclins A are degraded, and the CDK1-cyclin B 
complex forms and drives the cell through M-phase.  
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1.6 CIP/KIP family 
The CIP/KIP family consists of three genes, p21 (el-Deiry et al., 1993; Gu et al., 1993; 
Xiong et al., 1992), p27 (Polyak et al., 1994a; Polyak et al., 1994b; Toyoshima and 
Hunter, 1994) and p57 (Lee et al., 1995; Matsuoka et al., 1995). They contain a 
conserved amino-terminal domain responsible for binding of cyclin-CDK complexes 
and inhibition of CDK protein kinase activity (Harper et al., 1995; Matsuoka et al., 
1995; Polyak et al., 1994b) and can all cause cell cycle arrest in G1 when 
overexpressed (Fero et al., 1996; Harper et al., 1995; Lee et al., 1995). In addition to 
inhibiting cyclin-CDK complexes, including cyclin D-CDK4/6, p21, p27 and p57 are 
also involved in assembling catalytically active cyclin D-CDK4/6 complexes (LaBaer 
et al., 1997). 
The CIP/KIP proteins are intrinsically unstructured and adopt tertiary conformations 
after binding to a wide variety of interacting proteins (Adkins and Lumb, 2002; 
Esteve et al., 2003; Lacy et al., 2004). Phosphorylation events seem to be important 
for the binding of CIP/KIP proteins to other proteins and their affinity towards CDKs 
can be modulated by phosphorylation on specific residues (reviewed by Besson et 
al., 2008). Furthermore, their subcellular localisation is regulated by 
phosphorylation events (Borriello et al., 2007; Child and Mann, 2006). Although the 
CIP/KIP genes are best known as cell cycle regulators, they have a number of other 
functions, including apoptosis, tumorigenesis, transcriptional regulation and 
cytoskeletal regulation (Besson et al., 2008). 
1.6.1 p21 
p21 was first discovered in 1992 as a polypeptide that was detected in anti-cyclin 
D1, anti-CDK2, anti-CDK4, and anti-CDK5 precipitates (Xiong et al., 1992) but the 
molecular identity of the protein was not identified until 1993 in a human brain 
tumour cell line as a gene highly induced by the tumour suppressor gene p53 and 
was named wild-type p53-activated fragment 1 (WAF1) (el-Deiry et al., 1993). WAF1 
was shown to inhibit tumour growth in several tumour cell lines (el-Deiry et al., 
1993). In the same issue of Cell in 1993, Harper et al reported the identification of a 
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gene they called CIP1 (for Cdk-interacting protein) whose product bound to and 
inhibited cyclin-CDK complexes (Harper et al., 1995). The sequences of CIP1 and 
WAF1 turned out to be identical (el-Deiry et al., 1993; Harper et al., 1995). 
Subsequently it was shown that the expression of p21 during embryogenesis as well 
as during cellular differentiation was not p53 dependent (Macleod et al., 1995; 
Parker et al., 1995). The best known function of p21 is, however, as a transcriptional 
target of p53 that mediates G1- and G2-cell cycle arrest following DNA damage (el-
Deiry et al., 1993; Gartel and Tyner, 1999). In S-phase, p21 binds PCNA which is a 
DNA β processivity factor, thereby blocking subsequent DNA synthesis (Luo et al., 
1995). p57 has also been shown to bind PCNA in S-phase (Watanabe et al., 1998). 
p21 mouse mutants do not develop NTDs (Patterson et al., 2006). However, when 
double mutant embryos are generated with Gadd45a, another cell cycle regulator, 
the occurrence of exencephaly is relatively high (30.5%) and spina bifida occurs in 
2.9% of embryos suggesting a role for p21 in spinal neurulation (Patterson et al., 
2006). In comparison, Gadd45a null embryos develop exencephaly at an occurrence 
of 8.4% and p53 null embryos develop cranial NTDs with a frequency of 9.1% but no 
spinal NTDs (Patterson et al., 2006). Although the combinatorial loss of p21 and 
Gadd45a leads to NTDs, the genes do not seem to be co-expressed during 
neurulation: at all stages examined Gadd45a seems to be strongly expressed in the 
tips of the neural folds but not in the neural plate where p21 is expressed 
(Kaufmann et al., 2011). It is, however, not surprising that there seems to be some 
cooperation between Gadd45a and p21 since Gadd45a interacting proteins include 
cdc2/cyclinB1 and PCNA (reviewed by Kaufmann et al., 2011). The roles of p21, 
Gadd45a and p53 in neural tube closure are unknown. 
1.6.2 p27 
p27 was identified in 1994 as a p21 related protein that interacted with cyclin-CDK 
complexes (Polyak et al., 1994a; Polyak et al., 1994b; Toyoshima and Hunter, 1994). 
As opposed to p21 which has been reported to be expressed mainly in post-mitotic 
differentiated cells (Brugarolas et al., 1995; el-Deiry et al., 1993; Parker et al., 1995), 
p27 expression primarily increases in response to extracellular anti-proliferative 
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signals: p27 protein levels are high in non-proliferating cells, in cells grown to high 
density, in serum starved cells, as well as in cells treated with anti-mitogenic factors 
such as cAMP or rapamycin (Coats et al., 1996; Fero et al., 1996; Firpo et al., 1994; 
Kato et al., 1994; Nourse et al., 1994) suggesting that p27 might be an important 
element in pathways that connect mitogenic signals to the cell cycle at the 
restriction point in G1-phase. In G1-phase, p27 has been shown to bind to active 
cyclin E-CDK2 thereby preventing S-phase entry (Polyak et al., 1994b). Following re-
entry into the cell cycle, protein levels are rapidly downregulated (Coats et al., 
1996). Moreover, fibroblasts where p27 is blocked with antisense oligonucleotides 
fail to arrest at the G1-phase restriction point when mitogen starved (Coats et al., 
1996). 
During lens and pituitary development p27 expression is associated with the timing 
of cell cycle exit and differentiation as well as to prevent re-entry into the cell cycle 
of differentiated cells (Bilodeau et al., 2009; Zhang et al., 1998). In both the lens and 
the pituitary, differentiated cells re-enter the cell cycle in the absence of p27 
(Bilodeau et al., 2009; Zhang et al., 1998). As described in detail in Chapter 4, p27 
null mice are larger than wild-type littermates, highlighting the role for p27 in the 
regulation of cell proliferation and differentiation. 
1.6.3 p57 
p57 was identified in 1995 as a CIP/KIP gene with unique domain structure 
compared to p21 and p57 in addition to the CDK inhibitory amino-terminal domain 
(Lee et al., 1995; Matsuoka et al., 1995). p57 is a potent inhibitor of G1-phase CDKs 
and overexpression leads to G1-phase arrest (Lee et al., 1995; Matsuoka et al., 
1995). p57 expression during development is tissue restricted compared to p21 and 
p27, and is the only CIP/KIP gene that is required for embryogenesis (Lee et al., 
1995; Matsuoka et al., 1995). p57 is regulated at the transcriptional level by several 
factors that are critical during embryogenesis, including Notch/Hes1, MyoD, BMP2-
and -6, and p73 (Balint et al., 2002; Georgia et al., 2006; Gosselet et al., 2007; 
Vaccarello et al., 2006), possibly explaining the importance of p57 in development. 
In humans, p57 resides on chromosome 11p15 in an imprinted cluster that is 
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associated with development of Beckwidth-Wiedemann syndrome, a complex 
overgrowth syndrome with various developmental defects and tumour 
predisposition (Zhang et al., 1997). In the pituitary and lens, p57 is expressed in 
proliferating cells during development and seems to be important for cell cycle exit 
without affecting differentiation. Accordingly, cells proliferate inappropriately in the 
absence of p57 (Zhang et al., 1998).  
1.6.4 CIP/KIPs and regulation of the cytoskeleton 
All of the CIP/KIP genes have been implicated in cytoskeletal regulation and cell 
migration and have been associated with the ROCK/LIMK/Cofilin pathway which is 
important for cytoskeletal organisation through a net decrease in actin stress fibre 
formation and regulation of cell shape (Besson et al., 2004a). ROCK activates LIMK 
which then phosphorylates and inactivates cofilin to promote stress fibre formation 
(Etienne-Manneville and Hall, 2002). p27 binds RhoA thereby preventing interaction 
of RhoA with its activators, p21 binds Rho kinase (ROCK) 1 and 2 leading to a 
decrease in cofilin phosphorylation, and p57 binds to and targets LIM kinase from 
the cytoplasm to the nucleus, also resulting in decreased phosphorylation and 
inactivation of cofilin (Besson et al., 2004b; Lee and Helfman, 2004; Tanaka et al., 
2002; Yokoo et al., 2003). Further complicating the system, RhoA is implicated in 
cell cycle regulation, specifically by downregulating p21 and p27 in G1-phase (Olson 
et al., 1998; Weber et al., 1997). The CIP/KIP genes are all associated with 
tumorigenesis as is evident from the knock-out mouse models (Chapter 4). 
However, very rarely are the genes mutated in human cancers. It has been 
suggested that translocation of the genes to the cytoplasm, rather than 
mutagenesis, underlies the oncogenic role of the genes through cytoskeletal 
reorganisation (Besson et al., 2004a; Sherr and Roberts, 1999).  
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1.7 The INK4 family 
INK4 proteins are 15-19 kDa polypeptides, are approximately 40% homologous to 
one another, and each protein in the mouse is 90% homologous to its human 
protein counterpart (Malumbres and Barbacid, 2009). The gene family consists of 
p15INK4b, p16INK4a, p19ARF, p18INK4c and p19INK4d. The INK4a locus in both 
man and mouse is remarkable and gives rise to two genes encoding two distinct 
proteins that are immunologically and functionally unrelated, i.e. p16INK4a and 
p19ARF (Quelle et al., 1995; Stone et al., 1995). p16INK4a is encoded by exons 1α, 2 
and 3 while p19ARF is encoded by exon 1β, located 13 kb upstream of 1α, and by 
exon 2 though an alternative reading frame of exon 2 is used;  thereby the name 
ARF (Quelle et al., 1995; Stone et al., 1995). INK4 proteins, with the exception of 
p19ARF, specifically inhibit CDK4 and CDK6 with similar affinities in vitro (Hirai et al., 
1995; Zindy et al., 1997b). p19ARF does not bind CDKs but instead interacts with 
mdm2 and leads to cell cycle arrest by stabilising p53 and, interestingly, leading to 
p53-dependent p21 transcription (Kamijo et al., 1998; Pomerantz et al., 1998). The 
INK4 family members can all block cell cycle progression in G1 phase when 
expressed at high levels (Zindy et al., 1997b). p18INK4c and p19INK4d are the only 
genes in the family to be expressed in utero and are expressed differentially: 
p18INK4c is associated with proliferating and not differentiated neural cell 
populations while p19INK4d is expressed in both proliferating and differentiated 
cell populations (Zindy et al., 1997b). Low levels of p15INK4b and p19ARF transcript 
have been detected by RT-PCR in all postnatal tissues whereas p16INK4a is only 
detected in the adult mouse after 15 months (Hara et al., 1996; Serrano et al., 1996; 
Zindy et al., 1997a). 
INK4 proteins bind CDK4 and CDK6 directly regardless if they are bound to cyclin D 
or not. When they bind to a CDK-cyclin D complex their role is inhibitory towards 
the kinase whereas binding of INK4 proteins to CDK alone interferes with cyclin D-
CDK assembly (Hirai et al., 1995; Parry et al., 1995). p18INK4c and p19INK4d mutant 
mice develop an apparently normal central nervous system and show no overt 
phenotypic impairments at one year of age (Zindy et al., 1997b). 
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As introduced in section 1.3.3, cells of the MHP spend more time in S-phase than 
cells of the lateral neural plate, resulting in an increase in the proportion of cells 
with basal nuclei. The increase in cell cycle length coincides with MHP formation 
(McShane et al., 2015; Smith and Schoenwolf, 1987). The reason underlying the 
prolonged cell cycle in the MHP is unknown but could be due to cell cycle regulators 
that inhibit the cell cycle in late G1-phase or S-phase. In sections 1.6 and 1.7 two 
families of CDKIs were introduced that can inhibit the cell cycle at a relevant point 
of the cell cycle, i.e. when nuclei would be basal due to interkinetic nuclear 
migration. Of these two families, one CDKI, p21, has previously been shown to be 
expressed specifically in MHP cells during neurulation (Rita Carvalho, unpublished). 
The MHP expression of p21 led to the idea that CDKIs were responsible for the 
prolonged S-phase in MHP cells, and resulted in the current work on the role of 
CIP/KIP and INK4 cell cycle inhibitors on MHP formation.   
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1.8 Thesis aim and objectives 
This thesis aims to investigate the reason underlying the prolonged S-phase in MHP 
cells and to test the hypothesis that cyclin-dependent kinase inhibitors inhibit cells 
of the MHP in S-phase, thereby leading to a high proportion of cells with basal 
nuclei due to interruption of IKNM, causing crowding of midline cells and MHP 
formation (Figure 1.9).  
The thesis objectives are to: 1) Analyse the expression of CDKIs during neurulation 
with focus on the MHP. 2) Analyse the morphology of embryos lacking the CDKI, 
p21, and examine the possibility of redundancy between CIP/KIP genes in the MHP. 
3) Calculate S-phase length in the MHP and lateral neural plate in embryos with a 
null mutation in p21 and compare it to wild-type littermates. 4) Analyse MHP 
formation in electroporated embryos with high or low levels of CDKIs. 
 
 
Figure 1.9 – Hypothesis – Cyclin dependent kinase inhibitors prolong S-phase in the MHP 
During G1/S-phase transition, cyclin D-CDK4/6 complexes are inhibited by genes of the INK4 family 
and the CIP/KIP family of cyclin dependent kinase inhibitors. Furthermore, CIP/KIP genes inhibit 
cyclin E-CDK2 complexes important for G1/S-phase transition, and can in addition block progression 
through S-phase (reviewed by Besson et al., 2008). 
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Chapter 2 - Materials and methods 
2.1 Animals 
Mouse colonies were maintained by Dawn Savery at the Institute of Child Health 
animal facility, University College London. Animal rooms were kept at 22°C on a 12 
hours light/12 hours dark cycle. Females were kept in communal cages from the age 
of 6-8 weeks and males were kept separately. Standard pelleted food and water 
was accessible to the mice at all times. 
2.1.1 CD1 colony 
CD1 random-bred, wild-type mice (Charles River Laboratories International, Inc.) 
were maintained by the staff at the ICH animal facility. 
2.1.2 p21 and p21/p27  
p21-/- and p21+/-;  p27+/- mice were a gift from Dr. Marcos Malumbres (Cell Division 
and Cancer group, CNIO, Spanish National Cancer Research Centre) and have been 
previously described as follows. For p21, exons 2 and 3 were replaced with a pgk-
neo cassette (Figure 2.1) (Brugarolas et al., 1995). For p27 gene targeting, a neo 
cassette was inserted within exon 1, leading to an amino-truncated protein that 
does not inhibit cyclin-dependent kinases (Figure 2.2) (Kiyokawa et al., 1996). The 
mice were re-derived at the UCL transgenic services and bred onto a C57BL/6J 
background. p21 mice were maintained as a heterozygous colony and the p21/p27 
mice as a p21 homozygous; p27 heterozygous colony.  
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Figure 2.1 - p21 gene targeting 
The PCR primers for genotyping are indicated in red. Redrawn from (Brugarolas et al., 1995). 
 
 
Figure 2.2 - p27 gene targeting 
PCR primers for genotyping are indicated in red. Redrawn from (Kiyokawa et al., 1996). 
2.1.3 Shh 
Shh mice were from Prof. J.P.Martinez-Barbera (Developmental Biology of Birth 
Defects Section, Institute of Child Health, UCL) and were as described previously 
(Chiang et al., 1996). They were maintained as a heterozygous colony on a C57BL/6J 
background. 
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2.2 Mouse embryology 
2.2.1 Embryo collection and dissection 
Noon of the day a vaginal plug was found was designated E0.5. Pregnant females 
were culled by cervical dislocation and the uteri removed by laparotomy into warm 
(37˚C) dissecting medium: Dulbecco’s Modified Eagle’s Medium with 25 mM HEPES 
(DMEM, Invitrogen) supplemented with 10% inactivated foetal bovine serum (FBS, 
Invitrogen).  
The uterus was taken to a stereomicroscope (Zeiss SV6 or SV11), opened along the 
mesometrial side with two watchmaker’s forceps (number 5, Dumont) and the 
deciduas were gently removed from the uterine wall. The deciduas were opened 
from the antimesometrial base to expose the embryo which was gently removed, 
and Reichert’s membrane was carefully dissected away with the internally adherent 
parietal endoderm cells, taking great care not to damage the ectoplacental cone 
and yolk sac. If the embryos were not to be used for whole embryo culture, the yolk 
sac was removed, rinsed in ice-cold PBS, and kept at -20°C for genotyping. The 
embryos were dissected clear of all membranes, somites were counted and they 
were numbered for future reference. Embryos for in situ hybridisation were fixed in 
4% paraformaldehyde (PFA; 4% w/v in PBS-DEPC) overnight for 16-18 hours at 4°C, 
dehydrated to 100% methanol and stored at -20°C. Embryos for 
immunohistochemistry were fixed in 4% PFA in PBS on ice for 1 hour, dehydrated to 
70% ethanol and stored at 4°C. Alternatively, if the embryos were used for embryo 
culture, the yolk sac and ectoplacental cone were left intact. 
The length of the posterior neuropore was measured using an eyepiece graticule on 
a stereomicroscope. The length in graticule units was converted to mm: 1 graticule 
unit corresponded to 0.02 mm with the 5x objective which was used. 
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2.2.2 Whole embryo culture 
After dissection for culture, embryos were cultured in rat serum (0.3-0.5 ml per 
embryo) in 30 ml plastic culture tubes (Nunc) smeared with silicone grease (Borer 
Chemie) around the outer rim of the tube to create an airtight seal. The filtered rat 
serum was gassed with 5% O2 / 5% CO2 / 90% N2 for 1 minute and left to equilibrate 
for a minimum of 15 minutes at 37°C in a roller incubator (B.T.C Engineering) before 
the embryos were transferred to the serum using a plastic Pasteur pipette. The 
serum was then re-gassed with 5% O2 / 5% CO2 / 90% N2 for 1 minute, and re-
gassed every 8-14 hours. 
2.2.3 Rat serum preparation 
Blood serum was collected from adult male rats at UCL Biological Services. Animals 
were anaesthetised using isofluorane, and anaesthesia was confirmed by pinching 
one of the paws. The abdomen was surgically opened and, using a syringe, blood 
was withdrawn from the abdominal aorta until the animal had been exsanguinated. 
The blood was immediately centrifuged at room temperature (RT) for 5 minutes 
(10,000 x g) to separate the serum supernatant from the blood. Once the serum had 
coagulated, the clot was squeezed with flat forceps and the serum was transferred 
to fresh tubes and centrifuged at 4000 rpm at 4°C for 5 minutes to remove 
contaminating red blood cells. Any serum that remained pink in colour due to the 
presence of lysed red blood cells was discarded. The serum was pooled in fresh 
tubes, heat inactivated for 30 minutes at 56°C, chilled on ice, and aliquoted for 
storage at -20°C. Immediately prior to whole embryo culture, aliquots were thawed, 
warmed to 37°C and passed through a Millipore filter (0.45 μm pore size). 
2.2.4 Electroporation  
Following dissection for culture, E7.5 embryos (CD1 for overexpression, p21 for 
knock-down) were grouped by developmental stage (OB-LHF) according to the 
staging system described previously (Downs and Davies, 1993) and separated into 
equal treatment groups (Figure 2.3, A). For overexpression, all plasmids (Table 2.2) 
were at a concentration of 3.2 μg/μl in water (Sigma) and were mixed at a 1:1 ratio 
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for double or triple overexpression together with Fast Green at a final concentration 
of 0.01%. Alternatively, GFP control and Fast Green (0.01%) were injected for 
control groups. For siRNA knock-down, all stocks were 20 μM (Table 2.3). p57 or GC 
matched control siRNA was mixed with the fluorescent oligo at a 3:1 ratio. The 
fluorescent oligo has a red colour and Fast Green was not required for these 
experiments.  
 
Figure 2.3 - Electroporation of E7.5 embryos 
Embryos were divided into equal treatment groups (A), injected into the amniotic cavity (B; blue) 
and electroporated with the node (*) at the anode.  
Embryos were injected one by one into the amniotic cavity (Figure 2.3, B) with a 
handheld mouth pipetting tube attached to a glass micropipette needle pulled on a 
Flaming-Brown horizontal pipette puller (Sutter Instrument Co). Approximately 1 μl 
was injected per embryo and each embryo was immediately transferred to a 55 mm 
petri dish containing 1% agarose (w/v in DEPC-PBS) with DEPC-PBS, electroporated 
and transferred back to dissecting medium prior to injecting the next embryo. This 
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was done to limit the amount of solution that escaped from the amniotic cavity 
after injection, and to limit the time embryos spent in PBS. Embryos were 
electroporated between a pair of gold plated 5 mm point electrodes (BTX model 
508, Harvard Apparatus) attached to a BTX ECM 830 square wave electroporation 
system. Embryos were oriented as shown in Figure 2.3 with the node at the positive 
electrode so that nucleic acids enter cells in the node and the region around the 
node which give rise to the midline (Catala et al., 1996; Ybot-Gonzalez et al., 2007b). 
Once all embryos had been electroporated, they were transferred to equilibrated 
rat serum in culture tubes as described in Section 2.2.3. Electroporation settings 
were as follows: 
Mode LV 
Voltage 20 
Pulse length 50 ms 
Pulses 5 
Interval 950 ms 
Polarity unipolar 
Table 2.1- Electroporation settings 
Embryos at E7.5 were electroporated with these settings on the BTX ECM 830 electroporation 
system. LV, low voltage mode; ms, milliseconds. 
2.2.4.1 Plasmids and siRNAs  
The p27, p57 and GFP control expression plasmids were received from Dr DiCicco-
Bloom (Tury et al., 2011). They had been cloned into a modified pCIG vector 
(Megason and McMahon, 2002) containing an internal ribosomal entry site and the 
enhanced green fluorescent protein (EGFP) under the control of a chicken β-actin 
promoter and a cytomegalovirus immediate early enhancer (Tury et al., 2011). The 
p21 expression plasmid was from Addgene and had been deposited by Bert 
Vogelstein (el-Deiry et al., 1995). The p21 expression plasmid did not express GFP.  
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Gene Region Plasmid Reference 
pCMW35 p21 
(MGI:104556) 
All pBluescript SK (el-Deiry et al., 1995) 
p27 (NM_004064) 466-1062 bp pCIG2 (Tury et al., 2011) 
p57 (U20553) 41-1087 bp pCIG2 (Tury et al., 2011) 
GFP control  pCIG2 (Tury et al., 2011) 
Table 2.2 - plasmids used for overexpression studies 
The p21 plasmid was a gift from Bert Vogelstein (Addgene plasmid 16478). Other plasmids were 
received from Emanuel DiCicco-Bloom. 
The p57 siRNA was designed using the BLOCK-iTTM RNAi Designer on the Invitrogen 
website. The highest scoring siRNA (5 stars) was selected. Only the duplexes with 
the highest probability of success are provided in the designer tool search, with 5 
stars being the most likely to achieve high quality results. The p21 siRNA was 
designed according to the sequence provided by (Ishimura et al., 2012) and had 
been shown to reduce p21 levels by 80% in MEFs. The GC content of the p57 siRNA 
was 56% and was used with the matched Hi GC control, designed for siRNAs 
between 55 and 70%. The p21 siRNA had a GC content of 44% and the low GC 
control was used (35-45%). 
siRNA Sequence (RNA) Cat.No. 
p57 Stealth RNAiTM 
(NM_001161624) 
S, CCUCCAGCGAUACCUUCCCAGUGAU 
AS, AUCACUGGGAAGGUAUCGCUGGAGG 
 
- 
p21 Stealth RNAiTM 
(NM_007667) 
S, GCCUGACAGAUUUCUAUCACUCCAA 
AS, UUGGAGUGAUAGAAAUCUGUCAGGC 
- 
Stealth RNAiTM Negative 
Control Lo GC 
random, unknown 12935-200 
Stealth RNAiTM Negative 
Control Hi GC 
random, unknown 12935-400 
BLOCK-iT Alexa Fluor® 
Red Fluorescent Oligo 
- 14750-100 
Table 2.3 - siRNAs used in the knock-down studies 
All siRNAs were from Invitrogen at a concentration of 20 μM.  
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2.2.4.2 Post culture 
At the end of the culture, embryos were transferred to a petri dish in rat serum and 
rated according to heart beat and yolk sac circulation (Table 2.4). Embryos were 
then transferred to dissecting medium, dissected and, in p21 litters, yolk sacs were 
collected for genotyping. Somite number was counted and all embryos were 
imaged in PBS on a digital camera attached to a fluorescence stereomicroscope 
(Leica MZ FLIII). Embryos with a high rating (2 or 3; Table 2.4), a round healthy yolk 
sac and fluorescent midlines were processed for further analysis. Healthy looking 
young embryos with a strong heart beat and a healthy yolk sac were included in the 
absence of apparent circulation, as this was often difficult to find in the youngest 
embryos (5-6 somite stage). 
Rating Heart and circulation 
0 Dead. 
1 Weak heart beat and no circulation 
2 Good heart beat and weak circulation 
3 Very good heart beat and strong circulation 
Table 2.4 - Scoring system after embryo culture 
Embryos were rated according to heart beat and circulation. The appearance of the yolk sac was 
noted along with somite number. Embryos were imaged on an epifluorescence stereomicroscope 
with a digital camera. Embryos with a fluorescent midline and a rating of 2 or 3 with a healthy yolk 
sac were processed for further analysis.  
2.2.4.3 Midline dissection 
CD1 embryos at E7.5 were electroporated with the p57 siRNA or GC-matched 
control with the tagged fluorescent oligo and cultured for 24 hours. The midline 
isolation method was taught to me by Dr. Jean-Marie Delalande and was essentially 
as previously described (Delalande et al., 2015). In short, embryos with fluorescent 
midlines were briefly (2-3 minutes) digested in filtered (Millipore filter; 0.45 μm 
pore size) 2% Pancreatin (w/v in DEPC-PBS). After digestion, embryos were 
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transferred to dissecting medium with 10% FBS to inhibit enzymatic activity, and the 
midlines were dissected from the embryos using a tungsten needle, carefully 
removing all somites (Figure 6.14). The midlines were washed twice in DEPC-PBS 
and placed on dry ice. For each experiment, the midlines in each treatment group 
were pooled and stored at -80°C for RNA quantification. 
2.3 Cell transfection 
The cell transfection was done in duplicate plates, and four wells were used per 
treatment. 3T3 mouse fibroblasts were plated in a 24 well plate 18-20 hours prior to 
transfection at a density of 1x105 cells/well in DMEM supplemented with 10% FBS. 
This resulted in a confluency of approximately 60% at the time of transfection. 
Appropriate concentrations of plasmid and/or siRNA were diluted in OptiMEM at a 
volume of 50 µl per well and incubated at room temperature for 5 minutes. 
Lipofectamine 2000 (3 µl per well) was likewise diluted in 50 µl OptiMEM per well 
and incubated at room temperature for 5 minutes. The plasmid/siRNA-OptiMEM 
solution was combined with the Lipofectamine-OptiMEM solution and incubated at 
room temperature for 20 minutes. The medium of the 24 well plate was removed 
and 400 µl of fresh DMEM+10% FBS with 100 µl of the plasmid/siRNA-
Lipofectamine solution was added per well. Cells were incubated at 37°C and 5 
hours post-transfection the media was replaced by DMEM+10% FBS with 1% 
Pen/Strep antibiotics. At 24 hours post-transfection, RNA was extracted from one 
plate and the duplicate plate was stained with DAPI for estimation of transfection 
efficiency. 
2.3.1 Transfection efficiency 
The medium was removed from transfected cells and cells were washed once in 
PBS, fixed in 4% PFA for 5 minutes at RT, washed again in PBS and stained with DAPI 
(1:10,000 in PBS) for 3 minutes at RT. DAPI was removed, images were acquired on 
a digital camera attached to an epifluorescence inverted microscope (Olympus 
IX71), and the plate was stored in PBS, covered in foil, at 4°C. Cells were counted 
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manually in Image J and transfection efficiency was calculated as GFP-positive cells 
to total stained nuclei (DAPI). 
2.4 Quantitative reverse transcription PCR 
2.4.1 RNA extraction 
For the cell transfections, medium was aspirated, 1 ml TRIzol reagent (Invitrogen) 
was added to each well and the contents were pipetted up and down 10 times to 
lyse the cells. The lysed cells in TRIzol were added to an Eppendorf tube and 
incubated for 5 minutes at RT. For embryonic tissue, caudal and rostral tissue 
fragments stored at -80°C were pooled as specified in appropriate chapters. TRIzol 
(500 μl) was added to the first tissue sample in an Eppendorf tube on dry ice, 
pipetted up and down until the tissue had homogenised, transferred to the next 
tissue sample on dry ice, and so on. Once the samples had been pooled they were 
incubated for 5 minutes at RT. 
Chloroform was added to each sample (200 µl for cells, 100 μl for tissue) and the 
tubes were shaken vigorously for 15 seconds, followed by a 3 minute incubation at 
RT. The Trizol-Chloroform suspension was centrifuged at 12,000 x g for 15 minutes 
at 4°C and the top aqueous layer containing the RNA was transferred to a new tube. 
Samples were incubated in Isopropyl alcohol (500 μl for cells, 250 μl for tissue) for 
10 minutes at RT to precipitate the RNA, and centrifuged at 12000 x g for 10 
minutes at 4°C. The supernatant was poured off, and the pellet was washed with 
70% ethanol-DEPC-H2O (1 ml for cells, 500 μl for tissue), vortexed, and centrifuged 
again at 12,000 x g for 5 minutes at 4°C. The ethanol was poured off, the pellet was 
drained upside down, and left to airdry for 10 minutes. The semidry pellet was 
dissolved in DEPC-H2O (20 μl for cells, 10 μl for tissue) and put on ice. To remove 
DNA contamination, 1 µl RNAse inhibitor, 0.5 µl DNAse I, and 2.5 µl 10x DNAse 
buffer was added (DNA-free Kit, Ambion) and samples were incubated at 37°C for 
30 minutes. Inactivating buffer (2.5 µl) was added to stop the reaction and the RNA 
was incubated at room temperature for 2 minutes and spun at 10.000 rpm for 2 
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minutes before the supernatant was transferred to a fresh tube. The RNA was 
measured by spectrophotometry (NanoDrop 100; Thermo Scientific) and stored at -
80°C. 
2.4.2 Complementary (c) DNA synthesis 
First strand cDNA was synthesised using the Superscript VILO cDNA synthesis Kit 
(Applied Biosystems). RNA (300 ng) was added to RNAse free tubes on ice and 
DEPC-H2O was added to make up a volume of 14 μl. A mastermix was made (4 μl 5X 
VILO Reaction Mix and 2 μl 10X Superscript enzyme Mix per reaction) and 6 μl of 
the mastermix was added to each tube. The cDNA was synthesised in a thermal 
cycler with the following programme: 10 minutes at 25°C, 60 minutes at 42°C and 5 
minutes at 85°C. 
The quality of the cDNA was assessed by amplification in a standard PCR with 
primers against the house-keeping gene glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH). The standard PCR conditions are shown in Table 2.5 and 
the PCR programme in Table 2.6. The samples were subsequently run on an agarose 
gel to check for the correct size of GAPDH (177 bp). 
Reagent Volume (μl) 
10X Reaction buffer (Bioline) 3 
dNTPs (Promega) 1.5 
50 mM MgCl2 (Bioline) 0.7 
10 μM Primer-pair (Forward and reverse) 3 
5 U/μl Taq DNA polymerase (Bioline) 0.15 
H2O (Sigma) 20.65 
cDNA 1 
Final volume 30 μl 
Table 2.5 - Standard PCR reaction for checking cDNA with GADPH primers 
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Step Duration and temperature 
1. Heating 5 minutes, 94°C 
2. Denaturation 30 seconds, 94° 
3. Annealing 30 seconds, 60°C 
4. Extension 1 minute, 72°C 
5. Final extension 10 minutes, 72°C 
Table 2.6 - Standard running conditions for PCR 
Steps 2-4 were repeated 35 times. 
2.4.3 RNA quantification 
RNA quantification was performed on a BIO-RAD CFX96TM Real-Time System C1000 
TouchTM Thermal Cycler. 
2.4.3.1 Primers 
All primers were from Sigma and designed in NCBI Primer-BLAST to amplify 
between 150-250 bp of the target gene with an optimum temperature of 60°C. The 
primers were designed to span exons in order to avoid amplification of genomic 
DNA, and where applicable, detect all transcript variants. The primers used are 
listed in Table 2.7. β-actin was used as reference gene as GAPDH has been 
associated with cell cycle regulation, DNA replication, G1-phase arrest, and 
induction of p21 (Mansur et al., 1993; Phadke et al., 2009; Suzuki et al., 2000; Wang 
et al., 2013) while significantly fewer modulators of β-actin than GAPDH have been 
reported (Suzuki et al., 2000). In serum starved cells β-actin levels increase when 
growth factors are added but GAPDH levels rise even more (Suzuki et al., 2000). 
However, a link between β-actin and CIP/KIP genes cannot be excluded since β-actin 
is a major cytoskeletal structural protein and CIP/KIP genes are cytoskeletal 
regulators as described (section 1.6.4).  
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Primer Sequence Product size (bp) 
β-actin 
F: TCTTTTCCAGCCTTCCTTC 
R: ATCTCCTTCTGCATCCTGTC 
175 
GAPDH 
F: ATGACATCAAGAAGGTGGTG 
R: CATACCAGGAAATGAGCTTG 
177 
p57 (cdkn1c) 
F: TGCGGCCAATGCGAACGACT 
R: GCTGCCCAGATGCCCAGCAA 
202 
p27 (cdkn1b) 
F: TGGCGCAGGAGAGCCAGGAT 
R: CCAGCGTTCGGGGAACCGTC 
241 
p21 (cdkn1a) 
F: GCAGACCAGCCTGACAGATTT 
R: AAGACACACAGAGTGAGGGC 
154 
p15INK4b 
F: AGACTGCAAGCACGAAGAGG 
R: CGCGTCCTGAAAGGTAGAGG 
212 
p16INK4a 
F: ATGGGTCGCAGGTTCTTGG 
R: CGTGAACGTTGCCCATCATC 
215 
p19ARF 
F: CGAACTCGAGGAGAGCCATC 
R: TACGTGAACGTTGCCCATCA 
182 
p18INK4c 
F: CCTTCTGTCAGCCTCCGATG 
R: CAGCGCAGTTCTCCCAAATC 
232 
p19INK4d 
F: GCTCTGAGGCCGGCAAAT 
R: AAGCATAGTGGATACCGGTGG 
150 
Table 2.7 - Primers used for qRT-PCR 
F, forward; R, reverse. 
2.4.3.2 Sample preparation and thermal cycling 
Designated RNA pipettes, tip boxes and bench area were sprayed down with 
RNaseZAP (Sigma) before preparing 96 well qRT-PCR plates (BIO-RAD) on ice, taking 
great care not to contaminate equipment or area with DNA. The components listed 
in Table 2.8 were thawed at RT, mixed, briefly centrifuged and stored on ice 
protected from light. All the components except the cDNA were combined in a 
mastermix for each primer-pair. Each sample was analysed in triplicates for the 
target gene and the reference gene. cDNA was added to all wells followed by 19 μl 
of mastermix. Negative controls with mastermix and water instead of cDNA were 
included for each primer-pair. The plate was sealed with Microseal ‘B’ adhesive 
seals (BIO-RAD), briefly vortexed and centrifuged, and loaded onto the thermal 
cycler. The programme is shown in Table 2.9. Experiments were analysed using the 
Bio-Rad CFX Manager programme, version 3.1.  
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Reagent Final concentration Volume (μl) 
iTaq universal SYBR green supermix 
(BIO-RAD) 
1x 10 
Primer-pair 10 μM (F+R) (Invitrogen) 300-500 mM 2.4 
H2O (Sigma) - 6.6 
cDNA 300 ng/μl 100 ng – 100 fg 1 
Final volume - 20 
Table 2.8 - Reaction for gene quantification by qRT-PCR 
 
Step Duration and temperature 
1. Heating 3 minutes, 95°C 
2. Denaturation 10 seconds, 95°C 
3. Annealing and extension 30 seconds, 60°C 
4. Melt curve analysis 0.5 seconds 60°C and 5 seconds 95°C 
Table 2.9 - Programme for qRT-PCR 
Steps 2 and 3 were repeated 39 cycles.  
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2.5 Cell cycle analysis 
2.5.1 Injections 
For BrdU-pHH3 cell cycle analysis in CD1 mice, embryos were collected on ice at 
exactly 15, 30, 45, 60, 90 or 120 minutes after injection of 50 mg/kg BrdU intra- 
peritoneally (IP) into E8.5 pregnant mice. Embryos were collected into ice-cold 
DMEM supplemented with 10% heat-inactivated FBS, dissected in cold medium and 
fixed within 20 minutes of collection in 4% PFA. Cold medium was used to limit the 
extent of BrdU labelling that continued after embryo collection. 
For IdU/BrdU double labelling experiments, pregnant p21 mice at E8.5 were 
injected (IP) with IdU and BrdU (Table 2.10) at concentrations of 57.75 mg/kg (IdU) 
and 50 mg/kg (BrdU) to achieve equimolar amounts. IdU was injected at time 0 
followed by BrdU exactly 2 hours later. Precisely 15 minutes after the BrdU 
injection, embryos were collected as described above for CD1 embryos, and fixed 
within 20 minutes to reduce variability in IdU/BrdU uptake between litters. 
All embryos were fixed for 1 hour in 4% PFA on ice, yolk sacs were collected for 
genotyping (p21 embryos), and embryos were dehydrated to 70% ethanol and 
stored at 4°C. 
Thymidine 
analogue 
Dissolved in Concentration Supplier Cat.number 
BrdU PBS pH 7.4 50 mg/kg Sigma B5002 
IdU 1N NH4OH 57.75 mg/kg Sigma I7125 
Table 2.10 - Thymidine analogues used for cell cycle studies  
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2.5.2 Length of S-phase 
2.5.2.1 Experimental design 
As described above, p21 mice were injected with IdU and BrdU and embryos were 
collected and fixed. All embryos were genotyped and divided into two stage-
matched groups: Six p21-/- embryos and seven p21+/+ embryos. At this stage all the 
embryos were blinded and given new numbers (that were not made available to 
me) by another member of the laboratory. The embryos were subsequently paraffin 
embedded, sectioned, stained with antibodies, and all analysis (S-phase length, cell 
phase distribution, and nuclear position) was performed blinded. At the end, 
embryos were grouped by genotype for graphs and statistical analysis. 
2.5.2.2 Calculating S-phase length  
IdU and BrdU are incorporated into the DNA during S-phase of the cell-cycle. 
Therefore, the two hour interval between the injections results in some single 
labelled cells that have incorporated IdU but have left S-phase before the BrdU 
pulse. Other cells will have stayed in S-phase during both the IdU and BrdU pulse. 
Because the cells cycle asynchronously, the ratio of the number of cells in one 
phase (e.g. S-phase) in proportion to the number of cells in another phase (e.g. G2-
phase) is directly proportional to the ratio of the time between the two pulses (i.e. 
Ti) to the length of S-phase (Martynoga et al., 2005). Therefore, S-phase can be 
calculated by this formula: 
𝑆 = 𝑇𝑖 (2 ℎ𝑜𝑢𝑟𝑠)/ (
𝐿 𝑐𝑒𝑙𝑙𝑠 (𝑠𝑖𝑛𝑔𝑙𝑒 𝑙𝑎𝑏𝑒𝑙𝑙𝑒𝑑 (𝐼𝑑𝑈))
𝑆 𝑐𝑒𝑙𝑙𝑠 (𝑑𝑜𝑢𝑏𝑙𝑒 𝑙𝑎𝑏𝑒𝑙𝑙𝑒𝑑 (𝐼𝑑𝑈 𝑎𝑛𝑑 𝐵𝑟𝑑𝑈))
) 
where S is S-phase length, Ti is the interval between the injections, Lcells are cells 
labelled with IdU but not BrdU (i.e. have left S-phase during the experiment) and 
Scells are cells labelled with both IdU and BrdU (i.e. have been in S-phase throughout 
experiment). 
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The IdU and BrdU labelled cell populations were counted on imaged sections 
following immunohistochemistry with antibodies that detect IdU and BrdU, or only 
BrdU. A cell nucleus in the centre of the MHP was selected based on IdU/BrdU 
staining in the green channel and five nuclei were selected on either side of the 
centre nucleus to give a region of approximately 11 cells in the MHP (Figure 2.4, A; 
box 1.). Regions of approximately 11 nuclei were similarly selected in the left and 
right lateral neural plate regions based on IdU/BrdU staining, approximately 
halfway between the MHP and the surface ectoderm, taking care not to select 
nuclei in regions of bending (Figure 2.4, A; 2. and 3.). All IdU-positive nuclei in the 
regions selected were encircled manually in Image J in the green channel (Figure 
2.4, A). The circles were then observed in the red channel and any circle partially 
BrdU-positive was classified as being a double stained nucleus (Figure 2.4, B; single 
stained/double stained nuclei are indicated). The overall morphology of the neural 
plate is shown with a nuclear stain (Figure 2.4, C). The number of single and double 
stained nuclei was counted for each region on 5-13 slides per embryo, and S-phase 
was calculated from the average number of single and double labelled nuclei for 
each region (Appendix I). An example of calculation of S-phase length is shown for 
the section in Figure 2.4, D. The two lateral regions were averaged for the graphs, 
but the raw data (i.e. left and right lateral) was used for SEM and statistical analysis.  
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Figure 2.4 - Counting nuclei for S-phase calculation 
IdU/BrdU green positive nuclei were encircled in the MHP (A, 1.), the left lateral region (A, 2.) and in 
the right lateral region (A, 3.) The number of BrdU-positive nuclei was assessed in the red channel 
and the number of single labelled and double labelled nuclei was noted (B). Any nucleus partially 
positive was classified as double labelled. The numbers of single and double labelled nuclei was 
combined for all sections (5-13) per embryo to calculate S-phase length in each region. The overall 
morphology is shown in C. Example of S-phase length is shown for section example A-C (D). Scale 
bars = 30 μm. 
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2.5.3 Assigning cell cycle phases 
2.5.3.1 BrdU and pHH3 (CD1 embryos) 
As described in more detail in Section 5.2.2, BrdU and pHH3 immunohistochemistry 
was used as a tool to determine cell cycle phases in a population of cells, based on 
the distinct patterns of these during S-, G2-, and M-phase (Hendzel et al., 1997; 
Zhang et al., 2011). Cells assigned to early S-phase have a uniform BrdU pattern 
throughout the nucleus and no pHH3 staining. In late S-phase, the BrdU staining is 
more punctate and no pHH3 staining is observed. In G2 phase, BrdU and pHH3 are 
both observed in a punctate pattern; for BrdU, this pattern becomes more punctate 
as G2-phase proceeds, while pHH3 becomes more uniform. In mitosis, BrdU staining 
is very punctate and pHH3 is dense and bright (Figure 2.5, A-G and A’-G’) (Hendzel 
et al., 1997; Zhang et al., 2011). 
2.5.3.2 IdU and pHH3 (p21 embryos injected with IdU and BrdU) 
Sections from IdU/BrdU double labelled embryos were stained with an anti-IdU and 
anti-pHH3 antibody. IdU-positive nuclei were assigned to phases of the cell cycle in 
the same way as described above for BrdU and pHH3 in CD1 embryos. IdU was in 
the circulation for 2.25 hours and IdU-positive nuclei were found in S-, G2- and M-
phase of the cell cycle. 
2.5.3.3 BrdU pattern only (p21 embryos injected with IdU and BrdU) 
BrdU pattern was analysed in embryos from IdU and BrdU double injected p21 
mice. This analysis was done on immunofluorescence slides stained with anti-IdU 
and anti-BrdU and pHH3 was therefore not available. BrdU was in the circulation for 
only 15 minutes and BrdU-positive nuclei were grouped into early/mid S-phase 
(Figure 2.5, H) or late S-, G2-phase (Figure 2.5, I) based on similarity with the BrdU 
staining in Figure 2.5, A-G where the phases were revealed by pHH3 staining (Figure 
2.5, A’-G’). 
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Figure 2.5 - Distinct staining patterns associated with cell cycle phases 
BrdU (and IdU) and pHH3 have distinct staining patterns during S-, G2-, and M-phase of the cell cycle that was used to assign cells to different phases of the cell cycle (A-G 
and A’-G’) (Hendzel et al., 1997; Zhang et al., 2011). A-G and A’-G’ is the same nucleus viewed in two different channels. The cell cycle analysis that was done with BrdU 
pattern alone (Section 5.2.6) distinguished between two types of patterns: the distinct early/mid S-phase pattern that is homogenous (H) and similar to (A) which does not 
have any pHH3 staining (A’). The second type is late S-G2 phase (I) which is similar to the BrdU pattern observed in B-E. 
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2.5.4 Nuclear position measurements 
Neuroepithelial cell shape is associated with the position of the nucleus along the 
apico-basal axis. That is, a cell with a basal nucleus is widest at the base (wedge 
shaped). In order to assess whether loss of p21 led to fewer wedge shaped cells, the 
distance of nuclei from the basal surface was measured (Figure 2.6). The basal 
distance of nuclei is an indirect measure of how wedge shaped a cell is. A region of 
at least 10 cells was chosen in the MHP (the centre nucleus and 5 nuclei on each 
side) and in the two lateral regions, and all IdU- (for IdU nuclear position) or BrdU-
positive (for BrdU nuclear position) cells in that region were manually encircled. A 
macro in Image J, made by Bertrand Vernay, found the centre of the nucleus, and a 
line was drawn from the centre to the base of the neuroepithelium in the blue DAPI 
channel. The total thickness of the neuroepithelium was measured at the level of 
each nucleus, and basal distance was calculated: 
𝐵𝑎𝑠𝑎𝑙 𝑛𝑢𝑐𝑙𝑒𝑎𝑟 𝑝𝑜𝑠𝑖𝑡𝑖𝑜𝑛 =  
𝐵𝑎𝑠𝑎𝑙 𝑑𝑖𝑠𝑡𝑎𝑛𝑐𝑒 𝑓𝑟𝑜𝑚 𝑐𝑒𝑛𝑡𝑟𝑒 𝑜𝑓 𝑛𝑢𝑐𝑙𝑒𝑢𝑠
𝑁𝑒𝑢𝑟𝑜𝑒𝑝𝑖𝑡ℎ𝑒𝑙𝑖𝑎𝑙 𝑡ℎ𝑖𝑐𝑘𝑛𝑒𝑠𝑠
 
An example of a data sheet is shown in Appendix II. 
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Figure 2.6 - Measuring nuclear position 
From manually drawn circles (as shown in Figure 2.4), a macro in Image J was created by Bertrand 
Vernay to find the centre of the nuclei. A line was then manually drawn in Image J from the centre of 
the nucleus (A) to the basal surface of the neuroepithelium in the blue DAPI channel (B). The total 
distance of the neuroepithelium was measured at the level of each nucleus (C) and nuclear position 
was calculated as basal distance/total distance. Each nucleus has a number for future reference. 
Scale bars = 30 μm. 
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2.6 Histology 
2.6.1 Wax embedding 
PFA fixed embryos in 70% ethanol were washed twice for 30 minutes in 100% 
ethanol at RT, followed by two 15 minute washes in Histo-Clear (National 
Diagnostics) at RT in individual glass embedding moulds (Agar Scientific).The first 
Histo-Clear wash was at RT and the second at 60°C in an embedding oven 
(ThermoScientific). Histo-Clear was replaced with molten paraffin wax and embryos 
were incubated at 60°C for 2 hours with exchange of wax every 30 minutes. The 
embryos were arranged in the appropriate position with heated forceps under a 
stereomicroscope and left to set overnight at RT. 
2.6.2 Microtome sectioning 
Wax blocks were placed at -20°C for 20-30 minutes to loosen the wax from the glass 
mould. The blocks were cut to size and mounted onto wooden cubes using molten 
paraffin wax. Sections were cut at 5 μm on a microtome (Thermo Scientific) in serial 
sections (sets of 4) that were subsequently placed on SuperFrost Plus slides that 
were covered in Milli-Q water. Once the sections had flattened out, the water was 
removed and the sections were left to dry overnight at 37°C. 
2.6.3 Gelatin/albumin embedding 
Embryos that had been processed for in situ hybridisation were embedded in 
gelatin/albumin for vibratome sectioning. Gelatin (45% w/v; Sigma, type A) was 
dissolved in heated PBS and bovine albumin (27.3% w/v; Sigma) was added once 
the solution had cooled down to RT. Aliquots were stored at -20°C and thawed 
immediately prior to use. Whole mount in situ embryos stored in PBT were allowed 
to submerge in gelatin/albumin at 4°C. Small plastic moulds (capacity of ~330 μl) 
were filled up with gelatin/albumin and glutaraldehyde (2.3% v/v) was mixed in very 
rapidly. Embryos were added to the mix (one per mould), oriented, and the block 
was left to set for an hour. The solid gelatin/albumin block was stored in PBS at 4°C. 
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2.6.4 Vibratome sectioning 
The mould was attached to the specimen disc of the vibratome (Leica) with super 
glue. The tray was filled with PBS and the specimen disc was secured. Sections were 
cut at 40 μm and placed on SuperFrost Plus slides in order, going from rostral to 
caudal or vice versa. The sections were mounted in 50% glycerol (v/v in Milli-Q 
water) with glass cover slides (#1.5, Thermo Scientific) which were sealed with nail 
varnish. Sections were stored at 4°C and images were acquired on a AxioCam HRc 
camera (Zeiss) attached to a compound microscope (Zeiss). 
2.7 Whole mount in situ hybridisation 
2.7.1 Plasmid DNA templates 
Plasmid DNA templates for in situ hybridisation RNA probes are listed in Table 2.11. 
The p27 probe was cloned in the laboratory with following primer sequences: 
Forward: GCCCCTGGAGGGCAGATACGA, Reverse: CAGCCCAGATGGGGTGTCAGTTT. 
The INK4 probes were distributed to us by Prof. Andreas Kispert (Institut fur 
Molekularbiologie, Medizinische Hochschule Hannover, Germany) with permission 
from Prof. Charles Sherr (Tumor Cell Biology, St. Jude Children’s Research Hospital, 
US). 
2.7.2 RNA probe preparation 
Competent DH5α cells were transformed with the plasmid DNA templates 
according to standard protocols and plated on LB agar (Invitrogen) plates containing 
50 μg/ml ampicillin (Sigma). Negative control plates with competent cells but no 
plasmid were included in each experiment. Colonies were picked from the plates 
and bacterial cultures were grown in 15 ml falcon tubes containing 8 ml LB broth 
+ampicillin and incubated shaking at 37°C overnight. Bacterial cultures were spun 
down at 4,600 rpm for 20 minutes at 4°C and plasmid DNA was purified using a mini 
prep kit (Qiagen) according to manufacturer’s protocol (QIAprep spin Miniprep Kit 
using a microcentrifuge). All plasmids except p21 were sequenced for verification 
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and then linearised, purified and transcribed in a reaction containing DIG labelling 
mix (Roche) using the restriction enzymes (RE) and RNA polymerases listed in Table 
2.11. The transcribed probe was purified in a Chroma Spin-100 DEPC-H2O column 
(Clontech) and 40 μl formamide and 1 μl RNAse inhibitor was added to the 
approximately 50 μl of DIG-labelled, single stranded RNA probe. Probes were stored 
at -20°C. 
2.7.3 In situ hybridisation 
2.7.3.1 Tissue pre-treatment and hybridisation 
All steps were performed for 20 minutes shaking on ice unless otherwise stated. All 
solutions prior to hybridisation were DEPC treated to prevent degradation of RNA 
by RNAses. 
Embryos were rehydrated from 100% methanol in a series of methanol – PBT 
washes (75%-50%-25%) followed by two PBT washes. Embryos were bleached in 6% 
hydrogen peroxide (30% stock solution, Sigma) in PBT for 1 hour followed by three 
10 minute PBT washes, treated with proteinase K (5 µg/ml in PBT) for 1 minute 
(E7.5-8) or 1.5 minutes (E8.5) at RT to aid entry of the probe into the tissues, 
followed by 1 minute in glycine (2 mg/ml in PBT) at RT to inactivate proteinase K. 
Embryos were rinsed once in PBT, fixed for 20 minutes in 0.2% v/v glutaraldehyde 
(25% stock) in 4% PFA, and washed twice for 10 minutes in PBT. The embryos were 
transferred to 1 ml of pre-hybridisation mix (50% Formamide, 5xSSC pH 4.5, 50 
µg/ml yeast RNA, 1% SDS, 50 µg/ml heparin in DEPC-H2O) pre-heated to 70˚C and 
incubated for 2 hours. DIG labelled RNA probes were added (approximately 1 µg/ml 
final volume) and the embryos were hybridised at 70˚C overnight in an HB-1000 
Hybridizer oven (UVP). 
2.7.3.2 Post-hybridisation and immunohistochemistry 
On the following day, embryos were transferred to solution I (50% formamide, 5x 
SSC pH 4.5, 1% SDS in ddH2O) for a quick wash and then washed twice for 20 
minutes at 70˚C in solution I, followed by two 20 minute washes in solution II (50% 
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formamide, 2x SSC pH 4.5, 1% SDS in ddH2O) at 65˚C. Embryos were taken to RT and 
washed three times for 10 minutes in Tris-buffered saline containing Tween-20 
(TBST; 140 mM NaCl, 2.7 mM KCl, 25 mM Tris-HCl (pH 7.5), 2 mM tetramisole 
hydrochloride, 1% (v/v) Tween-20) followed by blocking at RT in 10% heat 
inactivated sheep serum (HI-SS) in TBST for at least 1 hour to block unspecific 
antibody binding sites. Embryos were incubated in 1:2000 alkaline phosphatase-
conjugated sheep anti-DIG Fab fragments (AP-anti-DIG, Roche) in 1% HI-SS at 4˚C 
shaking overnight. 
2.7.3.3 Post-antibody washes and development 
Unbound antibody was washed off in TBST (3 x 5 minutes RT, 5 x 1 hour RT) and left 
washing in TBST shaking overnight at 4˚C. For developing, embryos were washed 
three times for 10 minutes in NTMT (100 mM NaCl, 100 mM Tris-HCl pH 9.5, 50 mM 
MgCl2, 1% Tween-20) and the colour was developed using a reaction for the 
colorimetric detection of alkaline phosphatase activity with 4.5 μl/ml nitro blue 
tetrazolium chloride (NBT, Roche) and 3.5 μl/ml 5-bromo-4-chloro-3-indolyl 
phosphate (BCIP, Roche) in NTMT at RT. Alkaline phosphatase catalyses the 
hydrolysis of BCIP generating a compound that is oxidised by NBT to produce an 
insoluble, blue precipitate. To stop development, embryos were washed three 
times in PBT, post fixed for 1 hour in 4% PFA at RT, washed again in PBT and stored 
in PBT at 4°C until embedded in gelatin/albumin for vibratome sectioning. 
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Probe Vector Insert size (bp) 
RE and RNA 
polymerase AS probe 
RE and RNA 
polymerase S probe 
Source Reference 
p21 pGEM®-T Easy 612 NCoI, SP6 SaII, T7 A.Hoshino - 
p27 pGEM®-T Easy 446 NsiI, T7 NcoI, SP6 new - 
p57 unknown 668 Not linearised, T3 Not linearised SP6 A.Suzuki-Hirano 
(Suzuki-Hirano et 
al., 2011) 
Shh pBluescript SK (-) 640 HindIII, T3 PstI, T7 N.D.E.Greene 
(Greene et al., 
1998) 
Brachyury M13 1660 SacII, T7 - R.Beddington 
(Wilkinson et al., 
1990) 
p15INK4b pBluescript KS (-) 1300 SpeI, T3 - C.Sherr 
(Ludtke et al., 
2009) 
p16INK4a/ 
p19ARF 
pBluescript KS 
(+) 
1100 NaeI, T3 SalI, T7 C.Sherr 
(Ludtke et al., 
2009) 
p18INK4c pBluescript SK 510 NotI, T7 SalI, T3 C.Sherr 
(Ludtke et al., 
2009) 
p19INK4d pBluescript SK 500 NotI, T7 SalI, T3 C.Sherr 
(Ludtke et al., 
2009) 
Table 2.11 - Plasmid DNA templates for in situ hybridisation RNA probes 
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2.8 Immunofluorescence on tissue sections 
All protocols were performed on 5 μm paraffin sections and imaged with 
epifluorescence on an inverted LSM710 confocal system mounted onto an Axio 
Observer Z1 microscope (Carl Zeiss Ltd, UK). The Alexa-488 secondary antibodies 
were excited by a 488 nm line of Argon laser and the Alexa-568 by a 561 nm diode 
laser. Z-stacks, counting, measurements, and image processing (brightness and 
contrast only) were done in Image J. 
All steps were performed shaking at RT in plastic troughs with a capacity of 200 ml 
unless otherwise stated. For the DAPI-, PFA fixation-, antigen blocking-, and 
antibody incubation steps, slides were laid out horizontal in a humidified chamber 
with tissue soaked in MilliQ-water. 
2.8.1 IdU and BrdU 
2.8.1.1 De-waxing, rehydration and antigen retrieval 
Paraffin was removed in two 5 minute washes in Histo-Clear (National Diagnostics) 
and rehydrated in a series of 5 minute ethanol washes (2x 100%, 90%, 80%, 70%, 
50% and 25% in MilliQ-water) followed by 5 minutes under running dH2O water. 
Antigen unmasking was achieved by boiling the slides in 0.01 M citric acid buffer in 
MilliQ-water (adjusted to pH 6.0 with NaOH) for 8 minutes in a 1000 W microwave 
at the highest setting. Slides were allowed to cool at RT for at least 30 minutes and 
were then washed 4x 10 minutes in PBS with 0.1% Triton.  
2.8.1.2 Pre-fixation 
Nuclei were stained with 4′,6-diamidino-2-phenylindole (DAPI) 1:10,000 in PBS for 3 
minutes (1 ml per slide) prior to DNA denaturation as DAPI binds single stranded 
DNA very poorly. Slides were washed four times in PBS for 5 minutes and fixed in 
freshly made 4% PFA (w/v in PBS) for 50 minutes at RT (500 μl per slide, covered by 
Parafilm) to fix DAPI.  
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2.8.1.3 Post-fixation 
Slides were washed twice in PBS and the DNA was denatured in 0.1 M HCl for 30 
minutes at RT followed by a 2 M HCl solution for 30 minutes at 37°C. The slides 
were neutralised in 0.1 M Sodium borate buffer pH 8.5 for 10 minutes at RT and 
washed twice in PBS for 5 minutes. The slides were blocked in 10% heat inactivated 
sheep serum (HI-SS) in blocking buffer (0.2% BSA, 0.15% glycine and 0.1% triton in 
PBS) for at least 1 hour at RT (300 μl per slide + Parafilm). The blocking solution was 
replaced by mouse anti-IdU/BrdU and rat anti-BrdU at a 1:100 dilution in 10% HI-SS 
in blocking buffer (200 μl per slide + Parafilm) and incubated at 4°C overnight.  
Following day slides were washed three times in PBS + 0.1% triton and incubated in 
secondary antibodies: anti-mouse Alexa-488 and anti-rat Alexa 568 at a 1:200 
dilution in 10% HI-SS in blocking buffer (200 μl per slide + Parafilm) for 1 hour at RT. 
Slides were washed three times in PBS + 0.1% triton and mounted in Mowiol 4-88 
mounting medium (Sigma; prepared with glycerol and 0.2 M Tris-HCl pH 6.8). 
2.8.1.4 IdU and pHH3 
Slides were de-waxed, rehydrated and antigens were unmasked exactly as 
described above (Section 2.8.1.1). Subsequently, slides were blocked in 10% HI-SS in 
blocking buffer for 1 hour at RT (300 μl per slide + Parafilm) and then incubated 
with rabbit anti-pHH3 (1:250) in 5% HI-SS in blocking buffer for 1 hour at RT. Slides 
were washed three times for 10 minutes in PBS + 0.1% triton and incubated with 
anti-rabbit Alexa-568 secondary antibody (1:500) in 10% HI-SS in blocking buffer for 
1 hour at RT (200 μl per slide + Parafilm). The antibody was washed off in three 10 
minute PBS + 0.1% triton washes, incubated with DAPI 1:10,000 for 3 minutes at RT, 
washed 3 times with PBS + 0.1% triton and fixed in fresh 4% PFA for 50 minutes at 
RT. The rest of the protocol was exactly as described above for IdU (Section 2.8.1.3), 
excluding the primary rat anti-BrdU antibody and the secondary anti-rat Alexa-568 
antibody. 
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2.8.1.5 GFP (overexpressing slides) 
De-waxing, rehydration and antigen retrieval were as described in Section 2.8.1.1. 
Sections were blocked in 10% HI-SS in blocking buffer for at least 1 hour at RT and 
incubated with chick anti-GFP primary antibody (1:300) in 5% HI-SS in blocking 
buffer at 4°C overnight. 
The following day, slides were washed 3 x 10 minutes in PBS + 0.1% triton and 
incubated with anti-chick Alexa-488 secondary antibody (1:500) in 5% HI-SS in 
blocking buffer for 1 hour at RT. Slides were then washed 4 x 10 minutes in PBS + 
0.1% triton, incubated with DAPI 1:10,000 for 3 minutes at RT, washed twice in PBS 
and mounted in Mowiol. 
2.8.1.6 β-catenin (knock-down slides) and p21 
Sections were de-waxed with two Histo-Clear washes (10 minutes) and rehydrated 
in a series of washes of decreasing ethanol concentrations (2 x 100%, 90%, 80%, 
70%, 60%, 50% and 25%) followed by 5 minutes under running dH2O. Antigens were 
retrieved by adding slides to cold 1 x Declere solution (Cell Marque) in a plastic 
trough and boiling 60 minutes in a kitchen steamer. After the first 30 minutes the 
slides were transferred to a new trough with fresh, heated Declere. Sections were 
allowed to cool at RT for at least 30 minutes, washed three times with PBS + 0.1% 
triton, and blocked with 5% HI-SS in blocking buffer for at least 1 hour. Slides were 
incubated with rabbit anti-β-catenin (1:500) or mouse anti-p21 (1:100) in 5% HI-SS 
in blocking buffer overnight at 4°C. Slides were washed three times in PBS + 0.1% 
triton, incubated 1 hour in anti-rabbit Alexa-488 for β-catenin (1:500), or anti-
mouse biotin for p21 (1:250) in 5% HI-SS in blocking buffer. β-catenin slides were 
washed three times in PBS + 0.1% triton, stained with DAPI 1:10,000 for 3 minutes, 
washed in PBS and mounted in Mowiol. p21 slides were incubated for 1 hour in 
Streptavidin-555 (1:300) in 5% HI-SS in blocking buffer before the final washes, DAPI 
staining, and mounting. 
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2.8.1.7 Antibodies 
Target Raised in Dilution Supplier Cat.No. 
Anti-phospho Histone H3 
(Ser10), Mitosis marker 
Rabbit 
(polyclonal) 
1:500 Millipore 06-570 
BrdU (not IdU) 
[BU1/75 (ICR1)] 
Rat 
(monoclonal) 
1:100 abcam Ab6326 
BrdU (and IdU) clone B44 
Mouse 
(monoclonal) 
1:100 
BD 
Biosciences 
347583 
p21 (F-5) 
Mouse 
(monoclonal) 
1:100 Santa Cruz sc-6246 
p27 (Kip1) 
Mouse 
(monoclonal) 
1:200 
BD 
Transd.lab. 
610241 
p57 (Kip2) 
Rabbit 
(polyclonal) 
1:250 abcam ab4058 
GFP 
Chicken 
(polyclonal) 
1:300 abcam ab13970 
β-catenin 
Rabbit 
(polyclonal) 
1:500 abcam ab16051 
Table 2.12 - Primary antibodies 
 
Target Raised in Conjugate Dilution Supplier Cat.No. 
Rat IgG 
(H+L) 
Goat 
Alexa Fluor 
568 
1:200 
Thermo 
Fischer 
Scientific 
A-11077 
Mouse IgG 
(H+L) 
Goat 
Alexa Fluor 
488 
1:200 
Th rmo 
Fisher 
Scientific 
A-11001 
Mouse IgG 
(H+L) 
Goat 
Alexa Fluor 
568 
1:500 
Thermo 
Fisher 
A-11004 
Rabbit IgG 
(H+L) 
Goat 
Alexa Fluor 
568 
1:500 
Thermo 
Fisher 
A-11011 
Rabbit IgG 
(H+L) 
Goat 
Alexa Fluor 
488 
1:500 
Thermo 
Fisher 
A-11008 
Chicken 
(H+L) 
Goat 
Alexa Fluor 
488 
1:500 
Thermo 
Fisher 
A-11039 
Table 2.13 - Secondary antibodies for immunofluorescence 
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2.9 Genotyping 
Ear clips and yolk sacs were genotyped by polymerase chain reaction (PCR) 
amplification of DNA. The DNA was extracted using DNA lysis buffer (Invitrogen) 
with 0.5 mg/ml added proteinase K. PCR reagents, primers and programmes are 
shown in the tables below for p21, p27 and Shh genotypes. 
2.9.1 p21 genotyping 
Reagent Volume (μl) 
10X Reaction buffer (Bioline) 2 
dNTPs (Promega) 2 
50 mM MgCl2 (Bioline) 0.6 
40 μM Primer (Forward, Reverse and Neo) 3 x 0.12 
5 U/μl Taq DNA polymerase (Bioline) 0.2 
H2O (Sigma) 13.84 
DNA 1 
Final volume 20 
F primer: ACCCAGCAAAGCCTTGATTCT 
R primer: CAGGTCGGACATCACCAGGAT 
Neo primer: CCTTCTATCGCCTTCTTGACGA 
 
 
Table 2.14 - p21 PCR reaction 
Product size: p21 wt 760 bp, p21 KO 600 bp. 
Step Duration and temperature 
1. Heating 5 minutes, 94°C 
2. Denaturation 1 minute, 94° 
3. Annealing 1 minute, 60°C 
4. Extension 90 seconds, 72°C 
5. Final extension 10 minutes, 72°C 
Table 2.15 - PCR programme for p21 genotyping 
Steps 2-4 were repeated 35 times. 
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2.9.2 p27 genotyping 
2.9.2.1 p27 wild-type PCR 
Reagent Volume (μl) 
10X Reaction buffer (Bioline) 2.5 
dNTPs (Promega) 2.5 
50 mM MgCl2 (Bioline) 0.5 
Betaine 5 M 2.5 
40 μM Primer pair (Forward and Reverse) 0.5 
5 U/μl Taq DNA polymerase (Bioline) 0.2 
H2O (Sigma) 15.3 
DNA 1 
Final volume 25 
F primer: GATGGACGCCAGACAAGC 
R primer: CTCCTGCCACTCGTATCT 
 
 
Table 2.16 - p27 wt PCR reagents 
PCR product size: 190 bp. 
Step Duration and temperature 
1. Heating 5 minutes, 95°C 
2. Denaturation 30 seconds, 95° 
3. Annealing 30 seconds, 55°C 
4. Extension 45 seconds, 72°C 
5. Final extension 10 minutes, 72°C 
Table 2.17 - p27 wt PCR programme 
Steps 2-4 were repeated 40 times.  
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2.9.2.2 p27 knock-out PCR 
Reagent Volume (μl) 
10X Reaction buffer (Bioline) 2.5 
dNTPs (Promega) 2.5 
50 mM MgCl2 (Bioline) 0.75 
Betaine 5 M 2.5 
40 μM Primer pair (Forward and Reverse) 0.5 
5 U/μl Taq DNA polymerase (Bioline) 0.2 
H2O (Sigma) 15.05 
DNA 1 
Final volume 25 
F primer: TGGAACCCTGTGCCATCTCTAT 
R primer: CCTTCTATCGCCTTCTTGACG 
 
 
Table 2.18 - p27 knock-out PCR reagents 
Primers detect the Neo insert. PCR product size: 600 bp. 
Step Duration and temperature 
1. Heating 5 minutes, 95°C 
2. Denaturation 1 minute, 95° 
3. Annealing 1 minute, 57°C 
4. Extension 90 seconds, 72°C 
5. Final extension 10 minutes, 72°C 
Table 2.19 - p27 knock-out PCR programme 
Steps 2-4 were repeated 40 cycles.  
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2.9.3 Shh genotyping 
Reagent Volume (μl) 
10X Reaction buffer (Bioline) 2 
dNTPs (Promega) 2 
50 mM MgCl2 (Bioline) 0.6 
25 μM Primer pair Neo or wt (F+R) 2 
5 U/μl Taq DNA polymerase (Bioline) 0.2 
H2O (Sigma) 12.2 
DNA 1 
Final volume 20 
F primer: TGGAACCCTGTGCCATCTCTAT 
R primer: CCTTCTATCGCCTTCTTGACG 
 
 
Table 2.20 - Shh PCR reaction 
The Neo primer pair detects the Neo/deleted allele and produces a 500 bp product. The wild-type 
primer pair detects the floxed (550 bp) and the wildtype allele (500 bp). 
Step Duration and temperature 
1. Heating 2 minutes, 94°C 
2. Denaturation 30 seconds, 94° 
3. Annealing 30 seconds, 60°C 
4. Extension 45 seconds, 72°C 
5. Final extension 5 minutes, 72°C 
Table 2.21 - Shh Neo PCR programme 
Steps 2-4 were repeated 33 cycles.  
  
83 
 
Step Duration and temperature 
1. Heating 5 minutes, 95°C 
2. Denaturation 1 minute, 95° 
3. Annealing 1 minute, 70°C 
4. Extension 1 minute, 72°C 
5. Final extension 8 minutes, 72°C 
Table 2.22 - Shh wt/floxed PCR programme 
Steps 2-4 were repeated 35 cycles. 
2.9.4 Agarose gel electrophoresis 
PCR products were assayed by agarose gel electrophoresis. The size of the products 
was compared to molecular weight markers (Bioline Hyperladders). Ladder V was 
loaded alongside samples with expected PCR products between 25 and 500 bp, and 
ladder I was used for products between 200-10,000 bp. Gel concentrations were 2-
4% w/v agarose in TAE buffer (40 mM Tris acetate and 1 mM EDTA in water). 
Ethidium bromide was added to the molten agarose to label the DNA. Samples were 
loaded with loading dye made with Orange G for colour (50% glycerol and 50% 1xTE 
buffer [10 mM Tris EDTA pH 8]). 
2.10 Statistical analysis 
Statistical tests were performed in SigmaStat version 3.5. The student’s t-test was 
used to compare a single parameter between two groups, One way ANOVA was 
used to compare one parameter between more than two groups, and a Two way 
ANOVA was used to compare two parameters between more than two groups.  
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Chapter 3 - CIP/KIPs are expressed in the MHP 
3.1 Introduction 
As introduced in Section 1.3.3, it is thought that basal expansion of cells of the 
midline is responsible for cell shape changes and MHP formation. This basal 
expansion could be accounted for by changes in the cell cycle through IKNM, as 
keeping the nuclei at the base of the neuroepithelium would generate wedge 
shaped cells. Indeed, the cell cycle of MHP cells has been shown to be longer than 
that of lateral cells (Langman et al., 1966; McShane et al., 2015; Smith and 
Schoenwolf, 1987; Smith and Schoenwolf, 1988). In this chapter I examine the 
expression in wild-type (CD1) mice of negative regulators of the cell cycle, the 
cyclin-dependent kinase inhibitor (CDKI) families: CIP/KIP and INK4. CDKIs in general 
can inhibit transition from G1- to S-phase, thereby potentially keeping the nuclei 
basal. The CIP/KIP family has roles beyond G1- to S-phase transition and can halt the 
cell cycle in S-phase as well as interrupt S- to G2-phase transition and entry into 
mitosis (Section 1.6).  
Previous work conducted in our laboratory identified the CDKI, p21, as being 
expressed specifically in the MHP. This finding pointed to p21 and the CIP/KIP family 
as candidates for cell cycle regulation in the MHP, and provided the impetus for the 
present study. 
3.1.1 CIP/KIP expression 
In the literature, p21 expression has been reported from E8.25 in whole embryos by 
qRT-PCR (Ishimura et al., 2012). In situ hybridisation revealed p21 expression along 
the midline of the neural tube, hindgut and dermamyotome of somites at E8.5 
(Parker et al., 1995). By E10, p21 is expressed in muscle cells of the myotome and, 
at E13 to E15 p21 is expressed in the nasal epithelium, tongue muscles, hair 
follicles, the outermost embryonic epidermis, and in the cartilage; sites that all, with 
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the exception of cartilage, contain post-mitotic, differentiated cells (Matsuoka et al., 
1995; Parker et al., 1995).  
p21 has been reported to be expressed primarily in post-mitotic differentiated cells 
(Brugarolas et al., 1995; el-Deiry et al., 1993; Parker et al., 1995). The fact that p21 
mice develop normally does however suggest that the role in terminal 
differentiation must be redundant. Indeed, analysis of the induction of p21 in 
differentiating myoblasts has shown that p21 induction occurs at a late stage of 
differentiation after DNA synthesis has stopped, suggesting a role in maintenance of 
differentiation rather than a role in differentiation itself (Deng et al., 1995).  
During mouse embryogenesis, p27 protein is detected in the brain, dorsal root 
ganglion, lens, retina, lung, cochlea, endocardial cells of the heart, myocardium, 
kidney, adrenal medulla, liver, skin, thymus, spleen, testis and ovary (Nagahama et 
al., 2001). 
The expression pattern of p57 is similar in human and mouse tissues. During 
embryogenesis p57 protein is detected in the brain, dorsal root ganglion, lens, lung, 
endocardial cells of the heart, liver, kidney, skin, palate, pancreas, gut, adrenal 
cortex, cartilage, and skeletal muscle (Nagahama et al., 2001). Furthermore, mRNA 
is detected in the neural epithelium, heart, brain, lens epithelium of the eye, lung, 
kidney, limb buds, palate, skeletal muscle, cartilage and in somites (Matsuoka et al., 
1995; Nagahama et al., 2001; Westbury et al., 2001; Yan et al., 1997; Zhang et al., 
1997). The mRNA and protein expression of p57 in the mouse is in general 
consistent with tissues affected in Beckwith-Weidemann syndrome (BWS) in 
humans (Matsuoka et al., 1995; Westbury et al., 2001). There are, however, tissues 
that do develop normally in patients with the syndrome that express high levels of 
p57 in the mouse, i.e. the gonads, lungs and the brain (Westbury et al., 2001). p57 is 
associated with cells that have left the cell cycle, i.e. post mitotic differentiated cells 
although, interestingly, p57 is also expressed in many tissues whose cells are not 
terminally differentiated but instead are undergoing shape changing. Examples of 
these include the pituitary infundibulum, the lung columnar cells, and the kidney 
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(Westbury et al., 2001). p57 expression mainly ceases before birth whereas p27 
expression is sustained into adult life (Nagahama et al., 2001). 
3.1.2 Embryonic expression of INK4 genes 
Published work from Northern blots of whole, wild-type embryos has shown that 
p18INK4c and p19INK4d are expressed in the mouse embryo from E7, while 
p15INK4b, p16INK4a and p19ARF are not detected at embryonic stages (Zindy et al., 
1997a). By in situ hybridisation, however, none of the INK4 genes could be detected 
during early (<E11.5) mouse embryonic development, and their location during 
neurulation has therefore not been described (Zindy et al., 1997b). p19INK4d was 
detected from E11.5 and p18INK4c from E13.5. p15INK4b, p16INK4a and p19ARF 
were not detected at any embryonic stage by in situ hybridisation consistent with 
the Northern blot data (Zindy et al., 1997b).  
In the developing mouse cortex, the presence of p18INK4c mRNA transcripts are 
associated with a lengthening in G1-phase of the cell cycle as there is a switch from 
symmetrical cell divisions to asymmetrical cell divisions. Once neuronal 
differentiation has occurred, p18INK4c mRNA expression is lost (Zindy et al., 1997b). 
p19INK4d and p27 have been shown to be co-expressed in the developing mouse 
cerebral cortex (Zindy et al., 1997b). 
3.2 Results 
3.2.1 CIP/KIP expression in wild-type (CD1) embryos 
As mentioned, p21 had been shown to be expressed specifically in the MHP. p21 is 
well known as a cell cycle regulator able to prevent cells from entering S-phase, as 
well as blocking cells going from S-phase into G2-phase (Deng et al., 1995). Thus, 
p21 could be responsible for prolonging the time nuclei in the MHP spend at the 
basal neuroepithelium during S-phase, and possibly late G1-phase. To test this, I 
analysed the expression of p21 and the related genes, p27, p57 and the INK4 genes, 
in neurulation stage embryos.  
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The p21 and p27 in situ hybridisation probes were designed in the laboratory and 
the p57 probe, received from Dr Shimogori at the RIKEN institute, has been 
published (Suzuki-Hirano et al., 2011). The specificity of the probes was tested in 
CD1 embryos with p21, p27 and p57 in situ probes transcribed in the sense 
direction (Figure 3.1). The majority of embryos (4/5) hybridised with the p21 sense 
probe showed some staining in the rostral part of the embryo while no transcripts 
were ever detected in the caudal region, where transcripts were apparent with the 
antisense probe (Figure 3.1, A and B). No expression was detected in embryos 
hybridised with the p27 or p57 sense probes (Figure 3.1, C-F). 
In CD1 embryos, p21 is expressed in the PNP beginning at the 5 somite stage and is 
observed until the 19 somite stage which was the latest stage tested (Figure 3.2; 
arrows). At the 11 somite stage, p21 expression is detected in the head and 
primordium of the limb and from the 13 somite stage expression is observed in the 
ventral midbrain, branchial arches, and ‘oldest’ somites (Figure 3.2, D-F). To see 
which exact regions in the PNP express p21, the embryos were subsequently 
sectioned at 40 μm. 
At the 8 somite stage, sections reveal that p21 is strongly expressed in the PNP in 
caudal, relatively flat regions and is not specific to the midline (Figure 3.3, F-G; 
arrows). At more rostral levels p21 expression becomes restricted to the midline 
(Figure 3.3, D-E), gets weaker and is eventually lost just caudal to the closing neural 
tube (Figure 3.3, B-C). 
In embryos at the 19 somite stage, p21 is not expressed in the closed neural tube 
but is observed in the underlying dorsal hindgut (Figure 3.4, B). Posterior to the 
closed neural tube, p21 is expressed specifically in the MHP (Figure 3.4, C). This 
expression is strong and more widespread at posterior levels of newly formed 
neural plate (Figure 3.4, D). p21 is expressed in the hindgut at all levels, ventral at 
first and more uniform at posterior levels (Figure 3.4, B-D). 
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Figure 3.1 - Specificity of CIP/KIP probes 
Whole mount in situ hybridisation of E8.5 CD1 embryos with p21, p27 and p57 antisense (A, C, E) or 
sense (B, D, F) probes reveals non-specific p21 staining in the rostral region of the embryo (B). The 
staining observed in the caudal region for p21 with the antisense probe is not detected with the 
sense probe (A-B). The p27 and the p57 probes are specific and no apparent expression is observed 
(D and F). Scale bars = 100 μm. 
Next, the expression of other CIP/KIP gene family members was analysed. p57 is 
strongly expressed in the heart at all stages analysed, starting at the 5 somite stage 
(Figure 3.5, A-F). At the 9 somite stage, p57 is expressed in the notochord (Figure 
3.5, C; inset) and midbrain. At later stages, p57 expression is observed in the 
notochord, head, branchial arches, heart, limb buds and somites (Figure 3.5, C-F). 
Although p57 was not detected at the prospective closure 1 site at the 6 somite 
stage, it is expressed in the closed neural tube from 16 somites onwards. 
  
89 
 
p27 expression is not seen at the 8 somite stage (Figure 3.6, A) and is later observed 
in the ventral region of the anterior neural tube, the midbrain, and the branchial 
arches (Figure 3.6, B-C). At the 26 somite stage, p27 expression is widespread and 
seen in most regions of the head, branchial arches, limb buds and ventral neural 
tube. Note that p27 expression is excluded from the dorsal neural tube, the heart, 
and is weak, or excluded, from the notochord (Figure 3.6; arrow). 
CIP/KIP expression was further examined in the PNP of CD1 embryos at 12 and 15 
somites. At the 12 somite stage, p21 is expressed caudally in a wide region of the 
ventral neural plate including a region with more intense expression in the MHP 
(Figure 3.7, A-A’’). At more rostral levels p21 expression is restricted to the MHP 
and is weakest in the closed neural tube (Figure 3.7, A’’’-A’’’’). At the most caudal 
level, p27 is detected in the midline tissues underlying the neural plate and is 
detected in the ventral region of the neural plate at more rostral levels (Figure 3.7, 
B’-B’’’’). In the closed neural tube the expression of p27 looks similar to that of p21. 
p57 is expressed in the V-shaped neural plate in a broad domain covering almost 
the entire dorso-ventral axis (Figure 3.7, C’’-C’’’), the notochord and in the entire 
closed neural tube with possible exception of the dorsal-most region (Figure 3.7, 
C’’’’). 
At the 15 somite stage, p21 is strongly expressed in the PNP at all anteroposterior 
levels with a broad expression domain in the forming MHP (Figure 3.8, A’; arrow) 
that is more specific as the MHP sharpens, nearer to the closure point (Figure 3.8, 
A’’; arrow). In the closed neural tube p21 expression is relatively weak. Similarly to 
embryos at the 12 somite stage, p27 and p57 are expressed throughout most of the 
V-shaped neural plate at 15 somites, with no difference in intensity between the 
MHP and lateral neural folds (Figure 3.8, B’’ and C’’; arrows). However, they are not 
strongly expressed at very caudal levels (Figure 3.8, B’ and C’). p57 expression is 
strong in the notochord while p21 and p27 are weakly expressed, or excluded 
(Figure 3.8, A’’’, B’’’, C’’’; arrowheads). Note that p21, p27 and p57 are all expressed 
at the same axial level in the MHP at the 12 and 15 somite stage (Figure 3.7, A’’’-C’’’ 
and Figure 3.8, A’’-C’’). 
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Figure 3.2 - p21 gene expression in whole mounts at the 5-19 somite stage 
p21 expression in CD1 embryos by in situ hybridisation. Expression is first observed in the PNP at 5 
somites and this domain remains positive until 19 somites (A-F, arrows). p21 is not expressed at the 
level of closure 1 (B). At 11 somites, expression is observed in the ventral midbrain (m) and in the 
primordium of the limb (l) (C). From the 13 to 19 somite stage, p21 is expressed in the ventral 
midbrain (m), branchial arches (*), limb buds (l), somites (s) and in the PNP (arrow) (D-F). 
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Figure 3.3 - p21 expression in a sectioned embryo at 8 somites 
p21 expression at 8 somites as detected by in situ hybridisation. The plane of sections B-G is 
indicated on the whole mount in situ embryo (A). Section B is rostral and G is caudal (A). p21 is not 
expressed in the closed neural tube or in the sections immediately caudal to the closed region, 
including the region overlying the notochord (B-C; *). p21 expression is strong at caudal levels of 
MHP formation (E-G) and becomes weaker at more rostral levels (D; arrow). In the bent neural plate 
(D-E) p21 expression is specific to the MHP (arrows) whereas this expression domain is more diffuse 
caudally (F-G). At very caudal levels of the embryo, where the neural plate is more flattened, p21 
expression is observed throughout the newly formed neural plate and is strong in the roof of the 
hindgut (arrowhead), and the notochordal plate (*) (G). Scale bars = 50 μm. 
 
Figure 3.4 - p21 expression in a sectioned embryo at 19 somites 
p21 expression at 19 somites as detected by in situ hybridisation. The plane of sections B-D is shown 
in A; B is rostral and D caudal (A). p21 expression is not observed in the closed neural tube but is 
present in the roof of the hindgut (B-C; h). In the open neural tube, p21 expression is weak and very 
specific to the MHP (C; arrow). At more caudal levels expression is stronger and broader but still 
specific to the midline (D; arrow). p21 is expressed in the hindgut (h) at all planes examined. In the 
rostral sections this expression domain is limited to the roof of the hindgut and becomes stronger 
and wider to include all of the hindgut in the caudal most section (B-D). Scale bars = 50 μm.  
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Figure 3.5 - p57 mRNA expression in whole mount neurulation stage embryos 
p57 expression in mouse embryos from 5 to 26 somites detected by in situ hybridisation. At 5-6 
somites p57 is strongly expressed in the heart (h) and the allantois (a) but not at the level of closure 
1 (A-B). Expression in the heart is very strong at all stages examined (A-F). At 9 somites p57 
expression has spread to the ventral midbrain (m) and this expression is maintained until 26 somites 
(C-F). p57 is also observed in the notochord (C, inset, arrow) at this stage. At 16-26 somites, p57 is 
expressed in the ventral midbrain (m), branchial arches (*), heart (h), limb buds (l), somites (s), 
notochord (arrowhead), neural tube (arrow), and allantois (a) (D-F). This expression pattern is 
maintained through to the latest stages examined, with exception of expression in the allantois (a) 
which is lost by 26 somites (F).  
  
93 
 
 
Figure 3.6 - p27 expression in whole mount neurulation stage embryos 
p27 expression in mouse embryos from 8-26 somites as detected by in situ hybridisation. p27 is not 
detected at the 8 somite stage (A). At 12-15 somites p27 is expressed in the ventral midbrain (m), 
the anterior ventral neural tube (vnt), and in the first branchial arch (*) (B-C). At the 26 somite stage 
p27 is expressed in most tissues except the dorsal neural tube (dnt), the heart (h), and possibly the 
notochord (arrow) (D). Scale bars = 100 μm.  
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Figure 3.7 - Expression of p21, p27 and p57 in the PNP region of 12 somite stage embryos 
In situ hybridisation shows that p21 is expressed across the neural plate width at caudal levels and 
more specifically in the MHP at a more rostral level, nearer to the closure point (A’-A’’’). p21 is also 
expressed in the roof of the hindgut (A’-A’’’’). p27 transcripts are detected in the V-shaped neural 
plate, closed neural tube and the entire hindgut (h) (B’’-B’’’). p57 expression is similar to p27 in the 
V-shaped neural plate but covers a wider dorso-ventral area and is strongly expressed throughout 
the neural tube and notochord (arrowhead) (C’’-C’’’). Neither p27 nor p57 is expressed as intensely 
as p21 in the V-shaped neural plate and, unlike p21, do not show regional differences between the 
MHP and the lateral neural plate (A’’’, B’’’ and C’’’; arrows). Scale bars = 300 μm (whole mounts) and 
100 μm (sections). 
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Figure 3.8 - Expression of p21, p27 and p57 in the PNP region of 15 somite stage embryos 
At the 15 somite stage p21 is expressed at all levels of the PNP examined (A-A’’’). The expression is 
broad in the forming MHP (A’) and more specific in the mature MHP with weaker expression 
extending throughout the ventral neuroepithelium (A’’). In the closed neural tube, p21 expression is 
relatively weak (A’’’). p27 and p57 expression is detected in midline tissues underlying the PNP at 
caudal levels (B’-C’) and in the ventral V-shaped neural plate at more rostral levels with the same 
level of intensity in the MHP and more lateral regions (B’’ and C’’). p27 and p57 are expressed 
throughout most of the closed neural tube (B’’’ and C’’’). In the notochord, p21 and p27 show weak 
or no staining while p57 is strongly expressed (A’’’-C’’’, arrowheads). Note that p21, p27 and p57 are 
co-expressed in the MHP at the same approximate level (A’’-C’’; arrows). Scale bars = 300 μm (whole 
mounts) and 100 μm (sections).  
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To summarise the expression of the CIP/KIP genes in the PNP at 8-15 somites, p21 is 
strongly expressed in the caudal most region of the neuropore and becomes weaker 
and more specific to the MHP at more rostral levels close to the point of neural 
tube closure. p27 and p57 are faintly expressed in the flat and forming neural plate 
and become widely expressed in the V-shaped neural plate, with the same level of 
intensity for the MHP as the lateral regions. Thus, p21 is the only of the CIP/KIP 
genes to exhibit an expression pattern suggestive of a specific role in MHP 
formation. Nonetheless, all three genes are expressed in the MHP at the same 
approximate level at the 12 and 15 somite stage.  
I have established that p21, p27 and p57 are expressed in the MHP during PNP 
closure following the onset of neurulation at closure 1. Next, I investigated in more 
detail the expression of p21 and p57 prior to MHP formation and initiation of 
closure 1. p27 expression was consistently not observed in embryos at the 8-9 
somite stage (n=5) and p27 was therefore not included in further analysis. I 
repeated the analysis of CD1 embryos between the 5 and 8 somite stage, allowing 
the in situ hybridisation colour development process to proceed for longer to detect 
low levels of mRNA. I found that p21 and p57 are indeed expressed from the 5 
somite stage in the posterior neural plate, in a very specific ‘dotted’ domain of the 
midline (Figure 3.9, A’-B’; arrows) just posterior to the point where the neural folds 
are apposed (Figure 3.9, A’-B’; dashed lines). At the 6 somite stage, this dotted 
domain of midline expression of p21 and p57 is still visible, but is more posterior in 
relation to the point where the neural folds are apposed, so that it is now located in 
a relatively flat region of the neural plate, midway along the neuropore (Figure 3.9, 
C’-D’; arrows). At the 8 somite stage p21 expression is strong in the caudal part of 
the PNP and the specific dotted domain in the midline is visible within this larger 
expression area (Figure 3.9, E’; arrow). p57 expression is widespread at the 8 somite 
stage and the expression seems to be strongest in the hindgut (Figure 3.9, F; 
arrowhead) with some expression in the notochord (Figure 3.9, F; between white 
dashed lines). The dotted p57 domain is no longer visible at 8 somites. 
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Figure 3.9 - p21 and p57 are expressed in the midline from the 5 somite stage 
p21 and p57 are first observed at 5 somites in CD1 embryos in a specific ‘dotted’ domain of the 
midline (A’-B’; arrows) close to where the neural folds are apposed (A’-B’; dashed line). At the 6 
somite stage the specific dotted midline domain is slightly stronger and is relatively more caudal to 
the apposed neural folds in what seems to be a flat region of the neural plate (C’-D’; arrows). At the 
8 somite stage p21 and p57 expression is stronger and more widespread (E-F). Note the specific 
dotted domain is still observed for p21 (E’; arrow). p57 expression is very intense in the heart (h) and 
allantois (a) at all stages examined. Scale bars = 300 μm. 
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Figure 3.10 - p21 is expressed in the MHP and p57 in the underlying notochord at 6 somites 
Whole mount embryos were sectioned at 40 μm and imaged. p21 mRNA expression at 6 somites (A-
D) and p57 mRNA (E-H) is shown going from anterior (A) to posterior (P). Note that p21 is expressed 
in the neural plate midline (B, arrow) while p57 is expressed in the underlying notochord (F; arrow). 
p21 and p57 are not expressed close to the point of neural fold closure and not in the region caudal 
to the dotted domain (A, E; C, G). p21 is expressed throughout the neural plate and hindgut at the 
very caudal end of the embryo while p57 is expressed only in the hindgut (arrow). Scale bars = 50 
μm.  
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The 5-8 somite stage embryos were subsequently sectioned at 40 μm to determine 
whether the dotted expression domain of p21 and p57 was in the neural plate. 
Consistent with the images in Figure 3.9, p21 and p57 are not expressed anterior or 
posterior to the dotted midline domain (Figure 3.10, A, E; C, D). The specific dotted 
domain localises to the prospective MHP for p21 (Figure 3.10, B; arrow) and to the 
underlying notochordal plate for p57 (Figure 3.10, F; arrow). At the caudal end of 
the embryo, p21 is expressed throughout the neuroepithelium and in the hindgut 
(Figure 3.10, D) while p57 is expressed in the hindgut only (Figure 3.10, H). Figure 
3.11 summarises p21 and p57 expression at the 5-8 somite stage. The expression of 
both genes is specific and located in the forming MHP region, caudal to neural fold 
closure. p21 is expressed in the forming MHP and p57 in the underlying notochordal 
plate.  
 
Figure 3.11 - Summary of early p21 and p57 expression 
p21 and p57 expression is similar with a specific ‘dotted’ domain in the forming MHP at a similar 
anteroposterior level. The p21 ‘dot’ is in the MHP, mid-way along the neural plate, while p57 is 
expressed in the underlying prospective notochord at the same axial level. Dashed lines show the 
closure point of the PNP in each embryo. Scale bars = 300 μm (A-F) and 50 μm (B’ and E’).  
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CIP/KIP family genes were not studied at the protein level due to lack of suitable 
antibodies. Two p21 antibodies were tested (F-5 and C-19, Santa Cruz). One of them 
worked in somites which, based on the in situ hybridisation data (Figure 3.2), 
express high levels of p21 (Figure 3.12, C-E). The antibody revealed a few positive 
cells in the dorsal hindgut on a single occasion (Figure 3.12, A-B). The antibody was 
subsequently tested on sections from embryos deficient in p21. The staining pattern 
is very similar in both genotypes although the staining is stronger in wild-type 
embryos (Figure 3.12, G-I). The antibody was also tested on embryos and cells 
overexpressing p21 by electroporation or transfection with consistent negative 
results. The p27 and p57 antibodies were validated in pituitary tissue where they 
are routinely used (J.P Martinez-Barbera’s group), but these also failed to detect 
cells in the E8.5 mouse neural plate.  
I have shown that p21 and p57 are expressed in the relevant region at a relevant 
time during MHP formation and neurulation. In order to assess whether genes of 
the other family of cyclin-dependent kinase inhibitors, the INK4 family, could be 
important for MHP formation, their expression was analysed in CD1 embryos at 
E8.5. 
3.2.2 INK4 expression in CD1 embryos 
I analysed expression of the INK4 gene family members in CD1 embryos at E8.5 by 
whole mount in situ hybridisation with probes that had been previously published 
(Ludtke et al., 2009). p15INK4b and p16INK4a/p19ARF do not appear to be strongly 
expressed at this stage, and show no specific localisation of transcripts (Figure 3.13, 
A-B). p18INK4c and p19INK4d expression is more intense and both genes show 
specific mRNA localisation in the dorsal neural folds (Figure 3.13, C-D; arrows). None 
of the genes show strong or specific expression in the midline of the PNP. If 
anything, the expression of p19INK4d in the PNP is weaker than in surrounding 
tissues (Figure 3.13, D; white dashed outline). Sections through the embryos from 
Figure 3.13 do not show any staining in the MHP for any of the genes and the 
expression between the lateral neural folds and the MHP is identical (Figure 3.14, A-
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D). p19INK4d is expressed specifically at the dorsal tips of the neural folds (Figure 
3.14, D; arrow).  
To check the effectiveness of the in situ hybridisation probes, positive control 
experiments were attempted on E12.5 and E14.5 midsagittal sections through wild-
type embryos. However, results were inconclusive and not repeated. Because 
previous studies showed that p18INK4c and p19INK4d were detectable by Northern 
blot, but not by in-situ hybridisation from E7, I decided to examine the expression of 
the CIP/KIP genes as well as the INK4 genes at the mRNA level by qRT-PCR.  
CD1 embryos at the 8-10 somite stage were collected and the caudal and rostral 
parts were separated at the level of the 3rd somite pair. The expression of p27, p57, 
p15INK4b, p16INK4a, p19ARF, p18INK4c and p19INK4d was analysed in caudal 
regions relative to the expression of p21 (Figure 3.15). I chose p21 as the control as 
it was known to be expressed at this stage and it was the most likely candidate for 
involvement in MHP formation. p27 expression is approximately two thirds of p21 
expression and p57 level is approximately three-fold that of p21. None of the INK4 
genes are expressed at levels comparable to the CIP/KIP genes with mean Ct values 
of 30.8, 27.9, 32.4, 30.9, and 28.9 for p15INK4b, p16INK4a, p19ARF, p18INK4c and 
p19INK4d, respectively. In comparison, p21, p27 and p57 have mean Ct values of 
22.9-25.2.  
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Figure 3.12 - Difficulty in detecting p21 protein in E8.5 embryos 
The p21 antibody detected some cells in the wild-type embryo in the neural plate (B) and somites (D; 
arrows). The antibody was tested on p21
+/+
 and p21
-/-
 embryos (F-I). The staining is stronger in the 
wild-type embryo but seems solely cytoplasmic (G). The same staining pattern is observed in the 
mutant embryo with weaker staining (I). The intense hindgut (h) staining is trapping (G-I). Scale bars 
= 30 μm. 
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Figure 3.13 - None of the INK4 genes are expressed specifically in the neural tube at E8.5 
Whole mount in situ hybridisation shows that p15INK4b and p16INK4a/p19ARF are expressed at low 
levels, or not at all, throughout the embryo (A-B). p18INK4c and p19INK4d are expressed at higher 
levels throughout, with slightly stronger expression at a specific axial level on the dorsal tips of the 
neural folds (C-D; arrows). None of the genes show strong or specific expression in the neural plate 
midline. If anything, there is weaker expression in the PNP (D; white dashed outline). Scale bars = 
300 μm. 
 
Figure 3.14 - The INK4 genes are not expressed in the MHP at E8.5 
Sections of whole mount in situ hybridised embryos shows that p15INK4b, p16INK4a/p19ARF, 
p18INKc and p19INK4d are not expressed in the MHP. There is no difference in expression of any 
gene between the MHP and the lateral neural folds. Note the p19INK4d expression in the dorsal 
neural folds (D, arrow). Scale bars = 50 μm.  
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Figure 3.15 - INK4 gene expression is low in the caudal region during MHP formation 
Quantitative RT-PCR analysis of gene expression, presented as the expression of CIP/KIP and INK4 
genes relative to that of p21 in the caudal embryonic region at 8-10 somites. p27 is expressed at 
approximately 2/3 the level of p21, while p57 expression is 3-fold that of p21. None of the INK4 
genes are expressed at significant levels (Mean Ct values 27.9 - 32.4). Two caudal regions were 
pooled per sample, and three samples were assayed per gene. There is a statistically significant 
difference between gene expression among the CIP/KIP as well as the INK4 gene family (One way 
ANOVA). The difference in the level of the expression of p21 and the highest INK4 gene, p16INK4a, is 
statistically significant (t-test). **p<0.001.   
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It has been shown that the protein levels of p15INK4b, p16INK4a, p18INK4c and 
p19INK4d increase in mouse embryonic fibroblasts (MEF), isolated from embryos at 
E13.5, as the cells are passaged; a feature associated with cell senescence (Hara et 
al., 1996; Zindy et al., 1997a). After 2 to 4 passages of the MEFs the proteins are all 
detectable by Western blot even though p15INK4b and p16INK4a are not detected 
in embryos (Hara et al., 1996; Zindy et al., 1997a). To check that the INK4 primers 
detect the relevant genes in the CD1 embryo samples, the levels of p15INK4b, 
p16INK4a, p19ARF, p18INK4c and p19INK4d were analysed in MEFs that had been 
isolated from E13.5 wild-type embryos and passaged 3 times. All of the INK4 genes 
are expressed in the MEF sample (Figure 3.16) showing that the low values seen in 
the CD1 caudal regions are due to low expression. p19INK4d is expressed at higher 
levels in the CD1 caudal region compared to the MEF sample. This is due to the 
relatively low expression of p19INK4d in the MEF sample compared to the other 
genes and is consistent with previous studies (Zindy et al., 1997a).  
INK4 expression was analysed in CD1 embryos at the 11-13 somite stage to see 
whether the INK4 genes are expressed at a slightly later stage than the CIP/KIP 
genes. All five genes are expressed at very low levels, in the caudal as well as in the 
rostral region (Figure 3.17). Thus, it is unlikely that the INK4 genes are important 
regulatory genes during MHP formation and neurulation in the mouse. At the 11-13 
somite stage, p57 is expressed at much higher levels than p21 in the caudal region, 
approximately 8-fold. p27 expression is only slightly lower than p21 at this stage, 
possibly reflecting the caudal ‘movement’ of p27 gene expression in the neural tube 
(refer to Figure 3.6). 
Rostral and caudal p21, p27 and p57 expression was compared in CD1 embryo 
fragments at the 8-10 and 11-13 somite stage. The results are presented as the 
normalised expression relative to the expression of each gene in CD1 caudal regions 
at the 8-10 somite stage. That is, rostral p57 expression at either stage is presented 
relative to caudal p57 expression at the 8-10 somite stage, and p27 relative to 
caudal 8-10 somite p27 expression (Figure 3.18). As expected from the in situ 
hybridisation data, p21 expression is higher in the caudal, rather than rostral, region 
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of the embryo at 8-10 somites and at the 11-13 somite stage (Figure 3.18). In both 
stages examined, p27 expression seems slightly higher in the rostral part of the 
embryo (Figure 3.18). This is consistent with the in situ hybridisation study. p57 
expression is very high in the rostral part of the embryo at both stages compared to 
the caudal region of the embryo. This is likely to reflect the very high expression of 
p57 in the heart (Figure 3.18).  
To conclude, p21, p27 and p57 are expressed in the caudal region of the embryo at 
the 8-10 somite stage supporting the in situ hybridisation data on the expression in 
the neuroepithelium, the notochord, and the hindgut. INK4 gene expression is not 
significant in the caudal embryo by either in situ hybridisation or qRT-PCR 
quantification. Lastly, the expression levels of p21, p27 and p57 in the rostral 
compared to the caudal region seems in accordance with the in situ hybridisation 
data.  
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Figure 3.16 - All INK4 genes are detected in MEFs by qRT-PCR 
p15INK4b, p16INK4a, p19ARF, p18INK4c and p19INK4d were analysed in MEFs that had been 
passaged 3 times. The results are presented as the expression in CD1 caudal regions 8-10s relative to 
the expression in the MEFs. Only one MEF sample was run per gene and thus no error bars were 
calculated. All the INK4 genes are detected in the MEFs. p19INK4d is expressed at higher levels in the 
CD1 caudal region than in the MEFs and this reflects that p19INK4d had the lowest expression in the 
MEFs (Ct=27.5 cycles) compared to the other genes (21.61-24.9 cycles). Two CD1 caudal regions 
were pooled per sample, and three samples were assayed per gene.  
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Figure 3.17 - CIP/KIP vs INK4 expression at the 11-13 somite stage 
The normalised expression levels of CIP/KIP and INK4 genes are presented relative to p21 expression 
in CD1 caudal regions at the 11-13 somite stage. As for the 8-10 somite stage, p21 expression is 
highest in the caudal region, whereas p27 and p57 are expressed at higher levels in the rostral 
region. The INK4 genes are expressed at low levels, suggesting that they are unlikely to be required 
for MHP formation. *p<0.05, One way ANOVA. 
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Figure 3.18 - Comparison between anterior and posterior expression of p21, p27 and p57 
Expression of p21, p27 and p57 is shown relative to the expression of each gene in 8-10 somite CD1 
caudal regions. p21 expression is highest in the caudal region at 8-10 and 11-13s while the 
expression in the rostral region is similar at both stages. p27 seems expressed more strongly in the 
rostral part of the embryo than caudal at 8-10s and 11-13s. p57 expression is strongest in the rostral 
part of the embryo at 8-10s and 11-13s, most likely due to the strong expression in the heart. Two 
CD1 regions were pooled per sample, and three samples were assayed per gene.  
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3.3 Discussion 
3.3.1 CIP/KIP and INK4 expression in the MHP 
p21 mRNA has been reported to be found primarily in tissues containing post-
mitotic differentiated cells (Parker et al., 1995; Sherr and Roberts, 1999). This is not 
true for the neuroepithelium, however, where p21 is widely expressed, as all the 
cells are proliferating and non-differentiated prior to neural tube closure (Copp et 
al., 1988; McShane et al., 2015). I have shown that p21 expression in the caudal 
neural plate is dynamic and is observed predominantly in the flat neural plate at the 
6-8 somite stage where the MHP is forming. The temporal and spatial expression of 
p21 is in agreement with a role for p21 in shaping of the neural plate from flat to 
bending, i.e. a role in the forming of the MHP. p21 expression is strongest and 
widest in the most caudal region of the embryo at all stages examined, with 
expression becoming restricted to the midline in the V-shaped neuroepithelium. In 
the V-shaped neural plate just caudal of neural tube closure and in the closed 
neural tube p21 expression is weak or lost, suggesting that p21 is not important for 
maintaining the MHP. 
p57 is expressed in the notochord from the 6 somite stage and is later detected in 
the overlying neuroepithelium. It is curious that p21 and p57 are both expressed in 
very specific domains in the flat neural plate almost suggesting they are ‘paving the 
way’ for midline bending. It has been shown that notochordal factors are important 
for MHP formation (Smith and Schoenwolf, 1989) and it is tempting to speculate 
that p57 in the notochord could be involved in the induction of p21 expression in 
the overlying neural plate at this early stage. Furthermore, the fact that p21, p27 
and p57 are co-expressed in the neuroepithelium at later stages could mean that 
there is redundancy between the CIP/KIP genes in neural tube formation, explaining 
why the p21, p27 and p57 knockout mice develop apparently normal neural tubes 
(Deng et al., 1995; el-Deiry et al., 1993; Fero et al., 1996; Kiyokawa et al., 1996; Yan 
et al., 1997; Zhang et al., 1997). 
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The expression pattern of p21 and the other members is somewhat surprising as I 
would expect them to be expressed at the hindbrain/cervical boundary immediately 
prior to closure 1, i.e. at the prospective closure 1 site at the 5-8 somite stage. The 
rationale behind this expectation is the hypothesis that cell cycle regulators are 
responsible for cell wedging in the midline and that this produces the MHP prior to 
closure 1. I have not been able to detect p21, p27 or p57 in the prospective MHP at 
the site of closure 1. Alternatively, the MHP might not be required for closure 1 as 
the MHP is more pronounced in the PNP following the closure 1 event. RNAseq 
experiments conducted in our laboratory on prospective closure 1 tissue collected 
between somites 3 and 6 in wild-type embryos at E8 has failed to detect p21 
transcripts. Interestingly, and contrary to my in situ data, low levels of p27 and p57 
were found in the prospective closure 1 region (Oleksandr Nychyk, unpublished). 
The discrepancy between the studies most likely lies in the high sensitivity of the 
RNAseq method compared to the in situ hybridisation technique. It is also possible 
that the mRNA is degraded in embryos used for RNA in situ hybridisation as whole 
litters were dissected before the embryos were fixed (30-60 minutes) whereas 
embryos were snap-frozen one by one for the RNAseq experiment. It is interesting 
that p27 is found to be expressed in the prospective closure 1 site in the RNAseq 
experiment and at relatively high levels in the qRT-PCR experiments I conducted on 
CD1 caudal regions at the 8-13 somite stage, whereas I failed to detect p27 mRNA in 
these regions prior to 12 somites by in situ hybridisation. These results suggest that 
the p27 in situ probe is not very efficient in detecting p27 mRNA at low levels and 
highlights the importance of quantification of gene expression. 
The expression of p21, p27 and p57 is complementary as seen in Figure 3.7 and 
Figure 3.8. In particular, cells of the very caudal neural plate express high levels of 
p21 but not p27 or p57, and cells at more rostral levels express lower levels of p21 
while the levels of p27 and p57 are higher. It is interesting to speculate that the 
caudal cells switch of expression of p21 and instead start expressing p27 and p57 as 
the cells move rostrally, laying down the neural plate midline. Alternatively, it could 
seem as though p21, p27 and p57 are oscillating in a manner similar to that 
observed during somitogenesis in sense of the differential rostro-caudal expression 
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of the genes (Hubaud and Pourquie, 2014). However, the fact that I do not see 
variation in the rostro-caudal positioning of the gene expression pattern between 
embryos makes this theory unlikely. 
An important consideration in the analysis of CIP/KIP expression in this thesis is that 
it has only been examined at the mRNA level. I have not looked at the protein levels 
of p21, p27 or p57 in the MHP as the antibodies were not sufficiently good. I was 
able to detect p21 protein in the somites where expression is much stronger but 
nothing was detected in the neural tube in at least 3 separate experiments. The p27 
and p57 antibodies were validated in the mouse pituitary where they are routinely 
used (Gaston-Massuet et al., 2011) but again did not detect anything in the neural 
tube. The p21 protein has a half-life of approximately 2 hours (Roy et al., 2007) and 
as I have shown that the expression is dynamic, the protein could be present in the 
MHP during closure 1 a couple of hours after expression had been switched off. 
Moreover, the CIP/KIP genes are known to be tightly regulated at the 
posttranscriptional and posttranslational level leading to ubiquitination and 
degradation (Blagosklonny et al., 1996; Li et al., 1996; Schwaller et al., 1995; 
Starostina and Kipreos, 2012). In fact, it has been shown that the half-life of p27 
protein in proliferating cells is shorter than in quiescent cells, a change that is 
concomitant with a smaller amount of p27 ubiquitinating activity in quiescent cells 
(Pagano et al., 1995). Furthermore, targeted disruption of Skp2, the substrate 
recognition subunit of the SCF ubiquitin ligase, leads to abnormal accumulation of 
p27 protein (Nakayama et al., 2000). Thus, the gene expression studies, although 
informative, would ideally need to be backed up by immunohistochemical 
examination as post transcriptional mechanisms could alter the actual content of 
p21, p27 and p57 in the MHP. 
The INK4 in situ probes were provided by Prof. Charles Sherr and they have been 
validated and published previously. I did not detect INK4 expression in the neural 
plate midline of CD1 embryos at E8.5. As mentioned previously, the cell cycle is 
prolonged in the midline of embryos during neurulation. Thus, it is likely that the 
genes that play a role in this prolongation of the cell cycle are differentially 
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expressed between the MHP and the lateral neural plate regions. There is no 
difference between the expression of the INK4 genes in the MHP and in the lateral 
neural folds. The INK4 genes p18INK4c and p19INK4d have previously been 
detected by Northern blot in embryos at E7 (Zindy et al., 1997a). I have presented 
the expression of the two genes in the dorsal neural folds of embryos at E8.5. 
3.3.2 Quantification of CDKI levels during neurulation 
In general, the in situ hybridisation data corresponds to the gene quantification in 
CD1 embryos at the 8-13 somite stage. The levels of p57 in the caudal region of 
embryos at the 8-10 and the 11-13 somite stage are higher than p21 which was not 
apparent from the in situ hybridisation data. The allantois was removed from the 
embryos for the qRT-PCR analysis, but it is possible that some allantoic tissue 
remained, causing the high levels of p57 expression in caudal embryonic fragments. 
Consistent with the in situ hybridisation data the INK4 genes are expressed at very 
low levels and are unlikely to play roles in MHP formation. 
If time permitted it I would have done the qPCR analysis on isolated neural tubes. 
This would allow me to assess gene expression specifically in the neuroepithelium 
without other tissues such as the hindgut and would give a better idea of 
redundancy in the neural plate. I would include p18 and p19 in this analysis to 
exclude expression in the neural plate. 
In conclusion, p21 expression revealed by in situ hybridisation is in agreement with 
a role in MHP formation as it is expressed widely in the neural plate as the MHP 
forms, with an intense expression domain in the prospective MHP that becomes 
more specific as MHP formation proceeds. p27 and p57 are expressed in the MHP 
at the same axial level as p21, suggesting that there could be redundancy between 
the genes. There is, however, no regional difference in the expression of p27 and 
p57 as revealed by in situ hybridisation, between the MHP and the lateral neural 
folds as would be expected if they were involved in prolonging the cell cycle 
specifically in the MHP. Post-translational modifications of p27 and p57 might result 
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in regional differences between the MHP and lateral regions that I have been 
unable to detect. 
In order to analyse MHP formation more closely in relation to the CIP/KIP genes, 
p21+/- and p21-/-; p27+/- mouse lines were acquired and analysed as described in the 
next chapters. 
  
  
115 
 
Chapter 4 - p21 mutant embryos develop MHPs 
4.1 Introduction 
4.1.1 p21 mutant mouse model 
In 1995 two mouse models of p21 deficiency were generated and both groups 
reported mice at expected Mendelian ratio that developed normally with no 
histological abnormalities (Brugarolas et al., 1995; Deng et al., 1995; Hosako et al., 
2009; Patterson et al., 2006). Despite being associated with tumour suppression in 
relation to p53, p21 null mice do not develop spontaneous malignancies in the first 
7 months of life (Brugarolas et al., 1995; Deng et al., 1995). In comparison, over 60% 
of mice lacking p53 develop tumours spontaneously by the age of 6 months 
(reviewed by Kiyokawa et al., 1996). Yet, p21 deficient fibroblasts are defective in 
undergoing G1 arrest following DNA damage (Brugarolas et al., 1995; Deng et al., 
1995). In addition, the mouse models revealed that p21 is necessary for efficient 
p53 dependent cell cycle arrest in G1-phase following DNA damage and nucleotide 
depletion, but is not required for p53 dependent apoptosis or for the operation of 
the mitotic spindle checkpoint (Brugarolas et al., 1995; Deng et al., 1995). Thus, p21 
is only responsible for a subset of known p53 functions. 
Neural tube defects including exencephaly and spina bifida are not seen in p21 null 
mice although a p21-null allele was found to significantly increase the frequency of 
exencephaly in double mutants with Gadd45a-null, and also produced 3% spina 
bifida, unlike p53-null which only produced exencephaly in double mutants 
(Patterson et al., 2006). This shows that p21 is required for cranial and spinal 
closure in some genetic backgrounds. Overexpression of p21 in hepatocytes in vivo 
leads to dramatic inhibition of proliferation resulting in a reduction in the number 
of hepatocytes and aberrant tissue organisation, highlighting the importance of 
correct levels of CDKI during development (Wu et al., 1996). 
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4.1.2 p27 mutant mouse model 
Three p27 deficient mouse models were published in the same issue of Cell in 1996 
and all report homozygotes that are viable, without gross morphological 
abnormalities, and found at the expected Mendelian frequencies (Fero et al., 1996; 
Kiyokawa et al., 1996; Nakayama et al., 1996). p27 deficient mice are larger and 
weigh approximately 20-40% more than wild-type littermates from 2 weeks of age. 
This increase in size is due to an overall increase in skeletal growth, carcass, and 
organs in proportion to body size with no histological abnormalities, and due to an 
increase in cell number rather than cell size (Fero et al., 1996; Kiyokawa et al., 1996; 
Nakayama et al., 1996). An exception to this is the thymus, spleen and pituitary that 
are disproportionally large in the mice. While the pituitary growth is due to 
neoplastic growth resulting in pituitary adenomas, the thymic and spleen 
hyperplasia observed is not associated with any histological abnormalities (Fero et 
al., 1996; Kiyokawa et al., 1996; Nakayama et al., 1996). Interestingly, these regions 
of disproportionate growth express p27 at highest levels suggesting a role for p27 in 
regulating growth of many organs (Fero et al., 1996; Kiyokawa et al., 1996; 
Nakayama et al., 1996). The overall increase in size of p27 mutant mice is gene 
dose-dependent as shown by the intermediate size of heterozygous animals (Fero 
et al., 1996; Kiyokawa et al., 1996; Nakayama et al., 1996). There is no 
disproportionate level of body fat in the p27 mutant mice and problems with 
growth hormone (GH) or insulin-like growth factor 1 (IGF-1) signalling, common 
reasons for overgrowth, were ruled out in all three studies (Fero et al., 1996; 
Kiyokawa et al., 1996; Nakayama et al., 1996). In thymocytes isolated from p27 
mutant mice, CDK2 activity is 2-10-fold higher than in wild-type controls, suggesting 
that p27 is an important inhibitor of CDK2 (Fero et al., 1996; Nakayama et al., 1996). 
Thus, p27 deficiency might allow continued proliferation in a situation where 
mitogenic stimuli are low or absent, resulting in general hyperplasia of the animals.  
Female p27 mutant mice are infertile (Fero et al., 1996; Kiyokawa et al., 1996; 
Nakayama et al., 1996). Even though they are capable of mating, although 
infrequently, and undergo ovulation and fertilization they are unable to carry 
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pregnancies to full term and in most cases implantation fails. p27 mutant males, on 
the other hand, are able to impregnate wild-type females (Fero et al., 1996; 
Kiyokawa et al., 1996; Nakayama et al., 1996). The mutant females have prolonged 
oestrus cycles and defective formation of the corpus luteum, important for 
maintaining a pregnancy (Fero et al., 1996; Kiyokawa et al., 1996; Nakayama et al., 
1996). However, transplantation of morulas from pregnant p27 mutant females into 
pseudopregnant wild-type females develop to full term giving rise to normal sized 
litters (Fero et al., 1996; Kiyokawa et al., 1996).  
The phenotypes reported for all three existing p27-null models are very similar. The 
p27 mouse model used in this thesis contains a truncated protein lacking only the 
cyclin-CDK binding amino terminal domain of p27 (Kiyokawa et al., 1996) as 
opposed to deletion of the entire coding region in the other two models (Fero et al., 
1996; Nakayama et al., 1996). This strongly suggests that it is the cell cycle 
regulatory role of p27 that is responsible for most, if not all, of the abnormalities 
observed in p27 deficient mice. 
4.1.3 p57 mutant mouse models 
The CDKIs play important roles during development and tumour formation. 
However, most CDKI mutants develop normally, i.e. p21 (Brugarolas et al., 1995; 
Deng et al., 1995), p27 (Fero et al., 1996; Kiyokawa et al., 1996; Nakayama et al., 
1996), p16INK4a (Serrano et al., 1996), p15INK4b and p18INK4c (Yan et al., 1997) 
suggesting functional redundancy between CDK inhibitors. p57 mutant mice, on the 
other hand, have severe developmental defects related to altered cell proliferation, 
differentiation and apoptosis (Yan et al., 1997; Zhang et al., 1997). Most (>80%) 
mice die within 1 day of birth (Yan et al., 1997; Zhang et al., 1997) although there is 
a lot of variability in penetrance. Approximately 10% of p57 mutant pups are 
normal and live for months (Yan et al., 1997). Common defects include cleft palate 
(48.9%), a shortened and abnormal intestine (40%) and shortened limbs in all 
affected mutant pups (Yan et al., 1997). Other defects include abdominal muscle 
defects leading to occasional omphalocele, skeletal abnormalities resulting from 
increased proliferation and delayed differentiation of chondrocytes, renal medullary 
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dysplasia, adrenal cortical hyperplasia and cytomegaly, and lens cell 
hyperproliferation and apoptosis (Zhang et al., 1997). In addition, brains from p57 
deficient animals are larger than those of wild-type mice (Mairet-Coello et al., 
2012). p57 is highly expressed in postmitotic lens fibre cells. Accordingly, p57 loss 
results in inappropriate S-phase entry in lens fibre cells (Zhang et al., 1997). Many of 
the p57-/- defects are due to increased apoptosis including the cleft palate and GI 
tract defects (Yan et al., 1997). The apoptotic phenotype is similar to Rb mouse 
mutants and the phenotypes are normalised in a E2F1 mutant background, 
suggesting that abnormal activation of E2F1, that is bound and inactivated by Rb, is 
partly responsible for the increased apoptosis observed in p57 and Rb mutant 
animals (reviewed by Susaki and Nakayama, 2009).  
p57 is an imprinted gene and the paternal allele in the mouse is inactivated by 
transcriptional repression and methylation (Hatada and Mukai, 1995). Thus, 
heterozygous mice that inherit a defective maternal allele exhibit the same 
phenotype as homozygous mutants (Yan et al., 1997).  
Loss of p57 is detrimental during embryonic development. But what makes p57 
special compared to p21 and p27? And why do p27 mutant mice exhibit phenotypes 
related to over-proliferation whereas p57 deficiency leads to an increase in 
apoptosis rather than over-proliferation? A knock-in mouse model where p57 was 
replaced by p27 under the control of the endogenous p57 promoter answers this 
question in part. Replacement of p57 by p27 ameliorates the poor survival as well 
as most of the developmental defects observed in p57 mutant animals and p27 
knock-in mice are indistinguishable from wild-type littermates (Susaki and 
Nakayama, 2009). Thus, p57 is largely replaceable by p27 regarding the 
embryogenic functions of p57 (Susaki and Nakayama, 2009). This suggests that the 
differences observed between the p27 and p57 mutant mice models is the result of 
the spatial and temporal expression patterns of the genes, rather than differences 
in the genes themselves. Some defects remain in the p27 knock-in model including 
those of the renal papilla, the placenta and the abdominal wall muscle (Susaki and 
Nakayama, 2009). The defects that persist seem to be due to tissue specific 
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expression of p27, possibly resulting from p27 specific protein degradation in those 
tissues (Susaki and Nakayama, 2009). Importantly, the p27 knock-in model shows 
that the defects observed in p57 mutant mice are indeed related to the CDKI 
activity of p57 and can in large part be rescued by p27 (Susaki and Nakayama, 
2009). Moreover, detailed studies of p27 and p57 expression have shown that 
abnormalities in p27 deficient animals are restricted to tissues expressing p27 but 
not p57 and, vice versa, tissues that are abnormal in p57 deficient mice express p57 
but not p27 in the wild-type setting (Nagahama et al., 2001). Examples of this 
include the adrenal gland where p27 is expressed exclusively in the medulla and p57 
in the cortex. p27 mutant mice show hyperplasia of the medulla but not the cortex, 
and p57 mutant mice show hyperplasia of the cortex but not the medulla 
(Nagahama et al., 2001). Furthermore, tissues that express both genes, such as the 
brain, lung, skin and liver are not affected in p27 or p57 deficient mice (Nagahama 
et al., 2001).  
4.1.4 Combined CIP/KIP deficiency 
4.1.4.1 p21/p27 double deficiency 
A few double mutant mouse models have been generated. Simultaneous loss of p21 
and p27 was described in 2011 (Garcia-Fernandez et al., 2011). p21/p27 double 
mutant mice have a phenotype indistinguishable from wild-type littermates and 
body and organ weight is unchanged (Garcia-Fernandez et al., 2011). Contrary to 
previous studies, p27 mutant mice do not show any increase in body size, a 
difference the authors put down to the different genetic backgrounds used (Garcia-
Fernandez et al., 2011). No developmental abnormalities have been reported for 
the p21/p27 double mutant mice but they have an increased incidence of tumour 
formation; 72.2% of the mice develop tumours with an average tumour latency of 
11.6 months (Garcia-Fernandez et al., 2011). Parallel studies on p21 and p27 single 
mutant mice showed a tumour incidence of 55% in p21 mice and 50% in p27 mice 
with latency periods of 15.4 and 12.6 months, respectively (Garcia-Fernandez et al., 
2011). Whereas other studies have reported pituitary tumours with an incidence of 
approximately 50-100% from 12 weeks of age in p27 mutant mice (Fero et al., 1996; 
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Nakayama et al., 1996), the group behind the p21/p27 double mutant mouse line 
reported an incidence of pituitary adenomas of 27.7% with a latency of 11.1 months 
(Garcia-Fernandez et al., 2011). Even though the data is not in full agreement with 
previous studies it shows that embryonic development proceeds unperturbed in the 
absence of both p21 and p27 (Garcia-Fernandez et al., 2011).  
Simultaneous loss of p21 and p27 has also been analysed in vitro. In neonatal 
cardiomyocytes knock-down of p21 and p27 stimulates S-phase entry and triples 
the mitotic index (Di, V et al., 2011). Contrary to what has been reported in muscle 
myotubes, p21 and p27 knock-down does not affect apoptosis in cardiomyocytes 
(Pajalunga et al., 2007). Double knock-down of p21 and p27 in cardiomyocytes does 
not affect the levels of INK4 genes, but leads to upregulation of p57 (Di, V et al., 
2011). Triple knock-down of p21, p27 and p57 results in more than twice as many 
BrdU incorporating cardiomyocytes as compared to p21/p27 double knock-down 
and an increase in cyclin A, cyclin E, and hyperphosphorylation of Rb while cyclin D 
levels remain unchanged (Di, V et al., 2011). p57 knock-down on its own does not 
affect BrdU incorporation in cardiomyocytes whereas p21 and p27 single knock-
down leads to a slight increase in BrdU incorporation (Di, V et al., 2011). In adult 
cardiomyocytes, which do not normally proliferate, knock-down of p21 and p27 
results in upregulation of p57 and re-entry into the cell cycle in 12% of cells (Di, V et 
al., 2011). However, Rb phosphorylation decreased over time even when triple p21, 
p27, p57 knock-down was sustained suggesting compensatory additional CKI 
mechanisms in cardiomyocytes (Di, V et al., 2011). 
4.1.4.2 p21/p57 double mutant mice 
Mice lacking p21 and p57 die in utero mainly due to placental failure, and no live-
born mice are observed for p57 null or p21/p57 double null mice (Zhang et al., 
1999). The mice do, however, survive to E16.5 where a normal Mendelian ratio is 
observed. Double mutant mice display severe defects in skeletal muscle 
development as well as abnormal lung and skeletal development (Zhang et al., 
1999). The lung defect is not due to over-proliferation or apoptosis (Zhang et al., 
1999). Whereas loss of p57 leads to a delay in ossification and sternum defects, the 
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overall shape of the skeleton is unaffected in double mutants (Zhang et al., 1997). In 
the double mutant mice, however, the posture is abnormal and embryos lack the 
spinal curvature seen in wild-type mice and they have rib cage defects (Zhang et al., 
1999). In the absence of p21 and p57, skeletal muscle defects arise as myoblasts fail 
to withdraw from the cell cycle, leading to over-proliferation, endoreplication and 
apoptosis (Zhang et al., 1999). The severe phenotype of double mutant mice 
suggests that p21 and p57 play redundant roles in some tissues. In line with this, 
p21 and p57 co-localise in myotubes during development (Zhang et al., 1999). The 
skeletal phenotype observed in the p21/p57 double mutant mice is similar to that 
of Rb mutant mice, and their phenotype can be rescued by a Rb transgene 
(Zacksenhaus et al., 1996). Thus, the primary role of p21 and p57 in skeletal muscle 
is likely to be to down-regulate CDK activity and maintain Rb in a 
hypophosphorylated, active form (Zhang et al., 1999). Furthermore, p27 and p57 
have been implicated in the control of Rb in the pituitary and lens, while p57 has 
been implicated in the control of the Rb proteins p107 and p130 in chondrocyte 
differentiation (Zhang et al., 1997). 
4.1.4.3 p27/p57 double mutant mouse models 
p27 does not have much effect on the phenotype of p57 null embryos as no p57 
deficient mice survive past postnatal day 10 irrespective of p27 status (Zhang et al., 
1998). However, embryonic lethality between E12 and E16.5 is doubled in p27/p57 
double mutant mice compared to p27+/-; p57-/- mice (Zhang et al., 1998). Double 
mutant embryos most likely die from placental failure as the cardiovascular system 
and erythropoiesis develop normally in p27/p57 double mutant mice (Zhang et al., 
1998). Most developmental defects in the double mutant mice are identical to 
those observed in the p57 single mutant mice with exception of the lens which is 
more severely affected in double mutant animals (Zhang et al., 1998). Interestingly, 
the lenses of p27 mutant mice are indistinguishable from those of wild-type 
littermates (Zhang et al., 1998). p27 and p57 are expressed in the same cells during 
lens development, suggesting a redundant function of p57 in p27 loss (Zhang et al., 
1998). In the lens as well as in the placenta of p27/p57 double mutant mice, 
proliferation and differentiation is affected resulting in a lens phenotype similar to 
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that of Rb deficient mice (Morgenbesser et al., 1994). This suggests that the 
phenotype resulting from loss of p27 and p57 is related to their CDKI activity leading 
to increased Rb phosphorylation and inhibition of the differentiation promoting 
activity of (hypophosphorylated) Rb (Zhang et al., 1998).  
4.1.4.4 Triple knock-out CIP/KIP mouse 
In 2012 a triple knock-out mouse model was generated (Tateishi et al., 2012). Triple 
mutant embryos die around E13.5 from placental failure which is slightly earlier 
than the p27/p57 double null mouse (Zhang et al., 1998). Embryos were analysed at 
E11.5, E13.5 and E15.5. No NTDs were mentioned and the phenotype of the mice 
was very similar to that of p27/p57 double null mice (Tateishi et al., 2012) 
suggesting that p21 is more or less dispensable during embryonic development. 
In this chapter, my aims were to analyse MHP formation in mice lacking p21 and 
test the theory of redundancy in p21 null-, and p21/p27 double null mice, by 
quantitating the levels of p57 mRNA in these backgrounds. Furthermore, the role of 
the notochordal factor, Shh, in p21 induction was assessed in Shh null mice. 
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4.2 Results 
4.2.1 Development is normal in p21-/- embryos 
p21-/- embryos were generated from staged heterozygous matings. p21 null mice 
have been described before with no reports of developmental abnormalities 
(Brugarolas et al., 1995; Deng et al., 1995). In our laboratory no abnormalities were 
observed in p21-/- embryos. They develop normal MHPs (Figure 4.1; arrows) and 
they grow to become fertile mice. To assess whether p21-/- embryos develop at the 
same rate as p21+/+ embryos, average somite number at E8.5 was compared 
between genotypes in 65 litters (Figure 4.2). Average somite number for p21+/+ and 
p21+/- embryos at E8.5 was 8.1 while average somite number for p21-/- embryos was 
7. The difference was significant between genotypes (One way ANOVA p<0.001) 
and pairwise testing revealed a significant reduction in somite number of p21-/- 
compared to p21+/- and p21+/+ embryos. To see whether the developmental delay at 
E8.5 is observed at later stages, a limited number of mice were collected at E9 and 
E9.5. No difference in average somite number between genotypes was observed at 
either stage (p=0.82 and p=0.32, respectively) (Figure 4.3).  
 
Figure 4.1 – E8.5 p21 deficient embryos develop normal MHPs  
There is no morphological difference between the MHP (arrows) of p21
+/+
 (A) and p21
-/- 
embryos (B). 
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Neurulation was analysed in a small number of embryos. Posterior neuropore 
length is a measure of the rate at which neurulation proceeds in relation to axial 
growth and an enlargement of neuropore length can indicate early neurulation 
defects (Copp, 1985). No significant difference in PNP length was observed between 
p21 genotypes at E8.5 (Figure 4.4). In order to assess whether the PNP closure rate 
of p21 deficient mice is slower than that of wild-type littermates, somite number 
was plotted against PNP length. Due to the relatively small sample number, the 
correlation is poor for p21-/- and p21+/- embryos. Regression lines do not reveal any 
apparent differences between the closure rates of p21 genotypes (Figure 4.5). Thus, 
p21 mutant embryos have, on average, one somite less than heterozygous and 
wild-type embryos at E8.5 with no delay in neurulation. The developmental delay is 
not observed at E9 and E9.5 although the number of embryos analysed is smaller. 
Due to the large natural variation in somite number in embryos at E8.5 (~6-13 
somites), the biological significance of a one somite delay is questionable. I 
therefore conclude that p21 mutant embryos develop normally compared to wild-
type littermates. The observed phenotypes do not adhere to the expected 
Mendelian ratio (p=0.03) but are close, consistent with survival of all, or most, 
mutant embryos (Figure 4.6).  
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Figure 4.2 - p21 mutant embryos at E8.5 show developmental delay 
Average somite number of p21 mutant embryos is significantly lower than wild-type and 
heterozygous embryos. 134 wild-type, 219 heterozygous, and 94 mutant embryos from 65 litters 
were analysed. Error bars represent the SEM. One way ANOVA shows that the difference in somite 
number between genotypes is statistically significant (p<0.001). Pairwise testing (Holm-Sidak 
method) shows that p21
-/-
 embryos have a significantly lower somite number than p21
+/+
 and p21
+/-
 
embryos (p<0.05).   
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Figure 4.3 - p21 mutant embryos are not delayed at E9-9.5 
Somite number in embryos from heterozygous matings was analysed at E9 and E9.5. There is no 
difference between the genotypes at E9 or E9.5 (p=0.823 and p=0.317, respectively. One Way 
ANOVA). The number of embryos analysed is shown above the graphs. Error bars represent the SEM. 
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Figure 4.4 - Neurulation is not significantly different in p21 mutant embryos 
The length of the PNP was measured in E8.5 embryos. No significant difference was detected 
between genotypes (p=0.94, One Way ANOVA). Error bars represent the SEM. The number of 
embryos analysed is shown for each genotype. 
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Figure 4.5 - Correlation between somite number and PNP in p21 mice at E8.5 
Somite number of the embryos from Figure 4.4 was plotted against PNP length. Regression lines do 
not reveal delays in spinal neurulation in p21
-/-
 (closed circles) embryos compared to p21
+/-
 (open 
circles) or p21
-/-
 (triangles). The PNPs of p21
-/-
 shorten as somite number increases, similar to p21
+/+
. 
There is a poor correlation for p21
-/-
 (r
2
=0.56) and p21
+/-
 (r
2
=0.25) but not p21
+/+
 (r
2
=0.93).  
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Genotype Expected Observed Chi square 
 % Freq. % Freq.  
p21+/+ 25 112/447 30 134/447 4.32 
p21+/- 50 223/447 49 219/447 0.07 
p21-/- 25 112/447 21 94/447 2.89 
Deviation from 
Mendelian ratios: 
X2=7.28 with 2 degrees of freedom (p=0.03) 
Figure 4.6 - Mendelian ratio in the p21-null mouse line 
66 litters of embryos from a p21
+/- 
x p21
+/-
 deviate from the Mendelian ratio. p21 null embryos are 
found at a slightly lower frequency than expected.  
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4.2.2 p21/p27 double mutant embryos develop normally 
p21-/-; p27+/- mice did not breed well. Out of 42 plugged females, only 21 (50%) 
were pregnant at gestational day 8.5. A number of the 21 mice looked like they had 
been pregnant as they had swollen uterine horns. p27-/- female mice have been 
shown to be infertile and although they mate and fertilization takes place, they are 
unable to maintain a pregnancy (Fero et al., 1996; Kiyokawa et al., 1996; Nakayama 
et al., 1996). Our p21-/-; p27+/- females seem to be partially infertile. This has not 
been mentioned in previous reports with p21/p27 double mutant mice (Cerqueira 
et al., 2014; Garcia-Fernandez et al., 2011) but was a recognised problem in the 
laboratory that provided us with the mice (M.Malumbres, personal 
communication). 
In accordance with previous published studies, I do not find that p21/p27 double 
mutant embryos differ from wild-type littermates (Garcia-Fernandez et al., 2011). 
Embryos from 18 litters at E8.5 were analysed for average somite number, which 
ranged from 8.2 to 8.5 for all genotypes. The difference between the groups was 
not significant (p=0.879; One Way ANOVA) (Figure 4.7). The decrease in somite 
number I observed for p21-/- embryos at E8.5 is not reproduced in the double 
mutant embryos. 
p21-/-; p27+/- matings did not produce genotypes at the expected Mendelian ratios. 
This could be due to the relatively low numbers of p21-/-; p27+/+ and p21-/-; p27-/- 
embryos that were collected (Figure 4.8). It is unlikely to be due to embryonic 
lethality as the wild-type and the mutant embryos are both found at low ratios 
(Figure 4.8).   
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Figure 4.7 - p21/p27 double mutant embryos are not developmentally delayed 
Embryos from 18 litters were analysed at E8.5. There is no difference in somite number between 
genotypes (p=0.879; One Way ANOVA). The number of embryos analysed is shown on the graph. 
Error bars represent the SEM. 
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Genotype Expected Observed Chi square 
 % Freq. % Freq.  
p21-/-; p27+/+ 25 31.5/126 19 24/126 1.79 
p21-/-; p27+/- 50 63/126 62 78/126 3.57 
p21-/-; p27-/- 25 31.5/126 19 24/126 1.79 
Deviation from 
Mendelian ratios: 
X2=7.15 with 2 degrees of freedom (p=0.03) 
Figure 4.8 - p21
-/-
; p27
+/-
 matings did not produce litters at expected Mendelian ratio 
Embryos were analysed from 18 litters. There is a statistically significant deviation from the expected 
Mendelian ratio.  
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4.2.3 Are p21 and p57 redundant in the neural tube? 
Mice deficient in p27 have been shown to have normal tissue distribution of p21 
and p57 protein (Kiyokawa et al., 1996). The mouse models do, however, suggest 
that there is some level of redundancy between all three genes in other systems. As 
p21 and p57 are both expressed in the developing neural plate midline, I set out to 
examine the expression of p57 in p21 deficient embryos. 
At the 8 somite stage, p57 is expressed in the notochord and ventral hindgut and 
expression is similar in mutant and wild-type p21 embryos (Figure 4.9). At the 12 
somite stage, p57 is upregulated in the notochord and overlying neuroepithelium of 
p21 deficient embryos (Figure 4.10, A-C). Furthermore, the notochord in p21 
deficient embryos is wider (Figure 4.10, C; arrow). Due to variations in the in situ 
hybridisation results, it is difficult to draw definite conclusions regarding 
redundancy based on the in situ hybridisation data alone. Therefore, the caudal 
region of p21 embryos from the 3rd somite pair was collected for quantitative PCR 
analysis in order to quantify any change in p57 expression in the absence of p21. 
At the 5-7 and 8-10 somite stages, p21 expression corresponded to embryonic 
genotype with approximately 20-60% p21 mRNA in heterozygous p21 embryos 
compared to wild-type, and very little expression detected in p21 deficient embryos 
(Figure 4.11). This confirms that the p21 mutants are complete nulls. p57 expression 
was very varied as suggested by the large error bars. There is no apparent 
difference between p57 mRNA levels among the p21 genotypes (Figure 4.11). Thus, 
I am unable to show upregulation of p57 in the absence of p21 in this analysis. The 
varied results could be due to inconsistent cutting of the caudal part of the embryo. 
Since p57 expression is observed in the most rostral somites, some variation in the 
expression of p57 could have resulted from differences between embryos in the 
precise position of the cut, to separate the caudal regions. Moreover, the allantois 
expresses high levels of p57 and was therefore removed from the embryos prior to 
collection, but it is possible that some tissue remained in some embryos. Lastly, it 
could be that p57 is upregulated specifically in the neural plate and, as I collected 
caudal regions that included the hindgut and notochord, which both exhibit high 
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expression of p57, these areas might have masked any upregulation in the neural 
plate. Embryos from p21-/-; p27+/- matings were also analysed to determine whether 
p57 is upregulated in the absence of both p21 and p27. There was no difference in 
p57 mRNA levels between p21-/-; p27+/+ and p21-/-; p27-/- embryos although this 
could also have been due to inclusion of other tissues that express p57 strongly 
(Figure 4.12). 
Due to the limited number of embryos that could be obtained from the p21-/-; p27+/- 
matings, I was unable to assess specific upregulation of p57 in the neural tube by in 
situ hybridisation. 
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Figure 4.9 - p57 mRNA expression in p21
-/-
 and p21
+/+
 embryos with 8 somites 
Whole mount in situ hybridisation was performed, after which embryos were vibratome sectioned. 
There is no difference between p57 mRNA expression in the MHP of p21
-/- 
(A-C) and p21
+/+
 (D-F) 
embryos, although the notochord is wider in the p21 mutant. n≥3. Scale bars = 50 μm. 
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Figure 4.10 - p57 is expressed more intensely in p21
-/-
 compared to p21
+/+
 embryos with 12 somites 
Whole mount in situ hybridisation was performed, and embryos were vibratome sectioned. At 12 
somites there is upregulation of p57 mRNA in the MHP and basal neuroepithelium of p21
-/-
 embryos 
compared to p21
+/+
. Note the darker notochord in A-C as well as the very broad notochord observed 
in C (arrow), corresponding to the findings at 8 somites (Figure 4.9). n≥3. Scale bars = 50 μm. 
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Figure 4.11 - p57 expression in the caudal embryo does not differ between p21 genotypes 
Caudal parts from p21
+/+
, p21
+/-
 and p21
-/-
 embryos at E8.5, separated at the 3
rd
 somite pair, were 
analysed by qRT-PCR. p21 mRNA expression level corresponds to genotype while there is no 
difference in p57 mRNA between p21 genotypes (p=0.66 and 0.63; One way ANOVA). Caudal regions 
were pooled for each sample (3 for 5-7s and 2 for 8-10s) and 3-4 samples were assayed per 
genotype. Error bars represent the SEM. *p<0.05, **p<0.001; One way ANOVA.  
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Figure 4.12 - p57 is not upregulated in p21/p27 double mutant embryos with 8-10 somites 
Caudal embryonic regions were collected from the 3
rd
 somite pair, pooled two per sample, and p57 
mRNA was quantified by qRT-PCR. 4-5 samples were assayed per genotype. p57 is not upregulated in 
the caudal region of p21/p27 double mutant embryos (p=0.27; One way ANOVA). 
4.2.4 Is p21 expression dependent on Shh? 
Heat ablation of the notochord during embryonic development results in loss of the 
MHP in the mouse (Ybot-Gonzalez et al., 2002). Furthermore, notochordal 
fragments transplanted into the lateral neural tube in chick embryos induce MHP 
characteristics in the cells overlying the explant (Smith and Schoenwolf, 1989; van 
Straaten et al., 1988). Thus, it seems that factors emanating from the notochord are 
important for MHP formation. Shh, Chordin and Noggin are all expressed in the 
mouse notochord underlying the neural plate midline during neurulation (Ybot-
Gonzalez et al., 2002; Ybot-Gonzalez et al., 2007a) but the MHP forms in Shh 
deficient embryos, indicating that other notochordal factors are required for MHP 
formation (Ybot-Gonzalez et al., 2002). In order to assess whether notochordal 
factors are required for the induction of p21 expression in the MHP, p21 mRNA was 
  
139 
 
examined in embryos deficient in Shh which were expected to develop with no 
notochord. 
Contrary to what was expected, and in agreement with the original work (Chiang et 
al., 1996), the Shh mutant embryos used in this study form a notochord that 
appears normal at E7.5 but is subsequently lost in a rostral to caudal manner. This is 
seen by the discontinuity and loss of Brachyury expression especially in the rostral 
region (Figure 4.13, A) compared to the strong and continuous expression in wild-
type littermates at E8.5 (Figure 4.13, B). Brachyury is required for the differentiation 
of the notochord and is commonly used as a marker for primitive streak, node and 
notochord in E7.5 and E8.5 embryos (Herrmann and Kispert, 1994). Note that at 
E8.5, the notochord looks intact in the PNP where the MHP is forming (Figure 4.13, 
A-A’; arrow). 
The expression of p21 was examined in Shh deficient embryos to see whether Shh is 
required for p21 expression. The MHP morphology of Shh deficient embryos is 
indistinguishable from wild-type littermates (Figure 4.14). p21 expression is similar 
with or without Shh although the expression seems stronger in wild-type embryos 
(Figure 4.14, E-H). The notochord can be observed in Shh deficient embryos (Figure 
4.14, C; arrow) but interestingly, p21 is only expressed in the notochord in the 
absence of Shh, suggesting that Shh expression in the notochord might repress p21 
expression (Figure 4.14, C and G; arrows). Shh is not required for p21 expression. 
However, the presence of the caudal notochord in the embryos at E8.5 means that 
the notochord could be responsible for the induction of p21 independently from 
Shh. Indeed, it has been found that local application of Shh and Chordin together 
can induce strong expression of p21 in the neural plate (R.Carvalho and A.J.Copp, 
unpublished). A different model would be required to test whether notochordal 
factors are required for p21 (and p27, p57) induction in the MHP. For example, 
node ablation can be achieved using a hot tungsten needle, leading to 
notochordless embryos (Ybot-Gonzalez et al., 2002). There was insufficient time in 
this project to carry out notochord ablation experiments.  
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Figure 4.13 - Shh deficient embryos have some notochordal tissue, especially caudally 
Embryos at E8.5 were analysed by in situ hybridisation for Brachyury expression, a marker of the 
notochord. The notochord is almost completely lost in the rostral region of Shh
-/-
 embryos (A-A’) 
compared to Shh
+/+
 (B). The notochord Brachyury signal is strongest in the caudal region and looks 
intact in the PNP region (A-A’; arrow). Note the absence of notochord at more rostral levels (A-A’; *). 
Scale bars = 500 μm. 
In order to see if p21 has any effect on Shh expression, or if the notochord is wider 
in embryos lacking p21, Shh expression was analysed by in situ hybridisation in p21-
/- and p21+/+ embryos. The notochord is wider in p21-/- embryos compared to wild-
type littermates while overall MHP morphology and Shh expression is similar (Figure 
4.15). Shh is expressed in the notochord and in the ventral hindgut in both p21-/- 
and p21+/+ embryos. Interestingly, p21 is expressed in the dorsal hindgut further 
indicating that Shh and p21 expression could be mutually exclusive (Figure 4.14 and 
Figure 4.15).  
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Figure 4.14 - p21 expression is maintained in Shh deficient embryos at E8.5 
p21 expression detected by whole mount in situ hybridistaion followed by vibratome sectioning. 
Expression is maintained in the neuroepithelium of Shh deficient embryos (A-D). Note that p21 is 
expressed in the notochord only in the absence of Shh (arrows). Scale bars = 50 μm. 
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Figure 4.15 - Shh expression is unchanged in the absence of p21 at E8.5 
p21
-/-
 and p21
+/+
 embryos were analysed for Shh expression by in situ hybridisation followed by 
sectioning. There is no difference in neural plate morphology whereas the notochord is wider in the 
p21
-/-
 embryo (arrows). Shh is expressed normally in the notochord (arrows) and ventral hindgut (h). 
Scale bars = 300 μm (A-B) and 50 μm. (A’-B’). n=3.  
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4.3 Discussion 
Development of the MHP and the possibility of genetic redundancy between 
different CDKIs were examined in p21 and p27 mutant mice. p21 deficient mice 
form normal MHPs, undergo normal spinal neurulation and overall development is 
unaffected.  
The amounts of p21 and p57 mRNA in the caudal region of the embryo, assessed by 
quantitative RT-PCR varies a lot. The variation in p21 expression could be due to 
incorrect genotyping of one embryo in a pooled sample, as one of the p21+/- 
samples at the 5-7 somite stage and one sample of the p21-/- 8-10 somite stage 
expressed a much higher amount of p21 than the other two or three samples. The 
source of the variation in p57 expression is unknown but could be due to 
contamination of samples with allantoic tissue which expresses very high levels of 
p57, and which I aimed to remove in the dissection. 
Due to poor breeding of the p21-/-; p27+/- mice I had limited resources of embryos to 
work with and all were used to quantify p57 mRNA expression in double mutant 
embryos. Unfortunately I did not get conclusive results from the analysis. It would 
have been important to analyse the expression of p57 in isolated midline fragments 
of double mutant embryos by qPCR to exclude background expression from the 
hindgut and other caudal tissues. Furthermore, examination of MHP and notochord 
morphology and p57 expression in double mutant embryos by in situ hybridisation 
would have been informative.  
Interestingly, the expression pattern of p57 and Shh are similar in the PNP: i.e. they 
are both expressed in the notochord and ventral hindgut. In comparison, p21 is 
excluded from these regions and is instead expressed in the neuroepithelium and 
neural plate. It is intriguing that p21 expression is found in the notochord of 
embryos deficient in Shh which might suggest that Shh excludes p21 expression. 
This does not seem to be the case in the hindgut as p21 expression is localised to 
the dorsal hindgut in Shh mutant as well as wild-type embryos. Nonetheless, Shh is 
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expressed in the ventral hindgut in rostral regions of the PNP while the expression 
in the hindgut is lost at very caudal levels (Ybot-Gonzalez et al., 2002). In 
comparison, p21 expression is ventral in the hindgut underlying the rostral PNP and 
is uniform throughout the hindgut at more caudal levels. Although p21 and p57 are 
expressed in separate regions of the hindgut they are both expressed in the neural 
plate during neurulation. Thus, it is highly unlikely that p21 and p57 exclude 
expression of each other. On the contrary, they could co-operate in the neural plate 
to regulate the cell cycle of MHP cells. 
Shh and Chordin soaked beads, when implanted in the PNP region, were found to 
induce expression of p21 in the neural plate as visualised by in situ hybridisation 
(R.Carvalho and A.J.Copp, unpublished). However, this gain-of-function experiment 
was performed on wild-type mice where p21 is usually expressed. I have found that 
the level of expression detected by in-situ hybridisation of all three CIP/KIP genes 
varies somewhat from experiment to experiment. Thus, in a system where p21 is 
endogenously expressed, it is difficult to conclude that Shh and Chordin are 
sufficient for p21 induction based on more intense p21 staining as visualised by in 
situ hybridisation. With a loss-of-function experiment I have shown that Shh is not 
required for p21 induction as Shh-/- embryos display a normal distribution of p21 
mRNA in the neural plate. This is in agreement with the gain-of-function 
experiments using Shh soaked beads which did not lead to increased intensity of 
p21 expression on its own (R.Carvalho and A.J.Copp, unpublished). I cannot 
conclude whether notochordal factors are required for p21 induction in the Shh 
mouse model as the notochord is intact in the regions underlying MHP formation in 
the PNP. To determine this, it would be necessary to repeat the p21 expression 
analysis on embryos where the notochord had been ablated prior to neurulation 
(Ybot-Gonzalez et al., 2002). Alternatively, knock-down of Chordin and/or Noggin in 
the notochord could answer the question as to whether these ‘notochordal genes’ 
are required to induce p21 in the MHP. It would also have been informative to 
determine whether expression of p57 is dependent on Shh expression, as these are 
expressed in the same region. 
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In conclusion, the mouse models suggest that there is redundancy between the 
CIP/KIP genes in various systems. By in situ hybridisation experiments it seems that 
p57 mRNA is expressed more intensely in the notochord and neural plate in a p21 
deficient background, suggesting that in the mouse neural plate, p21 and p57 might 
be redundant. p21 is expressed specifically in the neural plate midline and could be 
important for the prolongation of the cell cycle in MHP cells. The MHP of p21 
mutant mice develops with a normal morphology, indicating that either p21 is not 
important for MHP formation, or that p27 and/or p57 in the neural plate have 
redundant roles. I was unable to conclude whether p57 is upregulated in the neural 
plate of p21 and p21/p27 double mutant mice and whether the MHP forms in 
p21/p27 double mutant animals. 
There is evidence that the notochord is required for MHP formation. I have shown 
that Shh, expressed from the notochord, is not required for p21 induction. This 
suggests that other notochordal factors could be required for p21 induction in the 
overlying neural plate. Nonetheless, p21 is not necessary for MHP formation in the 
mouse neural plate. 
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Chapter 5 - Reduced S-phase length in p21-/- mice 
5.1 Introduction 
5.1.1 The median hinge point is enriched in wedge shaped cells 
“Suppose we have a sheet of cells, the elements of which are as wide at their 
bases as they are at the free surface. If now, as a result of internal forces, the 
cells are all induced to become thicker at their bases and thinner at their free 
ends, the result will be that the sheet bends and folds together to form a 
hollow structure.” His, 1894 (Schoenwolf and Smith, 1990). 
As described in Section 1.3, median hinge point (MHP) formation is often regarded 
as a combination of apical constriction and basal cell expansion. It is clear, however, 
that in the spinal region, disassembly of microfilaments using Cytochalasin D is not 
sufficient to abolish existing MHPs, nor to prevent new MHP formation (Escuin et 
al., 2015; Ybot-Gonzalez and Copp, 1999). Therefore, microfilament-dependent 
apical constriction is not essential for MHP formation, although it remains to be 
determined whether apical constriction plays more secondary roles in supporting 
the shape of the neuroepithelium, when this is influenced by other factors. 
The cell composition of the MHP in the mouse and chick has been shown to consist 
of mainly wedge shaped cells (McShane et al., 2015; Schoenwolf and Franks, 1984; 
Smith et al., 1994). Smith and Schoenwolf published a detailed analysis of the cell 
shapes found in the mouse neural plate in 1997, and in 2015 members of our lab 
published an even more detailed study of nuclear position (which is an indicator of 
cell shape), and cell cycle times in the mouse neural plate (McShane et al., 2015; 
Smith et al., 1994). In the chick neural plate the cell shape composition has also 
been studied in detail (Schoenwolf and Franks, 1984). The main findings of these 
studies are summarised in Table 5.1. The three studies are not directly comparable 
as two of them were done by rating cell shape while the third measured nuclear 
localisation as a measure of cell shape. Furthermore, two of the studies were done 
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in mouse and one in chick. However, the studies suggest that, during midline 
bending, the proportion of wedge shaped cells is higher in the MHP than in the 
lateral, non-bending region. 
One of the main questions has, however, always been whether the cell wedging is 
an active event preceding bending, or whether the bending of the neuroepithelium 
at the MHP causes cell shape changes due to compression. Evidence consistent with 
the wedging-before-bending theory comes from McShane et al, showing that in the 
flat neuroepithelium there is no difference in the proportion of cells with basal 
nuclei in the prospective MHP and lateral regions (Table 5.1) (McShane et al., 2015). 
Furthermore, Schoenwolf and Franks show that in the avian midbrain, the increase 
in the proportion of wedge shaped cells in the MHP coincides with the formation of 
the midline furrow while the neuroepithelium is still very flat (Schoenwolf and 
Franks, 1984) (Figure 5.1). Thus, it is unlikely that compression occurs in the virtually 
flat neural plate midline causing cell shape changes (Schoenwolf and Franks, 1984). 
The increase in the proportion of wedge shaped cells is not observed in the lateral 
neural plate (Figure 5.1). In the avian spinal cord region, cell shapes were quantified 
after the midline furrow had started to form, and at this stage more wedge shaped 
cells were observed in the MHP (Schoenwolf and Franks, 1984). These studies show 
that cell shape changes in the MHP coincide with midline furrowing. No conclusive 
studies have been published on whether cell changes precede midline furrowing, or 
if the cell changes occur as a consequence of midline furrowing. As mentioned 
previously, midline furrowing is thought to be important for the position of the 
midline and thereby the normal morphology of the closed neural tube (Smith et al., 
1994).  
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Table 5.1 - Cell shape distribution (%) in the MHP and lateral regions 
All three studies find a higher proportion of wedge shaped cells in the MHP than in the non-bending 
lateral region. This increase is seen as soon as the ‘early’ neural plate starts to show an indent at the 
midline. Numbers are percentages of cells with each shape. *Note that Schoenwolf and Franks, 
1984, did not study the completely flat NE at the spinal level; numbers are from an already furrowing 
NP, hence the high proportion of wedge shaped cells in the early neural plate MHP. NP= neural 
plate, W= wedge shaped, S= spindle shaped, IW= inverted wedge shaped.  
 Early/flat NP Late/elevated NP  
 MHP Lateral MHP Lateral Reference 
Mouse E8 - - 
65.4 W 
25.1 S 
6.7 IW 
31.7 W 
40.2 S 
21.9 IW 
(Smith et al., 
1994) 
Mouse E9.5 
30-40 W 
20-30 IW 
30-40 W 
20-30 IW 
60 W 
5-10 IW 
30-40 W 
20-30 IW 
(McShane et 
al., 2015) 
Chick HH7-
11 
59.4 W* 
32.0 S 
8.5 IW 
26.1 W* 
56.3 S 
17.6 IW 
72.0 W 
25.7 S 
2.2 IW 
33.1 W 
54.7 S 
11.2 IW 
(Schoenwolf 
and Franks, 
1984) 
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Figure 5.1 - In the avian midbrain wedging precedes initial midline furrowing 
Schoenwolf and Franks quantified cell shapes in the completely flat avian neural plate (NP), NP with 
a thinning midline, and fully elevated NP at HH stages 4-8. The proportion of wedge shaped (black), 
spindle shaped (light grey) and inverted wedge shaped cells (dark grey) is presented for the MHP 
(top row) and the lateral region (bottom). Note how the proportion of wedge shaped cells in the 
MHP increases as the neural plate starts indenting at the midline. The proportion of wedge shaped 
cells in the lateral region is fairly constant. Redrawn from Schoenwolf and Franks, 1984.  
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5.1.2 Prolonged cell cycle in the MHP 
As it seems a possibility that wedging of MHP cells is important for the correct 
bending of the neural plate at a restricted site within the neuroepithelium, the 
mechanism of the shift from a mix of cell shapes to a more uniform wedged cell 
population in the MHP is a question of much interest. Due to interkinetic nuclear 
migration, nuclei are located basally during S-phase and apically during M-phase 
(Langman et al., 1966). As mentioned before, the position of the nucleus 
determines the cell shape of neuroepithelial cells (Schoenwolf and Franks, 1984). 
Therefore, basal cell expansion in the MHP could occur by altering the cell cycle so 
that cells are kept in S-phase for longer periods while other cell cycle phases are 
shortened, thus reducing the time nuclei spend at the apical site (Eom et al., 2011; 
Smith and Schoenwolf, 1987).  
Early studies in the chick have shown that the cell cycle of MHP cells is around 65% 
longer than that of cells in the regions outside of the MHP (Smith and Schoenwolf, 
1987). Furthermore, the cell cycle times of midline cells not yet differentiated into 
MHP in the flat neural plate are similar to those of non-bending lateral regions in 
the mature V-shaped neuroepithelium (Smith and Schoenwolf, 1987). This suggests 
that the cell cycle of MHP cells becomes longer as the cells become wedge shaped 
during neural bending. Moreover, Smith and Schoenwolf showed that in the chick 
neural plate, S-phase, G1-phase, and G2-phase are prolonged in MHP cells while M-
phase is 40 % shorter (Smith and Schoenwolf, 1988). Nuclei are basal during S-phase 
and likely during parts of G1-, and G2-phase as well. Thus, prolongation of S-, G1-, 
and G2-phase could lead to more basal nuclei overall. Recent work from McShane 
et al builds onto this evidence showing that the cell cycle in the MHP is significantly 
longer than in lateral non-bending regions, partly due to prolongation of S-phase 
(McShane et al., 2015). The findings of the studies mentioned are summarised in 
Table 5.2 - Length of the cell cycle (hr) in the MHP and lateral regions 
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In addition to prolonged cell cycle times, MHP cells are found to be shorter apico-
basally than lateral cells during bending (McShane et al., 2015; Smith and 
Schoenwolf, 1988). Together with the longer time spent in basal phases of the cell 
cycle, this means that nuclei may spend less time moving between the apical and 
basal side, and spend more time basally as wedged shaped cells. But what causes 
the prolonged cell cycle, and specifically S-phase in the MHP? 
 
 Early/flat NP Late/elevated NP  
 MHP Lat MHP Lat Reference 
Mouse E9.5 - - 6.7 (2.3) 5.5 (1.5) 
(McShane et al., 
2015) 
Chick HH4,7-10 7.7 9.9 6.3 
(Smith and 
Schoenwolf, 1987) 
Chick HH5-8+* - - 11.6 (3.6) 7.7 (2.4) 
(Smith and 
Schoenwolf, 1988) 
Chick 7-10ss** - - 8 (5) 
(Langman et al., 
1966) 
Table 5.2 - Length of the cell cycle (hr) in the MHP and lateral regions 
Studies that have quantified the length of the cell cycle (hr) show a longer cycle in the MHP 
compared to lateral regions. In cases where S-phase length was calculated this is shown in brackets. 
All the studies used thymidine labelling to calculate the cell cycle parameters. *Future midbrain 
region. **The whole V-shaped NP was analysed, no regional analysis was done, and rostro-caudal 
level is not clear from the paper.   
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5.1.3 The role of p21 in S-phase prolongation in the MHP 
The use of different thymidine analogues to calculate cell cycle length has been 
around for some time (Hayes and Nowakowski, 2000; Shibui et al., 1989), and the 
specific use of IdU and BrdU was described as early as 1989 to estimate S-phase 
length in human glioma cell lines (Shibui et al., 1989). In 1991, this method was 
even described in vivo in 5 patients diagnosed with solid tumours (Miller et al., 
1991). These patients received intravenous infusions of IdU followed by BrdU prior 
to removal of the tumours, after which the cell cycle times of their tumours were 
calculated (Miller et al., 1991). This method has since been modified by several 
authors. 
The method used in this thesis was modified slightly from Martynoga et al 
(Martynoga et al., 2005) and used to calculate S-phase length in embryos lacking 
p21 compared to wild-type littermates. The aim was to assess whether loss of p21 
lead to shorter S-phase lengths, specifically in the MHP. The method was developed 
in the mouse telencephalic neuroepithelium which, like the mouse neural plate, 
contains an asynchronous cell population (Martynoga et al., 2005). In such a 
population of cells, the number of cells in a particular phase of the cell cycle is 
proportional to the length of that given phase, in relation to the total length of the 
cell cycle (Martynoga et al., 2005; Nowakowski et al., 1989). 
A few assumptions are made for this model (Nowakowski et al., 1989). Firstly, it is 
assumed that cells of the asynchronous population under study form a single 
population with similar cell cycle times and distributions between the cell cycle 
phases. In my analysis, I have analysed the MHP separately from the lateral regions, 
and therefore this assumption can be made in my population of cells. Secondly, it is 
assumed that the cell population is growing at a steady state. McShane et al 2015 
showed by cumulative 3H thymidine labelling that the cells of the mouse MHP and 
lateral regions grow linearly, i.e. steady state (McShane et al., 2015). The data from 
McShane et al. also shows that the first assumption is true as the linear growth 
indicates that the proliferating cells comprise a single cell population (Nowakowski 
et al., 1989). The third assumption is that there are no non-proliferating cells to 
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consider. This assumption has been proven in the mouse neural plate (Copp et al., 
1988; McShane et al., 2015) and in the chick (Langman et al., 1966; Smith and 
Schoenwolf, 1988). 
BrdU and IdU, halogenated thymidine analogues, are incorporated into DNA during 
DNA synthesis in place of thymidine (Martynoga et al., 2005). The sequential 
injection of the two analogues enables calculation of cell cycle parameters such as 
the length of S-phase (Martynoga et al., 2005). Mice at gestational day 8 were 
injected with IdU at time 0 (T=0), labelling all cells in S-phase at the start of the 
experiment. After an interval, the mice received an injection of BrdU, which labels 
all cells in S-phase at the end of the experiment (Figure 5.2, A-B). Embryos were 
collected 15 minutes after the BrdU injection, and fixed in 4% PFA within 20 
minutes (Figure 5.2, A). Because the cell population is asynchronous, some cells will 
have left S-phase in the interval before the BrdU injection. This is the leaving 
fraction (Lcells: IdU
+BrdU-) (Figure 5.2, B; green nuclei). Cells that have remained in S-
phase throughout the experiment will have incorporated both IdU, which, contrary 
to what was previous thought (Cronkite et al., 1959; Langman et al., 1966) is not 
rapidly cleared and is still in the bloodstream (Hayes and Nowakowski, 2000; 
Martynoga et al., 2005), and BrdU. This is the population in S-phase at the end of 
the experiment (Scells: IdU
+BrdU+) (Figure 5.2, B; yellow nuclei). The interval between 
the injections (Ti) equals the time when cells can incorporate IdU and not BrdU. 
Because the cell population is asynchronous and growing at a steady state, cells will 
leave S-phase at a constant rate during the interval (Ti). The cells that have 
incorporated IdU only can be distinguished from the cells that have incorporated 
IdU and BrdU using specific monoclonal antibodies. Thus, Lcells and Scells can be 
counted. Because the number of cells in a given phase of the cell cycle equals the 
length of that phase relative to total cell cycle length (Martynoga et al., 2005; 
Nowakowski et al., 1989), I can say that the ratio of the length of one phase to 
another phase is equal to the ratio of the number of cells present in the first phase 
to the number of cells in the second phase (Martynoga et al., 2005; Nowakowski et 
al., 1989). Therefore, the ratio between the number of cells in the leaving fraction 
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(Lcells) and the S-phase fraction (Scells) equals the ratio between the interval (Ti) and 
the length of S-phase (Ts) (Martynoga et al., 2005; Shibui et al., 1989): 
𝑇𝑖
𝑇𝑠
=
𝐿 𝑐𝑒𝑙𝑙𝑠 (𝐼𝑑𝑈 + 𝐵𝑟𝑑𝑈−)
𝑆 𝑐𝑒𝑙𝑙𝑠 (𝐼𝑑𝑈 + 𝐵𝑟𝑑𝑈+)
 
Thus, the length of S-phase is calculated as: 
𝑆 = 𝑇𝑖 / (
𝐿 𝑐𝑒𝑙𝑙𝑠 (𝑠𝑖𝑛𝑔𝑙𝑒 𝑙𝑎𝑏𝑒𝑙𝑙𝑒𝑑 (𝐼𝑑𝑈))
𝑆 𝑐𝑒𝑙𝑙𝑠 (𝑑𝑜𝑢𝑏𝑙𝑒 𝑙𝑎𝑏𝑒𝑙𝑙𝑒𝑑 (𝐼𝑑𝑈 𝑎𝑛𝑑 𝐵𝑟𝑑𝑈))
) 
The method by Martynoga et al. complies with other studies in age and tissue 
matched animals, where cumulative BrdU labelling was used to calculate the cell 
cycle parameters, with a correlation of p=0.022 (Martynoga et al., 2005). Thus, in 
the mouse telencephalon, this IdU/BrdU labelling method gives the same results as 
cumulative BrdU labelling. The advantage is that it requires fewer animals while 
being very specific. 
5.1.4 Purpose of the study 
As introduced, several groups have shown that nuclei of MHP cells are mainly basal 
and have longer cell cycles than cells in lateral regions of the neural plate. I set out 
to examine if the CIP/KIP family of cell cycle regulators might be responsible for the 
regional change in cell cycle length observed in the MHP. I showed in Figure 3.3 that 
p21 is expressed in the forming MHP in the mouse neural plate. The next step was 
to assess whether loss of p21 resulted in altered cell cycle parameters in the MHP. 
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5.2 Results 
5.2.1 Validating the IdU/BrdU double labelling method 
p21+/- males and females were mated to give litters containing p21-/-, p21+/- and 
p21+/+ embryos. Pregnant p21+/- mice at gestational day 8 were given an injection of 
IdU followed by the same dose of BrdU after an interval (Figure 5.2, A). The initial 
IdU pulse labels all cells in S-phase at the start of the experiment, while BrdU labels 
all cells in S-phase at the end of the experiment (Figure 5.2, A-B). During the interval 
between IdU and BrdU, some cells will have left S-phase and have incorporated IdU 
only. Cells that have incorporated IdU can be distinguished from cells that have 
taken up IdU and BrdU using specific monoclonal antibodies (Figure 5.2, C-F). The 
number of nuclei in each group is counted and S-phase is calculated as shown 
above. Because of their large and reproducible litters, CD1 embryos were used to 
determine a suitable interval between the IdU and BrdU injections and for 
validating the antibodies.  
In order to check that the BrdU specific antibody does not cross-react with IdU, 
mice were injected with 56.75 mg/kg IdU on gestational day 8 and embryos were 
collected after 1.5 hours. Immunohistochemistry was performed with the 
IdU/BrdU-specific, and BrdU-specific-antibodies on serial sections from the same 
embryos (Figure 5.3). The BrdU specific antibody does not cross-react with IdU in 
any of the embryos tested (n=4) (Figure 5.3, A-C). Serial sections stained with the 
IdU/BrdU antibody reveal clear IdU uptake (Figure 5.3, D-F). The positive 
phosphohistone H3 staining in (B) serves as an additional control to show that the 
lack of BrdU staining is not due to problems with the immunohistochemistry 
protocol.
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Figure 5.2 - Sequential thymidine analogue labelling to calculate S-phase 
p21 mice at E8.5 were injected with IdU at time 0. After an interval BrdU was injected into the 
mouse and shortly after the embryos were collected (A). IdU and BrdU get incorporated in S-phase 
when the nuclei are basal during IKNM. Nuclei that stay in S-phase throughout the length of the 
experiment will be labelled with IdU and BrdU (B, yellow nuclei), while nuclei that have left S-phase 
before the BrdU pulse will only label with IdU (B, green nuclei). Example of an embryo with an 
interval of 3 hours between the IdU and BrdU pulse (C-F). The green nuclei (IdU) are found 
throughout the apico-basal axis of the neuroepithelium (D) while BrdU labelled nuclei (red) are more 
basal (E-F).  
  
157 
 
 
Figure 5.3 - The BrdU specific antibody does not cross-react with IdU 
The specificity of the rat anti-BrdU antibody is shown on two representative sections from the same 
embryo at E8.5. Pregnant CD1 mice were injected with IdU and serial sections from the embryos 
were stained with either specific BrdU antibody (C) or IdU/BrdU antibody (F). Section A-C and section 
D-F are 4 microns apart. pHH3 staining serves as a positive control (B). n= 4 embryos. 
Having shown that the BrdU specific antibody is truly specific, I wanted to see if 
both antibodies are equally efficient in localising BrdU labelled cells. If the 
IdU/BrdU-antibody labelled BrdU cells more efficiently than the BrdU-specific 
antibody, then the number of IdU+BrdU- cells would be overestimated and this, in 
turn, would underrepresent the length of S-phase. 
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Two embryos from mice injected with BrdU were collected and processed for 
immunohistochemistry. Serial sections 4 microns apart were stained with the BrdU-
specific antibody (Figure 5.4, A) or the IdU/BrdU antibody (Figure 5.4, B). Six 
sections were quantified per embryo (3 sections α-IdU/BrdU and 3 sections α-BrdU) 
and presented as mean BrdU labelling as a percentage of total nuclei estimated by 
counting all DAPI nuclei (Figure 5.4, C). The efficiency of both antibodies seems 
similar and with exception of the lowest and highest point on the graph, the other 
sections show a mean labelling index of between 71 and 81% (Figure 5.4, C). There 
is not a statistically significant difference between the two antibodies (t-test; 
p=0.255) although the mean for the BrdU-specific antibody is slightly higher. In the 
analysis of S-phase length both antibodies detect BrdU positive cells. Therefore, no 
IdU-BrdU+ cells are ever observed and a higher efficiency of the BrdU specific 
antibody would not distort the analysis. 
Next, the incorporation of IdU and BrdU was assessed. In order for the calculation 
of S-phase length to be accurate, IdU and BrdU need to be incorporated by 
comparable numbers of cells. IdU and BrdU uptake was quantified in embryos from 
mice injected with either IdU, or BrdU. Embryos were processed for 
immunohistochemistry, and the IdU/BrdU antibody was used to detect IdU and 
BrdU uptake (Figure 5.5, A-D). Total cell number in the MHP and in two lateral 
neural fold regions was estimated by counting nuclei stained with DAPI. IdU or BrdU 
uptake is given as percentage of total nuclei that were labelled with DAPI (Figure 
5.5, E). There is a trend towards more IdU positive nuclei in the MHP and in the 
lateral regions but this difference between uptake of IdU and BrdU is not 
statistically significant in n≥3 embryos (Figure 5.5, E). The embryos analysed are 
from different litters and I would need to analyse many more to overcome the 
possibility of interlitter variation as well as differences in the circulation of IdU or 
BrdU in the pregnant mice. Thus, I cannot prove that the uptake of the two 
thymidine analogues is equivalent, but in this small sample number it seems to be 
comparable.  
  
159 
 
BrdU antibody IdU/BrdU antibody
%
 B
rd
U
 l
a
b
e
lli
n
g
 o
f 
to
ta
l 
n
u
c
le
i
66
68
70
72
74
76
78
80
82
84
 
Figure 5.4 - No significant difference between efficiency of the BrdU and IdU/BrdU antibodies 
Embryos from BrdU injected CD1 mice at E8.5 were analysed with either α-BrdU (A) or α-IdU/BrdU 
(B) to see if the two antibodies are comparable in staining efficiency (A-B). Sections A and B are from 
the same embryo, 4 microns apart. A number of nuclei should be present in both sections as the 
nuclei span 8 microns. 6 sections from two embryos were counted (3x α-BrdU and 3x α-IdU/BrdU per 
embryo) and BrdU labelling was quantified as percentage of total nuclei (DAPI) (C). The points 
represent the % labelling per section from embryo 1 (circles) and embryo 2 (squares). Error bars are 
+/-SEM. There is not a significant difference between the two antibodies (p=0.255; t-test).  
C 
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Figure 5.5 - IdU and BrdU uptake is comparable 
Embryos from CD1 mice at E8.5 injected with either BrdU (A-B) or IdU (C-D) have comparable levels 
of labelling using the anti-IdU/BrdU-antibody (E). Each point on the graph represents the average 
labelling (% of DAPI) for a single embryo, calculated from 3 sections. Error bars are +/- SEM. There is 
no statistically significant difference between the uptake of IdU and BrdU in either the MHP 
(p=0.520) or the lateral region (p=0.191).  
E 
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5.2.2 G2 phase is approximately 2 hours 
Published methods using IdU/BrdU labelling to calculate cell cycle length are mostly 
from the mouse telencephalon or cortex (Mairet-Coello et al., 2012; Martynoga et 
al., 2005; Quinn et al., 2007; Wu et al., 2014) and all use an interval of 1.5 hours 
between injections. 
In order to test which IdU-BrdU interval is appropriate in the mouse neural plate at 
E8.5, a series of injections of BrdU were done in CD1 mice at gestational day 8. To 
account for between-litter variation, embryos were analysed from at least 2 
injected mice (Table 5.3). Embryos were collected on ice at 15, 30, 45, 60, 90, and 
120 minutes after injection of BrdU, dissected in cold medium, and fixed within 20 
minutes. Sections were stained with anti-BrdU antibody, which labels cells in S-
phase, and anti-phosphohistone H3 antibody, which labels cells in G2 and M phase 
(Hendzel et al., 1997). As BrdU and pHH3 give characteristic staining patterns in S-, 
G2-, and M-phase (Hendzel et al., 1997, Zhang et al., 2011), combining the 
antibodies is a useful way of assigning cells to specific phases of the cell cycle 
(Figure 5.6) and thereby estimating the time it takes BrdU labelled cells in S-phase 
to reach the apical surface and M-phase. It is important that the length of G2+M 
phase is longer than the interval between the IdU and BrdU injections as after that 
point single labelled cells will start to divide and this population of cells will be 
overrepresented (Martynoga et al., 2005). I also wanted to make sure that the 
interval between the IdU and BrdU injections is shorter than the time it takes cells 
that were in late S-phase during the IdU pulse to complete the cell cycle, and return 
to S-phase to be labelled during the BrdU pulse. This would otherwise over-
represent the population of double labelled cells and complicate the calculation of 
the length of S-phase. 
At 15 minutes after BrdU injection many BrdU positive cells are observed. Some 
lateral nuclei have reached the apical surface and are co-labelled with speckled 
phosphohistone H3 (yellow asterisk), indicative of G2-phase cells. Although these 
cells are likely to have been in late S-phase during the BrdU pulse, it suggests that 
either basal to apical interkinetic nuclear migration is very rapid in the E8.5 mouse 
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neural plate, or that cells are not necessarily completely basal during all of S-phase 
(Figure 5.7, A; 1st panel). Nuclei labelled with phosphohistone H3 but not BrdU 
indicate nuclei that have left S-phase prior to the BrdU pulse (Figure 5.7, A; panel 1 
and 2, white arrowheads). Nuclei in the MHP are very basal after the 15 minute 
BrdU pulse compared to the lateral regions. This regional difference in apico-basal 
position was quantified for two CD1 embryos. In the forming neural plate (Figure 
5.7, A; top), nuclei of the MHP are significantly more basal than nuclei of the lateral 
regions (Figure 5.8, top). Interestingly, there is not a significant difference in nuclear 
position along the apico-basal axis in the mature, V-shaped neural plate from the 
same embryos, suggesting that apico-basal migration of MHP nuclei is particularly 
slow in the forming neural plate (Figure 5.8). This coincides with the strong, wide 
expression domain of p21 in the forming neural plate (Figure 3.3). Many mitotic 
cells are seen after a 15 minute pulse of BrdU but none are co-labelled with BrdU 
(Figure 5.7, A; 1st panel, open arrows). 
At 30 and 45 minutes the BrdU pattern looks very similar to that at 15 minutes. 
Most of the MHP BrdU labelled nuclei are basal while nuclei of the lateral regions 
tend to be more apical with punctate pHH3 staining, indicative of a cell in G2 
(yellow asterisk). Several mitotic pHH3+BrdU- cells are observed at 30 and 45 
minutes (Figure 5.7, A; panels 2 and 3; open arrows). Embryos collected 1 hour after 
the BrdU injection exhibit many apical nuclei, both in the MHP and in the lateral 
regions. At this time-point, 22.11% of mitotic figures are BrdU positive, but the 
majority of mitotic cells are BrdU negative (Figure 5.7, B; 1st panel; open arrow and 
Table 5.3). 90 minutes after the BrdU injection 85.9% of the mitotic cells are BrdU 
positive (Figure 5.7, B; closed arrows and Table 5.3) while some BrdU negative cells 
in late mitosis are seen (Figure 5.7, B; open arrows). At 120 minutes after the BrdU 
injection almost all (94%) mitotic cells are BrdU positive, suggesting that the 
approximate time it takes a nucleus to travel through G2 phase is close to 2 hours 
(Figure 5.7, B; last panel; closed arrows and Table 5.3). At all time-points, very basal 
nuclei are observed that are labelled with BrdU and punctate pHH3 showing that 
these cells have entered G2 although very basal (Figure 5.7, turquoise asterisks). 
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The combined length of G2 and M can be estimated following a BrdU pulse long 
enough to ensure that all mitotic figures are BrdU positive (Takahashi et al., 1995). 
Seeing that 94% of mitotic figures are BrdU positive following a 2 hour BrdU pulse 
(Table 5.3) G2+M phase in the CD1 mouse neural plate at E8.5 is close to 2 hours 
(TG2+M =2). Therefore, the time it takes a cell to go from S-phase, through cell 
division, and return to S-phase exceeds 2 hours. 
In conclusion, just under a quarter of mitotic figures are BrdU positive after a 1 hour 
BrdU pulse, while almost all mitotic figures are BrdU positive after a 2 hour pulse 
(Table 5.3 and Figure 5.9). The 1 hour time-point suggests that a good fraction of 
cells leave S-phase in a 1 hour interval. Therefore, the IdU/BrdU double labelling 
method was tested under experimental conditions in the p21 mouse line with a 1 
hour interval between the injections. 
5.2.3 Calculating S-phase length in p21-/- and p21+/+ embryos 
In the experiments above, using CD1 outbred mice, almost a quarter of mitotic cells 
after a 1 hour BrdU pulse are co-labelled with BrdU, suggesting that a fair 
proportion of cells leave S-phase within a 1 hour interval. On the other hand, it 
seemed very unlikely that many BrdU-labelled cells would have divided, and their 
nuclei re-entered S-phase, in this time period. Therefore, 1 hour was chosen as the 
best interval to use between the IdU and BrdU pulse for subsequent experiments in 
the p21 mouse, in order to limit the number of IdU+BrdU- dividing cells, and to best 
avoid including IdU+BrdU+ cells that had been labelled in two successive cell cycles. 
p21+/- mice were mated, and pregnant females at gestational day 8 were given an 
injection of IdU followed by the same dose of BrdU 1 hour later. Embryos were 
collected 15 minutes after the BrdU pulse and processed for 
immunohistochemistry, exactly as in the CD1 studies above. In the first experiment I 
noticed that the pattern of IdU and BrdU looked identical in the embryos analysed 
(Figure 5.10) and when counting the number of single labelled cells in 6 sections 
from 3 p21+/+ embryos I found on average only 1.67 single labelled cells. Thus, a 1 
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hour IdU-BrdU interval is not sufficient to give enough single labelled cells to 
calculate S-phase length in p21 mutant mice.  
Next, the interval between IdU and BrdU injection was increased to 2 hours (Figure 
5.11, A) which resulted in a distinct population of single labelled cells (Figure 5.11, 
C-E; circled nuclei) that were labelled with IdU (C) but not BrdU (D). The number of 
single and double labelled nuclei was counted and the length of S-phase was 
calculated as shown (Figure 5.11, F). S-phase length in the MHP (Figure 5.11, C-E; 
inside white dotted lines) was compared to a region in each of the lateral neural 
folds (Figure 5.11, C-E; red boxes). 
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Figure 5.6 - Determining cell cycle phases 
The BrdU staining pattern changes in different phases of the cell cycle (Zhang et al., 2011) as shown in Figure 2.5. A-G and A’-G’ is the same nucleus viewed in two different 
channels. In early/mid S-phase the pattern is uniform (A), turning more punctate with an outline of the nucleus visible in the first part of G2 (C-D). In late G2 and through to 
mitosis (E-G) the staining is punctate with no staining of the nuclear outline (Zhang et al., 2011). pHH3 stains nuclei in G2-phase and mitosis (C’-G’). The pattern starts out 
very punctate in small nuclear domains (C’-D’), turning more uniform throughout the nucleus in late G2 (E’-F’) and is very condensed and strong during mitosis (G’) (Hendzel 
et al., 1997). In a subset of cells the BrdU pattern looks like late G2 but no pHH3 staining is observed (B-B’). These are classified as late S-cells. 
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Figure 5.7 - BrdU +ve mitotic cells are observed after 1 hour 
CD1 mice at E8.5 were injected with BrdU and left for different time periods before embryos were 
collected and analysed. Cells labelled with BrdU are observed as soon as 15 minutes after BrdU 
administration (A; top panel). Mitotic cells labelled with pHH3 are observed at all time-points 
(pHH3
+
BrdU
-
; open arrows, pHH3
+
BrdU
+
; closed arrows). The first time at which double pHH3
+
BrdU
+
 
cells are observed is after 60 minutes. At 90 minutes mitotic cells that are BrdU+ve (B, middle panel, 
closed arrows) and late mitotic cells that are BrdU-ve (open arrow) are observed along with G2 cells 
(B, middle panel, *). At 120 minutes most mitotic cells are BrdU+ve (B, bottom panel, closed arrows). 
Yellow asterisks indicate apical G2 nuclei and turquoise asterisks indicate basal G2 nuclei. White 
arrowheads indicate G2 nuclei that left S-phase prior to the BrdU pulse. Scale bars = 30 μm. 
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Nuclei in the forming MHP stay mainly basal following a 15 minute BrdU
pulse while lateral nuclei have moved towards the apical surface.
p<0.001, One Way ANOVA. Distance was measured in ImageJ
on 6 sections from two biological replicates. 
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Nuclear position along the apicobasal axis is not statistically
differerent between the lateral neural folds and the MHP in 
V-shaped regions (p=One way ANOVA).Distance measured
on 6 sections from two biological replicates. 
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Figure 5.8 – Apical migration of MHP nuclei is slower than that of lateral nuclei 
CD1 embryos at E8.5 received a 15 minute pulse of BrdU (Figure 5.7; top panel) and nuclear position 
along the apico-basal axis was measured. Nuclei of the MHP are significantly more basal in the 
forming MHP compared to the lateral regions. This significant difference is not observed for the 
mature, V-shaped neural plate in the same embryos, suggesting that MHP nuclei have the longest 
‘basal cell cycle phase(s)’ in the forming neural plate. Nuclear distance was measured on 6 sections 
from two embryos. p-value; One way ANOVA. Error bars are +/-SEM. 
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 Mitotic pHH3+BrdU+ Embryos Mice injected 
 
% Freq.   
15' BrdU 0 0/97 n=5 2 
30' BrdU 0 0/86 n=6 2 
45' BrdU 0.8 1/132 n=8 3 
60' BrdU 22.1 21/95 n=7 4 
90' BrdU 85.9 61/71 n=4 2 
120' BrdU 94.0 63/67 n=4 2 
Table 5.3 - Almost all mitotic cells in wild-type embryos are BrdU positive after a 2 hour pulse 
CD1 mice at E8.5 were injected with BrdU and embryos collected following 15, 30, 45, 60, 90, or 120 
minutes. α-pHH3 was used to identify mitotic cells, and α-BrdU to identify cells labelled in S-phase. 
Mitotic cells co-labelled with BrdU are shown as a percentage of total number of mitotic cells 
counted on ≥3 sections per embryo. 
 
Figure 5.9 – G2 phase is approximately 2 hr 
Cells take up BrdU (green) during S-phase at the basal neuroepithelium and pHH3 labels cells in G2-
phase and mitosis (red). The earliest mitotic cells that are BrdU+ve are observed after 1 hr, 
suggesting that some cells that were in late S-phase during the BrdU pulse have reached mitosis. At 2 
hours the majority of mitotic cells are BrdU positive, indicating that the time it takes a cell to move 
through G2 is approximately 2 hours.  
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Almost all mitotic cells were IdU positive at the end of a 2 hour interval in CD1 mice 
(Figure 5.7, B and Table 5.3). Assuming p21 mice behave similar to CD1 mice, a 2 
hour interval between IdU and BrdU injections is the upper limit for the interval in 
this p21 mutant experiment to avoid IdU+BrdU- dividing cells. In order to estimate 
whether a 1.5 hour interval would suffice, which in theory would reduce the chance 
of single labelled dividing cells, the number of single labelled cells was counted on 
all the slides from a 2 hour IdU-BrdU interval in p21 mice as shown in Table 5.4. 
With a 2 hour IdU-BrdU interval, 11.65% of sections analysed had no single labelled 
cells in the MHP. Furthermore, 36.89% of sections analysed contained 1 or 2 single 
labelled cells in the MHP, strongly suggesting that 2 hours is the lower limit for the 
interval in p21 mice (Table 5.4). Interestingly, the number of sections with no 
IdU+BrdU- cells was twice as much for p21+/+ compared to p21-/-. Thus, cells of p21 
wild-type embryos were more likely to stay in S-phase during the 2 hour interval 
compared to mutant embryos. Furthermore, 2.4 times as many sections from p21+/+ 
embryos had only one or two single labelled cells compared to p21-/-. This suggests 
that nuclei of p21-/- embryos are more likely to leave S-phase during the 2 hour 
interval compared to p21+/+ embryos, indicating that p21-/- cells, in particular MHP 
cells, might spend less time in S-phase compared to wild-type littermates (Table 
5.4).  
Furthermore, the number of mitotic cells that are IdU negative was found to be 
higher for p21+/+ than for p21-/- embryos in the MHP as well as in the lateral regions, 
suggesting that it takes longer for S-phase labelled wild-type cells to reach mitosis 
compared to mutant littermates (Table 5.5). In CD1 embryos, I showed that 94% of 
mitotic cells were labelled with BrdU after a 2 hour pulse (Table 5.3). Here, I found 
in p21+/+ embryos, that approximately 91% of mitotic cells co-labelled with IdU, 
which had been in the bloodstream for 2.25 hours (Table 5.5; between 8.7 and 9% 
of mitotic cells were IdU-ve). Thus, in p21+/+ embryos there is strong evidence that 
the length of G2+M is more than 2 hours, similar to what I previously suggested for 
CD1 mice. Moreover, p21-/- embryos hardly show any mitotic cells that are not co-
labelled with IdU, suggesting that p21-/- IdU labelled S-phase cells reach mitosis 
quicker than in the wild-type setting, i.e. almost all (~97.6%) p21-/- mitotic cells are 
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IdU positive (Table 5.5). For both genotypes, the number of mitotic cells in the MHP 
is almost half of that observed in the lateral regions (Table 5.5). 
 
 
Figure 5.10 – A 1 hour interval is too short for S-phase calculation in p21 mutant mice 
Pregnant p21
+/-
 mice at E8.5 were injected with IdU followed by BrdU 1 hour later (A). Embryos were 
collected and analysed with antibodies for IdU/BrdU and BrdU (B). Nuclei labelled with IdU, but not 
BrdU, were quantified in 6 sections from 3 embryos. The average number of single labelled cells was 
1.67. Note how the IdU and BrdU staining is very similar. 
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Figure 5.11 - Sequential labelling with IdU and BrdU enables calculation of S-phase length 
Pregnant p21
+/- 
mice at E8.5 were given an IP injection of IdU followed by BrdU two hours later. The 
mice were culled and the embryos collected on ice 15 minutes after the second injection (A). The 
IdU/BrdU antibody detects both IdU and BrdU (C) while α-BrdU is specific for BrdU (D). Combining 
the IdU/BrdU and BrdU staining pattern reveals a group of cells that have left S-phase and the basal 
neuroepithelium (IdU
+
BrdU
-
; yellow circles in C-E) and another group of cells that remain in S-phase 
at the end of the experiment (IdU
+
BrdU
+
; C-E). S-phase length was calculated in the MHP (inside 
white dotted lines; C-E) and in the lateral neural folds (red boxes; C-E) using the formula as shown 
(F).  
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 #Sections Embryos 0 Lcells ≤2 Lcells 
p21-/- 47 6 3.9% 10.7% 
p21+/+ 56 7 7.7% 26.2% 
Total 103 13 11.7% 36.9% 
Table 5.4 - A 2 hour IdU/BrdU interval is required for S-phase calculation in p21 mutant mice 
Mice at E8.5 were injected with IdU followed by BrdU 2 hours later. Embryos were collected after 15 
minutes and analysed with monoclonal antibodies to distinguish cells labelled with IdU and BrdU 
from cells that had left S-phase prior to the BrdU pulse (Lcells; labelled with IdU only). 12 sections out 
of the total 103 analysed did not have any single labelled cells in the MHP (Sections with 0 Lcells; 
11.65%). The high number of sections with 1 or 2 single labelled cells in the MHP (≤2 Lcells) suggests 
that a 2 hour interval is required in the early p21 neural plate for S-phase calculation. 
 
  Mitotic cells IdU-ve mitotic cells #Sections 
p21-/- 
MHP 
23 0/23 (0%) 31 
p21+/+ 23 2/23 (8.7%) 37 
p21-/- 
Lateral 
41.5 1/41.5 (2.4%) 31 
p21+/+ 39 3.5/39 (9%) 37 
Table 5.5 - Fewer pHH3
+
IdU
-
 cells in p21
-/-
 than p21
+/+
 
The number of mitotic cells in the MHP and lateral regions counted in six p21
-/-
 and 7 p21
+/+
 E8.5 
embryos collected 2.25 hours after the IdU injection. For both genotypes almost half as many mitotic 
cells are found in the lateral regions compared to the MHP. Fewer IdU-ve mitotic cells are observed 
in p21
-/-
 embryos compared to wild-type littermates.  
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5.2.4 S-phase is significantly shorter in p21-/- embryos 
E8.5 embryos from p21+/- crosses were stained for IdU and BrdU (Figure 5.12 and 
Figure 5.13). Between 5 and 13 sections per embryo were imaged, the single-
labelled Lcells and the double-labelled Scells were counted in the MHP and in two 
lateral regions (Figure 5.11, C-E), and S-phase length was calculated as the mean per 
embryo, combining the number of single and double labelled nuclei from all the 
imaged sections (Figure 5.11, F) (Appendix I). Overall morphology was normal in 
p21-/- embryos, both in the forming, flat neural plate (Figure 5.12) as well as in the 
V-shaped, elevated neural plate (Figure 5.13). 
p21-/- and p21+/+ embryos were analysed at two stages of MHP development: the 
early stage, forming MHP, and the later stage, V-shaped mature MHP (Figure 5.12 
and Figure 5.13). This allowed any differences in S-phase length to be detected at 
different stages of MHP formation. Some embryos appear in both groups as some 
sections from the embryo were posterior and had a forming MHP morphology, 
while other sections from the same embryo were more anterior with a V-shaped 
morphology. Therefore, for each MHP developmental stage, 2-7 sections were 
analysed per embryo, and average S-phase length per embryo was calculated. 
In the forming neural plate, cells in the p21-/- MHP as well as in lateral regions spend 
significantly less time in S-phase compared to wild type littermates: 3.9 vs 7.1 
hours, and 3.4 vs 4.5 hours, respectively (Figure 5.14, forming and Table 5.6). This 
difference is statistically significant (p=0.009). In the mature neural plate, three 
embryos had very high S-phase length values as there were no single labelled cells 
in the MHP in 3 out of 5 sections. Thus, the number of single labelled cells was very 
low (approx. 2-3) while the number of double labelled cells was as high as for other 
embryos (approx. 30-50). This resulted in S-phase lengths of 20, 29 and 54 hours. 
These embryos are shown as red outliers on the graph (Figure 5.14, mature). The 
difference in S-phase length between genotypes in the mature neural plate was not 
statistically significant when the outliers were included (Figure 5.14, mature). When 
the outliers were excluded from the statistical analysis, there was a statistically 
significant difference between the length of S-phase in p21-/- and p21+/+ embryos in 
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the mature neural plate (p<0.001) (Figure 5.15) with a decrease in length from 8.4 
to 3.2 hours in the MHP and from 6 to 3.5 hours in the lateral regions (Table 5.6). 
The difference between S-phase length in the MHP and lateral regions was not 
significant (p=0.309). That is, in all regions, and during all stages of MHP formation, 
p21-/- cells spend significantly less time in S-phase than comparable cells in wild-
type littermates. 
As the S-phase times were very similar between the forming neural plate and the 
mature neural plate when the outliers were not considered (Table 5.6) the pooled 
data were plotted on a graph to determine effect of genotype (Figure 5.16). A 
significant difference in S-phase length is seen in the MHP as well as in the lateral 
regions when the outliers are excluded (p=0.005; Two way ANOVA). There is not a 
significant difference between S-phase length of the MHP and lateral regions 
(Figure 5.16). The reduction in S-phase length for the pooled data is from 7.7 to 3.9 
hours for the MHP and from 5.2 to 3.8 hours for the lateral regions (Table 5.6). 
In the MHP, S-phase length is decreased by 49.4% for p21-/- compared to p21+/+, and 
in the lateral region the reduction in S-phase length is 26.9% (Table 5.7). 
Interestingly, the length of S-phase is decreased in the lateral neural plate regions 
although this is not where p21 is most strongly expressed (Table 5.7). The decrease 
in S-phase length in the p21-/- lateral region is smaller than that seen in the MHP. 
Thus, the effect of p21 deficiency is more pronounced on MHP cells than cells of 
lateral regions, but the reduction in the lateral region suggests that p21 action is not 
solely restricted to the MHP. The regional difference in S-phase length between the 
MHP and the lateral non-bending regions is seen in p21+/+ embryos: S-phase in the 
MHP is 32.5% longer than it is in the lateral region (Table 5.7). This regional 
difference is essentially abolished in p21-/- embryos with S-phase being 2.5% longer 
in the MHP than in lateral region, strongly suggesting that p21 is responsible for the 
prolongation of S-phase in the MHP. The loss of the regional increase in S-phase 
length in the MHP of p21-/- embryos has no effect on the morphology of the neural 
plate (Figure 5.12 and Figure 5.13), suggesting that prolongation of S-phase is not 
necessary for midline bending. 
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Figure 5.12 - Example sections through embryos at the level of the forming MHP 
p21
+/+
 and p21
-/-
 embryos at E8.5 were stained with α-IdU/BrdU (B and F) and α-BrdU (C and G) 
following injections of IdU and BrdU 2 hours apart. Embryos lacking p21 show the same overall 
morphology as well as pattern of IdU and BrdU labelling (compare A-D to E-H). In both genotypes IdU 
labelled nuclei are found throughout the apico-basal axis with some mitotic looking cells at the apex 
(B and F, arrows). BrdU labelled cells are overall more basal but some apical nuclei are observed, 
mainly in lateral regions (C and G, open arrows). The overall pattern of staining is comparable 
between the two genotypes. 
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Figure 5.13 – Normal V-shaped MHP formation in p21
-/-
 embryos 
There is no apparent difference in MHP formation between p21
+/+
 and p21
-/-
 embryos at E8.5. IdU 
and BrdU labelling patterns are comparable in the V-shaped neural plate of both genotypes.  
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Difference between genotypes is not significant p=0.116. Two way ANOVA
 
Figure 5.14 - S-phase length is shorter in p21
-/-
 embryos compared to wild-type littermates at E8.5 
Neural plate cells lacking p21 have a shorter S-phase than wild-type littermates. This is true for the 
MHP as well as the lateral neural folds, and for the forming as well as the mature neural plate. 
Between 4 and 6 embryos were analysed in each group. There is a significant difference between S-
phase length between genotypes in the forming NP (p=0.009) while the regional difference in the 
forming NP fails to reach statistical significance (p=0.06). The difference between S-phase length in 
the mature neural plate is not statistically significant between genotypes (p=0.116) or regions 
(p=0.091). p-values were calculated by Two way ANOVA. Error bars are +/-SEM. 
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Figure 5.15 - S-phase length is significantly reduced in the p21
-/-
 mature neural plate at E8.5 
The same data is shown as above but the outliers are excluded. S-phase length is significantly shorter 
for p21
-/-
 than p21
+/+
 embryos (p<0.001). Length of S-phase is not significantly different between the 
MHP and lateral regions (p=0.309). p-values were calculated by Two way ANOVA. Error bars are +/-
SEM. 
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Figure 5.16 - Neuroepithelial cells deficient in p21 spend significantly less time in S-phase 
Pooling data from the immature and mature neural plate shows a significant difference between the 
length of S-phase in p21
-/-
 embryos compared to p21
+/+
 when the outliers (red) are excluded, 
(p=0.005; Two way ANOVA). At least 6 embryos were analysed per group. There is not a significant 
difference between S-phase in the MHP and the lateral region when genotype is accounted for 
(p=0.137). Error bars are +/-SEM. 
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 S-phase length 
 MHP Lateral 
 p21-/- p21+/+ p21-/- p21+/+ 
Forming 3.9 (0.55)* 7.1 (0.90) 3.4 (0.94)* 4.5 (0.46) 
Mature 3.2 (0.76)** 8.4 (1.48) 3.5 (0.59)** 6.0 (1.02) 
Combined 3.9 (0.5)* 7.7 (1.4) 3.8 (0.7)* 5.2 (0.59) 
Table 5.6 - S-phase is significantly shorter in p21 null embryos at E8.5 
Table showing the mean length of S-phase (hours) (+/- SEM) in the MHP and lateral neural plate of 
p21
-/-
 and p21
+/+ 
embryos. The outliers from Figure 5.14 and Figure 5.16 are not included in the 
mean. *p=0.005, **p<0.001. 
 
 Mean S-phase MHP Mean S-phase lateral 
 p21-/- p21+/+ p21-/- p21+/+ 
p21-/- vs p21+/+ -49.4% -26.9% 
p21-/- MHP vs p21-/- lat. +2.5% - x - 
p21+/+ MHP vs p21+/+ lat. - +32.5% - x 
Table 5.7 - Length of S-phase is decreased by 49.4 % in the p21 mutant MHP at E8.5 
Percentage differences in mean S-phase length between p21
+/+
 and p21
-/- 
embryos for the MHP and 
lateral regions based on the numbers presented in Table 5.6. Data for the forming and mature neural 
plate have been combined in this analysis. S-phase length is decreased by 49.9% in the mutant MHP 
compared to wild-type, and by 26.9% in the lateral region. In wild-type embryos (last row), S-phase 
in the MHP is 32.5% longer than in the wild-type lateral region (x). In p21
-/-
 embryos (middle row) S-
phase in the MHP and lateral region is essentially the same (x).  
  
183 
 
5.2.5 Cell cycle phase distribution is slightly altered in p21 mutants 
Embryos used in the analysis of S-phase length were sectioned serially. One set of 
sections was stained with anti-IdU and -BrdU for S-phase length analysis, and the 
next set 4 microns away was stained with anti-IdU and -pHH3 to estimate cell cycle 
phase distribution in order to examine whether nuclei of p21-/- were more likely to 
be found in G2- or M-phase rather than S-phase due to the shorter S-phase. 
As with the IdU/BrdU analysis, 5 to 13 sections were analysed per embryo. 
Approximately 11 IdU positive cells in the MHP were chosen (5 nuclei on each side 
of the central-most nucleus) and two regions in the lateral regions containing at 
least 11 positive IdU cells. Cells were assigned to early/mid S-phase, late S-phase, 
G2 phase, or mitosis depending on the pattern of IdU and pHH3 staining (Figure 5.6 
and Figure 5.17). The percentage of cells in each cell cycle phase was calculated as 
the mean per embryo, calculated from 5-13 sections, based on the total number of 
cells in the analysis for that embryo (Appendix II). 
The percentage of cells in early/mid S-, late S-, G2-, or M-phase was plotted for p21-
/- and p21+/+ embryos (Figure 5.18). In the MHP as well as in the lateral region there 
are fewer cells in early/mid S-phase than what is seen in p21+/+ embryos. 
Concurrently, there are more cells in late S-phase in the mutant embryos in the 
forming as well as the mature neural plate (Figure 5.18 and Table 5.8). This 
difference is highly significant in the lateral region. In the forming neural plate the 
number of cells in S-phase in total (early/mid + late) is 34.4% for the mutant 
embryos while this number is 43.4% for wild-type. In the lateral region there is also 
a decrease in total cells in S-phase, 30.6% vs 33.6% (Table 5.8). The decrease in cells 
in S-phase that is observed in the mutant embryos corresponds to an increase in 
cells in G2-, and M-phase although this does not reach statistical significance (Figure 
5.18). In the mature neural plate, there is less difference between the total number 
of cells in S-phase between mutants and wild-type; 46.4% vs 44.5% in the MHP and 
35.2 vs 40% in the lateral region (Table 5.8).  
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In conclusion, the decrease in S-phase cells in p21-/- embryos corresponds with the 
decrease in S-phase length as these cells tend to move to G2- and M-phase quicker 
than cells in the p21+/+ embryo. 
 
Figure 5.17 - Cell phase distribution based on nuclear pattern 
Nuclei were grouped into early/mid S-phase, late S-phase, G2-phase or M-phase based on BrdU (top) 
and pHH3 (bottom) pattern as described in 2.5.3.2. The same nuclei are shown in two different 
channels. Scale bars = 2 μm. 
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Figure 5.18 – A shift from early to late S-phase in p21 null embryos at E8.5 
The distribution of cells in S-, G2, and M-phase, based on the pattern of pHH3 and IdU staining as 
shown in Figure 5.17, is shown in the MHP (top) and the lateral neural folds (bottom). In both 
regions there is a shift from early/mid S-phase to late S-phase in p21
-/-
 embryos. In the lateral neural 
folds this difference is statistically significant whereas in the MHP the same trend is visible, but 
statistically non-significant. There is no statistically significant difference in the distribution between 
cells in G2 and M phase between p21
-/-
 and p21
+/+
 littermates. Cell cycle phase distribution was 
calculated from ≥5 sections from at least 6 embryos per genotype. Percentage of cells was calculated 
from a total of IdU+ve cells in the MHP and lateral regions. p-values were calculated using the 
student’s test. Error bars are +/-SEM.  
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 Cell cycle phase distribution (%) in the forming neural plate 
 MHP Lateral neural fold 
 p21-/- p21+/+ p21-/- p21+/+ 
Early/mid S-phase 27.2 39.6 20.8* 30.7 
Late S 7.2 3.8 9.8** 2.9 
S-phase total 34.4 43.4 30.6 33.6 
G2 54.2 47.4 56.9 53.2 
Mitosis 11.4 9.2 12.5 13.1 
 
 Cell cycle phase distribution (%) in the mature neural plate 
 MHP Lateral neural fold 
 p21-/- p21+/+ p21-/- p21+/+ 
Early/mid S-phase 32.6 42.4 27 36.9 
Late S 13.8 2.1 8.2* 3.1 
S-phase total 46.4 44.5 35.2 40 
G2 49.5 47.8 51 50.4 
Mitosis 4.1 7.7 13.8 10.2 
Table 5.8 - Distribution of cells in S-, G2-, and M-phase in p21
-/-
 vs p21
+/+
 embryos at E8.5 
Summary of the cell cycle phase distribution data for the forming (top) and mature (bottom) neural 
plate separately. In the forming neural plate, there are more cells in late S-, G2- and M-phase in the 
mutants compared to wild-type, and fewer cells in S-phase overall in mutant than wild-type. Total 
number of cells in S-phase is more similar between mutant and wild-type in the mature neural plate, 
but there is a shift towards more cells in late S-phase compared to wild-type controls. *p<0.05, 
**p<0.001.  
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5.2.6 No change in number of wedge shaped cells in the mutant MHP 
As shown in Figure 5.19, neuroepithelial cell shape is directly related to the position 
of the nucleus (Schoenwolf and Franks, 1984). This can be visualised on tissue 
sections stained with an antibody against beta-catenin which serves as a marker of 
the membranes of neuroepithelial cells (Figure 5.19). Nuclei are found at all levels 
of the apico-basal axis of the neuroepithelium, as a result of interkinetic nuclear 
migration. Some basal nuclei, visualised with DAPI (blue), are indicated in Figure 
5.19. Note the very thin apical process in a cell with a basal nucleus (Figure 5.19; 
arrow). Because of the relationship between nuclear position and cell shape, 
measurement of the distance of nuclei from the basal surface of the 
neuroepithelium is an indirect measure of cell shape. 
To see whether p21-/- nuclei are less basal than their wild-type counterparts, 
nuclear distance was measured as illustrated for BrdU-labelled nuclei in Figure 5.20. 
More than 10 stained nuclei per section were selected in the MHP (5 on each side 
of the centre nucleus) and in the lateral regions, nuclei were outlined in image J and 
a macro was used to find the centre of the nuclei (Figure 5.20, A-B). Lines were 
drawn from the centre of the nuclei to the basal surface (Figure 5.20, C) and basal 
distance was calculated as a proportion of total neuroepithelial thickness, at the 
level of each nucleus (Figure 5.20, D-E). 
Firstly, nuclear position was measured using IdU-labelled nuclei in p21-/- and p21+/+ 
embryos from the IdU/BrdU double labelling experiment. Again, 5-13 sections were 
analysed per embryo, for at least 6 embryos per genotype. The average distance of 
nuclei from the basal surface per embryo is presented in Figure 5.21. IdU was given 
2.25 hours prior to embryo collection and the nuclei are expected to be scattered 
along the apico-basal axis with many cells undergoing mitosis. In both the MHP and 
the lateral region, p21-/- nuclei appear slightly more apical than those of p21+/+ 
although this is not statistically significant (Figure 5.21). 
Next, nuclear position was quantified for BrdU positive nuclei. This measurement is 
more interesting, as the embryos were collected 15 minutes after the BrdU pulse 
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and therefore any instant changes can be identified. Based on the data presented 
so far, I expected that nuclei of the mutant MHP might be more apical than wild-
type MHP nuclei in this snapshot. As shown in Figure 5.22, there is no difference in 
nuclear position in the MHP or lateral regions between mutants and wild-types. The 
forming neural plate and the mature neural plate are represented separately and 
for that reason the number of embryos on each graph is relatively small. In the 
mature neural plate, mutant MHP nuclei are more basal than wild-type although 
not statistically significant (Figure 5.22). This was un-expected as p21-/- MHP cells 
spend less time in S-phase. 
The forming and mature neural plate data were combined to show the overall basal 
position of BrdU positive cells in the MHP and lateral region of p21-/- and p21+/+ with 
greater numbers. Nuclei are significantly more basal in the MHP than in the lateral 
regions (p=0.02) showing that the apico-basal movement of nuclei is more rapid in 
the lateral neural plate compared to the MHP (Figure 5.23). This was also shown in 
Figure 5.7, A and Figure 5.8. In the MHP, p21-/- nuclei are slightly more basal than 
wild-type nuclei although this is by very little, 0.36 vs 0.38. In the lateral region 
there is no difference between p21-/- and p21+/+. Thus, the changes seen in cell cycle 
phase distribution and overall nuclear position as measured for IdU is not evident 
after 15 minutes of BrdU labelling. 
In order to get more information about the cell cycle phase distribution of the BrdU 
positive cells, and to see if p21-/- MHP nuclei were more likely to have a BrdU 
pattern indicative of late S-, or G2-phase, nuclei were assigned to either early/mid 
S-phase or late S/G2 phase based on BrdU staining pattern alone (see Section 
2.5.3.3). pHH3 staining was not used in this analysis, as it was not available on the 
IdU/BrdU slides used for S-phase analysis. In the MHP, there is no difference 
between the distribution of cells in early/mid S phase or late S/G2 between the 
genotypes (Figure 5.24, left). In the lateral region, there are significantly more cells 
in early/mid S-phase for p21-/- embryos compared to p21+/+ and fewer cells in late 
S/G2 phase (Figure 5.24, right). This is completely opposite from what I saw in the 
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IdU/pHH3 analysis and again suggests that the changes I see in S-phase length 
between p21-/- and p21+/+ are not instantaneous. 
 
 
Figure 5.19 – Nuclear position determines cell shape in the neuroepithelium 
Nuclei (DAPI) are found throughout the apico-basal axis in the neuroepithelium due to interkinetic 
nuclear migration. Beta catenin is a marker of the cell membrane and shows the outline of the cells. 
Apical (A) and basal (B) nuclei are indicated. Note the very thin apical process in a wedge shaped cell 
with basal nucleus (arrow). 
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Figure 5.20 – Apicobasal nuclear position as a measure of cell shape 
Basal nuclear distance was measured from BrdU labelled cells to the base of the neuroepithelium. In 
image J, BrdU positive nuclei were circled (A-B) and a macro was used to find the centre of the 
drawn circles. A line was subsequently drawn from the nuclear centre to the basal surface (C) and 
total neuroepithelial thickness was measured at the level of each nucleus (D). Basal distance is 
shown as a proportion of total neuroepithelial thickness where a value of 1 represents an apical 
nucleus, and 0 a basal, wedge shaped, nucleus (E). The MHP (inside white dotted lines) was 
compared to the lateral neural plate. The red dotted line indicates the division between the lower 
and upper half of the neuroepithelium.  
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Figure 5.21 - Apico-basal position of IdU+ve nuclei is similar between p21
-/-
 and p21
+/+
 embryos 
The apico-basal nuclear position was measured for IdU positive cells in the MHP and the lateral 
neural folds of at least 6 p21
-/-
 and p21
+/+
 embryos at E8.5. Each dot represents the sample average 
for a single embryo. Error bars are +/-SEM. The difference between nuclear apico-basal position is 
not statistically significant between genotypes (p=0.11) but is highly significant between the MHP 
and lateral region (p<0.001). Two way ANOVA.  
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Figure 5.22 - Apicobasal position of BrdU +ve nuclei 15 minutes after injection at E8.5 
Distance to the basal surface of BrdU+ve nuclei in the forming MHP (top) and in the mature neural 
plate (bottom). There is no statistically significant difference in the apico-basal positioning of nuclei 
between p21
-/-
 and p21
+/+
 in the forming or mature neural plate (p>0.21) although p21
-/-
 nuclei in the 
mature MHP are slightly more basal than p21
+/+ 
embryos. For the mature neural plate, nuclei are 
significantly more basal in the MHP than in the lateral region (p=0.007). This difference is not 
significant in the forming neural plate (p=0.68). Each point represents the mean for each of at least 3 
embryos. Error bars are +/- SEM. p-values were calculated by Two way ANOVA.  
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Figure 5.23 - Similar apico-basal position of BrdU+ve nuclei in p21
-/-
 and p21
+/+
 at E8.5 
Data were combined from forming and mature stages of neural plate bending to determine whether 
there is an overall difference in nuclear basal position between p21
-/-
 and p21
+/+
 neuroepithelial cells. 
In the MHP, there is a very small, statistically non-significant difference, i.e. 0.02 points, with p21
-/-
 
MHP cells being more basal. In the MHP and lateral regions, there is no difference between 
genotypes (p=0.39) but MHP nuclei are significantly more basal than nuclei of the lateral regions 
(p=0.02). p-values were calculated by Two way ANOVA. Error bars are +/-SEM. At least 5 embryos 
were analysed per genotype.  
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Figure 5.24 - p21
-/-
 and p21
+/+
 embryos have similar cell phase distribution in a 15 minute snapshot 
Embryos at E8.5 were given a 15 minute pulse of BrdU before being collected on ice. BrdU positive 
cells in the MHP and lateral neural folds were rated for being in early/mid S-phase or late S/G2 
phase, based on the staining pattern of BrdU (see Figure 2.5). In the MHP, the number of cells in the 
two categories is very similar. In the lateral neural folds there are significantly more cells in early/mid 
S-phase and fewer in late S/G2 phase in the p21
-/-
 embryos than p21
+/+
 littermates. Five p21
-/-
 and 7 
p21
+/+
 embryos were analysed.  
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5.3 Discussion 
5.3.1 Reliability of methods 
The most important prerequisites for the IdU/BrdU double labelling method are 
that the antibodies are specific, enabling accurate counts of single and double 
labelled cells, and that the thymidine analogues are incorporated into equal 
numbers of cells. I have shown that IdU is incorporated into a slightly higher 
number of cells than BrdU in a small sample number. In the original method by 
Martynoga, and several other IdU/BrdU studies, the same amount of IdU and BrdU 
was injected without concerns about their molecular weights (Mairet-Coello et al., 
2012; Martynoga et al., 2005; Quinn et al., 2007; Wu et al., 2014). It has, however, 
been shown that administration of equivalent wt/vol concentrations of the 
thymidine analogues IdU and CIdU leads to distorted results as the compounds are 
not taken up by equal numbers of cells, whereas injection of equimolar amounts co-
labels all cells (Vega and Peterson, 2005). Other studies have used equal, not 
equimolar, amounts of IdU and BrdU and found that the number of IdU cells was 
within 5-7% of the number of BrdU positive cells (Bauer and Patterson, 2005). To 
account for any differences in uptake due to differences in molecular weight, I have 
used IdU and BrdU in equimolar amounts, i.e. 56.75 mg/kg and 50 mg/kg, 
respectively. As the molecular weight of the compounds is close, this modification 
of the method should not make a big difference to the incorporation of IdU into 
cells and should not cause the slightly higher uptake of IdU observed. Because the 
embryos analysed for IdU and BrdU incorporation were from different mothers and 
potentially from different days, I would need to collect many more litters to do a 
proper comparison. Another complication is the difficulty of locating nuclei reliably 
as DAPI does not stain the single stranded DNA very well. Therefore, the total 
number of nuclei in the analysis cannot be given with 100% confidence. 
If it is true that IdU is incorporated more easily than BrdU at equimolar amounts, 
then the number of single labelled cells will be overrepresented in all the embryos, 
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and all regions. Thus, the comparison between S-phase length in the MHP and 
lateral regions, as well as comparisons between genotypes is still reliable. 
5.3.2 BrdU and pHH3 staining as cell cycle phase markers  
In order to get detailed information about the cell cycle progression in the MHP and 
in the lateral regions of the mouse neural plate, BrdU and pHH3 antibodies were 
used as tools to determine cell cycle phases of neuroepithelial cells. Wild-type CD1 
embryos were analysed at different time-points following BrdU injection of the 
mother. Strikingly, there is a wide apico-basal range of BrdU+ nuclei 15 minutes 
after the BrdU injection, suggesting that some (mainly lateral) nuclei move very 
rapidly between basal and apical neuroepithelial regions during, or soon after, 
completion of DNA synthesis. The range of BrdU staining patterns observed 
suggests that BrdU labels cells that have just entered S-phase, as well as cells that 
are in late S-phase. Furthermore, many nuclei, both basal and apical, are co-stained 
with punctate pHH3, indicating that these cells have already entered G2-phase 
(Hendzel et al., 1997). The cells in G2-phase are likely to have been in late S-phase 
during the BrdU pulse. The very basal position of many G2-phase cells suggests that 
during parts of G2-phase, nuclei are basal. 
Smith and Schoenwolf have suggested that in the chick, S-phase cells can adopt all 
cell shapes. That is, DNA synthesis is not necessarily restricted to the basal 
neuroepithelium (Smith and Schoenwolf, 1988). They proposed a model whereby 
nuclei of all regions are apical during M-phase (inverted wedge shaped), apical or 
central during the transition from G1 to S-phase and during late G2 (spindle 
shaped), and basal during S-phase and most of G2 phase (wedge shaped). Based on 
that model they predicted that the non-S-phase part of the cell cycle that is 
prolonged in the MHP is G2 phase, when cells are mostly wedge shaped (Smith and 
Schoenwolf, 1987; Smith and Schoenwolf, 1988). The model proposed by Smith and 
Schoenwolf that cells in S-phase can have any shape, i.e. any nuclear position, is 
very interesting and could explain the number of BrdU-positive nuclei I observed at 
the apex 15 minutes after the BrdU injection. More recently, it has been shown in 
the zebrafish neuroepithelium by live imaging that S-phase cells are found at all 
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levels of the apico-basal axis, and that S- to G2-phase transition occurs at all levels 
(Leung et al., 2011). This is in agreement with my findings. 
In line with other studies (Hayes and Nowakowski, 2000) BrdU labelled cells are 
observed shortly after IP injection. I show here that a 15 minute pulse is sufficient 
to label a large population of cells in the mouse neural plate. Assuming that cells are 
basal during S-phase, and that it takes approximately 5 minutes for the embryos to 
start incorporating BrdU, this suggests that basal to apical migration is extremely 
rapid in the E8.5 neural plate. Alternatively, supposing Smith and Schoenwolf’s 
model is true in the mouse, some cells undergoing S-phase might not be basal. It 
will be difficult to test which of these is true. I could collect the embryos 5 and 10 
minutes after the injection to see if this would limit the amount of apical nuclei and 
thereby support the theory of rapid apical migration. Based on the model by Smith 
and Schoenwolf, G2 is the main non-S-phase that is increased in the MHP. It would 
be very interesting to compare the length of G2-phase in the p21-/- embryos 
compared to p21+/+ to see if G2 phase is decreased alongside S-phase in p21 mutant 
embryos. 
Using BrdU and pHH3, I show that 2 hours after a BrdU pulse almost all mitotic 
nuclei are also BrdU-positive. Because the time when all mitotic nuclei are BrdU 
positive equals the time it takes for G2+M phase (Takahashi et al., 1995), this shows 
that G2 and M phase together are close to 2 hours in CD1 as well as p21 mice. Thus, 
I can estimate that it takes nuclei approximately 2 hours to go from basal S-phase to 
mitosis at the apical surface. The presence of BrdU labelled basal nuclei in embryos 
collected 2 hours after injection suggests that BrdU does indeed stay in the 
bloodstream for at least 2 hours, labelling new cells entering S-phase. Alternatively, 
the cells might be stalled in S-phase, or be in a basal G2-phase. As mentioned 
previously, it has been suggested in the chick neural tube that cells in G1-phase are 
mostly inverted wedge shaped or spindle shaped while cells in G2-phase are mainly 
wedge shaped (Smith and Schoenwolf, 1988). This suggests that G1-phase and G2-
phase do not proceed in the same manner. Thus, my estimation of the time it takes 
cells to go from the basal surface through G2 to the apical surface, is not necessarily 
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representative of the time it takes the cell to get back from the apical surface to the 
base (Smith and Schoenwolf, 1988). In line with this, it has been suggested that 
apical to basal INKM is a passive process as opposed to basal to apical INKM, 
suggesting that the two movements should not be assumed to be regulated in the 
same way (Kosodo et al., 2011). However, as I estimate that the length of G2+M is 
close to two hours, and as published studies of the cell cycle in the avian and mouse 
neural plate estimate the cell cycle to be 9.9 and 6.7 hours, respectively (Table 5.2) 
(McShane et al., 2015; Smith and Schoenwolf, 1987), I am confident that the double 
labelled population I observe does indeed represent cells that have been in S-phase 
during both pulses, and have not returned to undergo a second S-phase, after one 
cell division. 
5.3.3 S-phase length 
I have used a double thymidine labelling technique to directly calculate S-phase 
length in the neuroepithelium. By modifying the method by Martynoga et al. by 
increasing the interval between IdU and BrdU injection to two hours, I have 
managed to calculate the length of S-phase in p21 mutant embryos. It is notable 
that a 1 hour injection interval in p21 mice is not enough to get a population of 
single labelled IdU+BrdU- cells when I see many apical cells in BrdU timepoint 
experiments in CD1 mice where embryos were collected 15-45 minutes after BrdU 
injection. This difference is likely to be strain dependent and is further highlighted 
by the fact that it seems to take longer for p21 mice to reach 100% IdU-positive 
mitotic cells than it does CD1 mice. That is, in CD1 embryos 94% of mitotic nuclei 
co-labelled with BrdU after a 2 hour pulse, while p21 embryos, after 2.25 hours, 
showed 91% co-labelling of mitotic nuclei. However, the MHP is the region with the 
longest S-phase, as previously suggested, and even in CD1 mice I do see very few 
apical nuclei in the MHP at 15-45 minutes after BrdU injection. At 1 hour after the 
BrdU injection 22.1% of mitotic cells are BrdU+ve in the neuroepithelium, and the 
majority of these are found in the lateral regions. Thus, the IdU+BrdU- cell 
population after a 2 hour interval in p21 mice does, largely, fit with the BrdU time-
point experiments conducted in CD1 embryos. 
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I have found that in the forming neural plate, which does not have a distinct MHP, 
as well as in the mature V-shaped MHP, S-phase length in the midline is decreased 
in the absence of p21. As shown in Chapter 3, p21 is strongly expressed in the 
forming MHP as well as in the V-shaped MHP. Surprisingly, loss of p21 also leads to 
a decrease in S-phase length in lateral regions, away from the strong expression 
domain normally observed in the midline. This result suggests that p21 action is not 
restricted to the midline but rather extends further up through the neural folds. 
This is in line with the lateral p21 expression I occasionally observed by whole 
mount in situ hybridisation. Loss of p21 essentially abolishes the difference in length 
of S-phase between the MHP and lateral regions compared to the wild-type 
situation. Thus, p21 is strongly implicated by these findings as being required for the 
prolongation of S-phase in the MHP. Importantly, the MHP still forms with no 
apparent morphological differences in the absence of a prolonged S-phase in the 
MHP. It would be interesting to examine differentiation in the floor plate to assess 
whether increased proliferation in the MHP in the absence of p21 causes aberrant 
subsequent differentiation. Unfortunately, due to problems of mouse breeding, I 
had insufficient time to calculate S-phase length in p21-/-; p27-/- embryos that we 
had available in the laboratory. It would have been important to see if the loss of 
p27 had any additional effect on the length of S-phase or MHP morphology, in p21 
mutants. 
The length of S-phase I have found varies from other work recently published on the 
cell cycle in the mouse neural plate. I find that S-phase is longer in the wild-type 
setting than was reported by McShane et al.; namely 7.7 hours in the MHP and 5.2 
hours in the lateral region compared to 2.3 and 1.5 hours, respectively, reported by 
McShane et al. (McShane et al., 2015). The reason for the discrepancy between the 
two studies could be that I have done my analysis in the forming and newly formed 
MHP at E8.5 whereas the previous work by McShane et al. was done in the closing 
neural tube at E9.5. Furthermore, different techniques were used to calculate the 
cell cycle parameters. I have used a relatively new technique to directly calculate S-
phase while, in the study by McShane et al., cell cycle time and S-phase was 
estimated by cumulative 3H thymidine labelling in cultured embryos, followed by 
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linear regression analysis (McShane et al., 2015). Martynoga et al. have shown that 
in the telencephalon, the IdU/BrdU double labelling method produces cell cycle 
lengths that correlate significantly with values published for the same tissue and at 
the same stage, using cumulative BrdU labelling (Martynoga et al., 2005). Thus, the 
two methods should in theory be comparable in the developing mouse neural plate 
as well, although there might be differences in using BrdU and 3H thymidine. The 
correlation between S-phase length calculated by 3H thymidine cumulative 
injections and IdU/BrdU double labelling was not assessed by Martynoga, and it is 
also possible that differences lie in the calculation of S-phase in the two methods, 
although ultimately all were based on the work by Nowakowski (Nowakowski et al., 
1989).  
A way to validate the IdU/BrdU method in the forming neural plate would be to 
compare the total length of the cell cycle using IdU/BrdU to parallel experiments 
with cumulative BrdU labelling. This was not done for a few reasons. Firstly, nuclei 
that have undergone the stringent IdU/BrdU immunohistochemistry protocol are 
left with single stranded DNA which binds DAPI, and Hoechst, very poorly. Thus, I 
was unable to consistently and accurately count the number of total nuclei using 
DAPI in my experiments and therefore unable to calculate total cell cycle length. 
Secondly, it would require a lot of mice to do the cumulative labelling, and as this 
had been done previously in our lab in the early mouse neural plate using 3H 
thymidine (McShane et al., 2015), I decided not to do this. 
5.3.4 Do dividing IdU positive cells distort the analysis? 
The original method by Martynoga et al. used an interval of 1.5 hrs between IdU 
and BrdU injections. I found, at 1 hour there were only 1-3 single labelled cells per 
sample, which was not enough to calculate S-phase as the formula in most samples 
would be: 
 𝑆 = 𝑇𝑖 (1 ℎ𝑜𝑢𝑟)/ (
𝑠𝑖𝑛𝑔𝑙𝑒 𝑙𝑎𝑏𝑒𝑙𝑙𝑒𝑑 (0)
𝑑𝑜𝑢𝑏𝑙𝑒 𝑙𝑎𝑏𝑒𝑙𝑙𝑒𝑑 (𝑛)
) 
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Increasing the interval to 2 hours did, in the majority of cases result in a 
reproducible number of single labelled cells in all regions, although there were 12 
MHP sections with no single labelled cells that led to very high values for average S-
phase length in 3 embryos. Following a 2 hour IdU pulse, 94% of all mitotic figures 
were co-labelled with IdU in CD1 embryos while the first IdU+ mitotic figures were 
observed after a 1 hour pulse. Therefore, I cannot exclude the possibility that the 
number of single labelled cells in p21 embryos is overestimated when the embryos 
are collected at 2.25 hours, as a proportion of IdU+ cells might have recently gone 
through cell division. This problem is difficult to overcome and might be quite 
specific to the mouse neural plate during early development due to the very short 
apico-basal length of the neuroepithelium, the shortening of this axis in the MHP 
(McShane et al., 2015; Smith and Schoenwolf, 1988), as well as the relatively long S-
phase. Adapting this method to a shorter interval between injections, e.g. 1.5 hours, 
could possibly have limited the number of dividing IdU+ cells. However, the 
proportion of mitotic IdU+ cells in CD1 embryos only fell from 94% to 85.9% when 
the pulse was reduced from 2 hours to 1.5 hours. Moreover, a 1.5 hour interval 
would probably not produce enough single labelled cells in the p21 mouse line for 
the analysis. Single labelled cells, i.e. IdU+ cells that have left S-phase, should 
theoretically increase linearly during the interval between the injections (Hayes and 
Nowakowski, 2000). I have shown in CD1 and p21 embryos that 2 hours is below the 
limit for 100% IdU+ mitotic figures, i.e. close to the length of G2+M. Therefore, a 
two hour interval should still be in the linear phase before the slope doubles as IdU 
labelled daughter cells are produced by mitosis (Hayes and Nowakowski, 2000). 
Importantly, an over-representation of single labelled cells would result in a shorter 
calculated S-phase length whereas, as I discussed above, my analysis of S-phase 
gave higher S-phase length values than were described before (McShane et al., 
2015). This suggests that dividing IdU-labelled cells was not an over-riding problem 
in the current study. 
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5.3.5 Cell cycle phase distribution 
Cell cycle phase distribution was quantified in the p21-/- and p21+/+ embryos using 
the IdU and pHH3 staining pattern as a tool. I have shown that S-phase is reduced 
by almost half in the MHP of p21-/- embryos compared to wild-type. Therefore, I 
expected there to be fewer cells in S-phase in the mutant MHP. I do, indeed, see 
fewer cells in S-phase in the forming neural plate and to a lesser extent in the 
mature neural plate. Interestingly, in the mutant embryos, a relatively high 
proportion of cells have a nuclear IdU pattern similar to that seen in G2-phase but 
with no pHH3 staining. These cells, which I classified as late S-phase, were very 
rarely seen in the wild-type neuroepithelium.  
One possible reason for finding so many p21-/- cells in late S-phase could be because 
the cells become stalled in late S-phase in the absence of p21. However, this seems 
unlikely considering that S-phase length was found to be reduced significantly in 
p21 mutants. Another possibility is that there are just many more cells that are 
ready to leave S-phase in mutant embryos compared to wild-type and that this 
phase is only truly picked up in the mutant setting. It is surprising that the changes 
in cell cycle phase distribution in the MHP do not reach significance when 
considering how much S-phase length is decreased. In the lateral region there are 
significantly fewer early/mid S-phase cells and significantly more cells in late S-
phase. Statistics are generally more powerful for the lateral regions because I 
analysed two regions, one on each side, and averaged these. This generates larger 
n-values and the standard error is generally smaller than in the MHP where I have a 
smaller population of cells with greater variation (e.g. compare the size of SEM 
values between MHP and lateral in Figure 5.18). Hence, the different findings 
between MHP and lateral regions may be a reflection of sample size and statistical 
power. 
Based on the analysis of S-phase length I would expect there to be a trend towards 
more cells in G2 and M-phase for p21-/- embryos compared to p21+/+. I do see more 
cells in late S-, G2-, and M-phase but the results are not very striking. A larger 
dataset would have painted a clearer picture. 
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In conclusion, p21-/- mutant MHP and lateral region cells both show a trend towards 
an increased proportion of cells in late S-, and G2- phase while fewer cells are 
observed in early/mid S-phase compared to wild-type. This finding correlates with 
the observed decrease in S-phase length in both regions of p21-/- embryos. 
5.3.6 Nuclear position measurements  
I analysed nuclear position to get an idea of whether there are fewer basal nuclei in 
p21-/- embryos, consistent with the decreased S-phase length and number of cells in 
S-phase. Analysis of nuclear position in IdU positive cells showed that, in the MHP 
and lateral regions of p21-/- embryos, there is a small increase in the number of 
apical nuclei compared to wild-type. This difference was not statistically significant. 
The IdU-positive cell fraction contains many cells that were in S-phase for variable 
periods of the 2.25 hours of labelling in the experiment. This therefore gives an 
overall picture of nuclear position in the two genotypes. To get a snapshot of 
nuclear position immediately after injection, the position of BrdU-positive nuclei 
was analysed in embryos that had been exposed to BrdU for only 15 minutes. Nuclei 
should all be, or have been, in S-phase just prior to collection. In the MHP as well as 
the lateral regions, p21-/- nuclei were slightly, but not significantly, more basal than 
wild-type. In the V-shaped neural plate this same trend was seen. When combining 
the forming and mature plate, I found that p21-/- nuclei in the MHP were slightly 
more basal than p21+/+ whereas in the lateral region no difference was seen. To 
conclude, there is not a big difference in nuclear position between mutant and wild-
type embryos at this early phase, and changes in S-phase length and overall nuclear 
apico-basal position (IdU) observed later are likely to take more time than 15 
minutes to occur. Considering that the reduced S-phase length in the MHP of p21-/- 
embryos is still 3.2-3.9 hours, 15 minutes is a very short time to see any differences. 
Calculating overall nuclear position in the MHP and lateral regions with DAPI would 
be informative, but was not possible due to technical difficulties with the DAPI 
staining.  
Lastly, cell cycle phase distribution of BrdU positive cells was estimated to see if 
there were fewer cells in early/mid S-phase in the mutant setting. As for the nuclear 
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position of BrdU positive cells, 15 minutes is likely to be too short to see a 
difference as cell phase distribution was very similar in the p21-/- and p21+/+ MHP. 
Surprisingly, p21-/- nuclei in the lateral region tended to be in early/mid S-phase and 
not in late S or G2 phase as seen in the wild-type embryos. This analysis was done 
by approximation only, by looking at the BrdU staining pattern, and is therefore not 
very reliable. It does, however, give an idea of the overall trend of the cell phases. 
In conclusion, I have shown that S-phase is significantly reduced in the absence of 
p21, and that p21 is strongly implicated as being responsible for the regional 
difference in S-phase length between the MHP and lateral non-bending regions, as 
this difference is abolished in the absence of p21. I have not detected changes in 
MHP morphology or major changes in the apico-basal position of MHP nuclei. It is 
possible that there is redundancy between p21 and p27 and/or p57 in the MHP and 
that these other genes keep the nuclei at a basal position, independently of cell 
cycle prolongation. The fact that the long S-phase in the MHP is abolished upon loss 
of p21 suggests that: 1) the role of p21 in prolonging S-phase specifically in the MHP 
is not redundant, and 2) prolongation of S-phase in the MHP is not necessary for 
MHP formation and neural tube closure. The long S-phase might be the result, 
rather than the cause, of the cell shape changes occurring in the MHP during neural 
plate bending. However, it is hard to imagine how cell shape changes would be due 
to cell-cycle-independent changes in IKNM, resulting in secondary effects on the 
length of S-phase, since IKNM does not affect cell cycle progression (Ueno et al., 
2006).   
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Chapter 6 - CIP/KIP genes are redundant in MHP 
formation 
6.1 Introduction 
Electroporation of developing mouse embryos enables gene manipulation that is 
relatively cheap with the possibility of knocking down several genes at once, 
avoiding the problem of genetic redundancy often observed in genetic mutant 
mice, or overexpressing several genes locally. The development of culture methods 
of intact mouse embryos provides the means to study neural tube development 
(Cockroft, 1990) following gene manipulation by electroporation. Gene knock-down 
can be achieved with RNA interference (RNAi), which was discovered in C.elegans 
and in plants in the late 1990s (Calegari et al., 2004) and is based on double 
stranded RNA molecules that can silence the expression of genes with 
complementary sequences. Overexpression can be achieved with plasmids that 
express any gene of interest. 
In Chapter 3 I showed that p21, p27 and p57 are expressed in the MHP region 
during early neurulation. In the present chapter, I aimed to test whether the CIP/KIP 
genes are necessary or sufficient for MHP induction. I electroporated siRNAs to 
achieve knock-down, or plasmids to overexpress CIP/KIP genes in the neural plate. 
The aim was to abolish CIP/KIP genes in the MHP to see if loss of the inhibitors led 
to a shorter S-phase, fewer wedge shaped cells, and a broader MHP (Figure 6.1, A). 
On the other hand, I planned to overexpress the genes in the lateral neural tube to 
see if a high local concentration of p21, p27 and p57 would be sufficient to cause an 
ectopic hinge point. Due to technical difficulties it was not possible to routinely 
target the lateral neural plate, and instead I targeted the MHP to examine whether 
the midline bend would be sharper with more basal nuclei in an overexpressing 
setting (Figure 6.1, C).  
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For the knock-down experiments, a p57 siRNA or a GC-matched control siRNA was 
electroporated into neural plates of p21+/+ and p21-/- embryos, using a tagged 
fluorescent oligo to trace the electroporated siRNA. For the overexpression, p27 
and/or p57 cDNA in bi-cistronic expression plasmids that also expressed EGFP (Tury 
et al., 2011), were electroporated into the neural tube together with a plasmid 
expressing p21. 
 
 
Figure 6.1 - Manipulating CIP/KIP gene expression by electroporation 
In order to achieve a scenario where CIP/KIP genes are downregulated or overexpressed, siRNAs or 
plasmids were electroporated into the neural plate at E7.5 (A-C). The hypothesis was that 
downregulation of CIP/KIP genes in the MHP would lead to a shorter S-phase, fewer basal cells, and 
a broader MHP (A). Overexpression of CIP/KIP genes in the MHP was hypothesised to lead to a 
prolongation of S-phase, cause an enrichment of basal cell nuclei, and exaggerate the MHP (C). 
Green wedges represent electroporated fluorescent cells.  
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6.2 Results 
6.2.1 Validating siRNA and plasmid in cell culture 
Prior to starting the work on genetic mouse mutants (Chapter 4), I attempted to 
manipulate p21 levels specifically in the neural tube by electroporation. I obtained 
two anti-p21 antibodies (p21 C-19 and p21 F-5, both from Santa Cruz 
Biotechnology) but found they did not detect p21 protein in immunohistochemistry 
of the embryonic neural tube. Hence, it was difficult to validate the siRNA and 
plasmid actions directly in electroporated embryos and so, as an alternative 
method, I used a cell culture system. For gene knock-down experiments, mouse 3T3 
fibroblasts were transfected with a p21 siRNA plus a GFP plasmid or a GC-matched 
siRNA control with a random sequence +GFP. For overexpression experiments, the 
3T3 cells were transfected with a p21 plasmid plus a GFP plasmid or with the GFP 
plasmid alone. A standard approach was taken using the widely available 
transfection reagent, Lipofectamine-2000. RNA was extracted from the cells 24 
hours after transfection and p21 levels were quantified by qRT-PCR. The 
transfection efficiency was estimated by calculating the ratio of GFP transfected 
cells to total nuclei.  
Following transfection with p21 siRNA +GFP, a dose dependent decrease in p21 
expression was observed for 10 pmol and 25 pmol concentrations of siRNA 
compared to transfection with GFP alone (Figure 6.2). p21 knock-down with a 
higher dose, i.e. 50 pmol siRNA, did not reduce p21 expression further. The 
reduction in p21 expression was not observed with the GC-matched siRNA control 
+GFP or GFP alone (Figure 6.2). p21 expression was significantly decreased in cell 
transfected with p21 siRNA compared to siRNA control (p<0.001; Two way ANOVA) 
although the difference between the concentrations of p21 siRNA was not 
statistically significant. Transfection of cells with the p21 plasmid +GFP led to a 3-
fold overexpression of p21 mRNA levels compared to GFP on its own (Figure 6.2). It 
was found that transfection of cells with GFP alone consistently led to higher 
expression levels of p21. To assess if this was a specific response to the GFP plasmid 
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or a stress response to the transfection procedure itself, a random plasmid (Msx2) 
of the same size as GFP was transfected into the cells. Msx2 transfection resulted in 
an up-regulation of p21 gene expression, similar to that observed for GFP alone, 
compared to untreated cells (Figure 6.2). The difference in p21 expression following 
transfection with GFP only or Msx2 was not significant (p=0.147; One way ANOVA). 
Furthermore, the transfection reagent, Lipofectamine-2000, led to slight up-
regulation of p21 gene expression compared to non-treated cells (Figure 6.2). 
The transfection efficiency of the different treatments was roughly equal as 
estimated by the amount of GFP-positive cells (Figure 6.3). GFP-positive cells and 
DAPI stained nuclei were counted manually in three random fields of view in Image 
J to estimate transfection efficiency, calculated as the percentage GFP-positive cells 
to total nuclei (Figure 6.4). The cells were confluent at the end of transfection, 
making it difficult to distinguish GFP positive cells from one another and get an 
accurate number (Figure 6.3). For that reason the efficiency presented in Figure 6.4 
is probably an underestimate of the actual efficiency. The efficiency ranged from 
32% to 45% with SEM values ranging from 1.4 % to 7.9 % (Figure 6.4). While 
perhaps not accurate, the transfection efficiency indicates that the failure of the 
highest concentration of p21 siRNA to further knock-down p21 gene expression was 
not due to lower transfection efficiency. Statistically, there was no significant 
difference between the treatments (p=0.178; One-way ANOVA). 
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Figure 6.2 – p21 levels can be manipulated in cell culture 
A 3T3 fibroblast cell culture system was used to validate knock-down by the p21 siRNA and 
overexpression by the p21 plasmid. p21 siRNA +GFP caused a significant, dose dependent reduction 
in p21 gene expression compared to siRNA control (p<0.001; Two way ANOVA). The reduction in p21 
mRNA levels was not observed with the control siRNA +GFP. The p21 plasmid +GFP resulted in a 3 
fold increase in p21 expression compared to GFP alone. Furthermore, an unspecific upregulation of 
p21 expression was observed with GFP alone, the random plasmid Msx2, or Lipofectamine compared 
to untreated cells. Error bars are +/-SEM. Three samples were assayed per treatment group. 
0.43 
0.26 0.31 
1.12 
0.95 1.05 0.94 
3.00 
1.11 
0.75 0.68 
0
0.5
1
1.5
2
2.5
3
3.5
Relative expression of p21 
  
210 
 
 
Figure 6.3 - Transfection efficiency of siRNA and/or plasmids in 3T3 cells 
The amount of GFP positive cells appears equal for all siRNA treatment groups. The cells are very 
confluent and difficult to distinguish from one another. n=3. 
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Figure 6.4 - Transfection efficiency in 3T3 fibroblasts 
Approximate transfection efficiency shown as the percentage of GFP-positive cells to total nuclei, 
counted in 3 random fields of views per treatment. The transformation efficiency (%) ranges from 
32% to 45%. Error bars are +/-SEM. There is no significant difference between the percentage of 
GFP-positive cells among treatments (p=0.178; One-way ANOVA). 
Due to time constraints and difficulty in finding a cell line that endogenously 
expressed p57, this analysis was not performed for p57. Nevertheless, the p21 
siRNA assay in 3T3 cells serves as a proof of principle for the commercially available 
siRNAs used in this thesis and the previously published plasmids. 
6.2.2 Electroporating the mouse neural plate 
All the electroporation experiments were performed at E7.5. Embryos were 
dissected from the uterus keeping the yolk sac and ectoplacental cone intact, and 
divided into a treatment and a control group (Figure 6.5, A). siRNA +tagged oligo or 
overexpressing plasmid(s) +fast green was injected into the amniotic cavity using a 
handheld mouth pipette. Injected embryos were immediately electroporated 
through the node region at the base of the embryo (Figure 6.5, B). 
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Figure 6.5 - Electroporation of E7.5 embryos 
Embryos at E7.5 were dissected and grouped into two identical treatment groups based on 
developmental stage (A), and subsequently injected with p57 siRNA or GC-matched control together 
with the tagged oligo. For overexpression experiments, embryos were allocated into three groups: 
one group was injected with p21 and p57, one group with p21, p27 and p57, and one group with GFP 
control. In the overexpressing experiments, fast green (0.01%) was used to visualise the plasmid 
mixture. The amniotic cavity was injected (B; arrow) until the amnion bulged slightly into the 
exocoelomic cavity. The embryos were subsequently electroporated through the node (*) and 
cultured for 24 hours in rat serum.  
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6.2.3 Overexpressing CIP/KIP genes in the neural plate midline 
Embryos electroporated with a GFP plasmid exhibit strong GFP expression along the 
neural tube and PNP after 24 hours of culture (Figure 6.6). The number of embryos 
with midline GFP expression was approximately 90% and only embryos showing 
GFP expression in the midline were processed for further analysis. Cross-sections 
through electroporated embryos reveal that GFP is expressed mainly in the midline 
(Figure 6.6, C’; arrow), consistent with work showing that the node region gives rise 
to the embryonic midline (Patten et al., 2003). Some cells in the medial part of the 
paraxial mesoderm are also GFP-labelled (Figure 6.6, C’; arrowheads). At E7.5, when 
the embryos were electroporated, neuromesodermal progenitors (NMps) are 
located in the node streak border in the anterior primitive streak and in the caudal 
lateral epiblast (Henrique et al., 2015). These NMps give rise to neural progenitors 
found in the CLE and PNP, and mesoderm progenitors contributing to presomitic 
mesoderm by E8.5 (Henrique et al., 2015). Consistent with the GFP labelled paraxial 
mesoderm, it has been suggested that individual NMps are retained caudally in the 
tail bud and give rise to cells that can contribute to neural as well as mesodermal 
lineages as the body axis extends (Tzouanacou et al., 2009).  
In order to further validate the p21 plasmid, embryos electroporated with p21 + 
GFP or GFP only were processed for in situ hybridisation following a 24 hour culture 
period. Five out of five embryos electroporated with the p21 plasmid showed 
ectopic p21 mRNA expression along the entire mouse midline in a pattern 
corresponding to the GFP expression observed at the end of culture (Figure 6.7, A-
A’). Embryos electroporated with GFP only showed midline GFP expression but 
none of three embryos displayed ectopic p21 expression (Figure 6.7, B-B’). A cross 
section through the PNP of a p21 electroporated embryo with subsequent 
detection of p21 mRNA by in situ hybridisation reveals cells with strong ectopic p21 
expression that are centred around the midline (Figure 6.7, A’’). This analysis was 
not done using the p27 and p57 expression plasmids due to time constraints, as 
these plasmids came into my possession at a very late stage in my PhD. However, I 
can conclude that the p21 plasmid induces strong ectopic expression of p21 in cell 
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culture as well as in an intact mouse embryo culture system. The p27 and p57 
plasmids have been shown to induce expression of p27 and p57 when 
electroporated in utero during corticogenesis (Tury et al., 2011). 
In order to see if overexpression of the CIP/KIP genes in the neural plate is sufficient 
to cause an exaggerated midline bend, CD1 embryos were electroporated with p21 
and p57, p21, p27 and p57, or the p27 and p57 backbone plasmid expressing EGFP 
only (Tury et al., 2011). As the p21 expression plasmid does not express GFP, it was 
assumed that the plasmid would enter the same cells as the EGFP tagged p27 and 
p57 plasmids. None of the electroporated embryos displayed any morphological 
MHP changes regardless of treatment (Figure 6.8). Electroporated GFP-positive cells 
were observed scattered throughout the medial part of the neural plate, and in fact 
relatively few GFP-positive cells were located in the MHP (Figure 6.8) although 
quantification revealed that the number of GFP-positive cells on average was higher 
in the MHP than in the lateral regions (Table 6.1). Hence, my aim of overexpressing 
the CIP/KIP proteins specifically at high levels in the MHP was not achieved in this 
experiment. 
One embryo that was electroporated with both p21 and p57 expression vectors 
contained a cluster of GFP-positive cells that coincided with a slight indentation of 
the lateral neural plate resulting from basal nuclei in that region (Figure 6.8, C and 
Figure 6.9). This suggests that at high density, p21 and p57 overexpression might be 
sufficient to induce bending, although this is hard to test in this system due to the 
scarcity of overexpressing cells. Interestingly, in another embryo electroporated 
with both p21 and p57, the majority of GFP-positive nuclei were very apical, 
suggesting that p21 and p57 overexpression does not necessarily result in basal 
nuclei (Figure 6.8, B-B’’; arrows). Triple overexpression did not have any effect on 
midline bending. This was not due to a lower number of overexpressing cells in the 
MHP compared to the other treatments (Table 6.1), although electroporated cells 
are likely to be too few and scattered to induce localised bending (Figure 6.8). This 
is true for all the treatment groups. 
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Interestingly, most of the embryos electroporated with CIP/KIP genes exhibited 
dorsolateral hinge points (DLHPs): this was true of 3 out of 6 embryos 
electroporated with p21/p57 and 3 out of 3 embryos electroporated with 
p21/p27/p57. This is something I never observed at this stage in non-electroporated 
embryos, and only rarely in embryos electroporated with GFP only (1 out of 4) or 
siRNAs (0 out of 9). It might suggest a role for enhanced CIP/KIP expression in 
regulating DLHPs, although the dorsal most neural plate, where DLHPs are located, 
was only rarely GFP-positive in these embryos. 
 
Figure 6.6 - Example of electroporated embryo 
Electroporation of a GFP plasmid at E7.5 with a 24 hour subsequent culture period leads to GFP 
midline expression in approximately 90% of embryos (A-C). Cross-section through the embryo shown 
in C reveals a number of wedge shaped cells in the MHP (C’; arrow). Note also the GFP labelled cells 
in the paraxial mesoderm which probably reflects electroporation of the primitive streak (C’; 
arrowheads), as well as the node. Scale bar = 30 μm.   
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Figure 6.7 - p21 plasmid electroporation causes ectopic expression of p21 mRNA at E8.5 
Embryos at E7.5 were electroporated with p21+GFP (A), or GFP only (B) and cultured for 24 hours. 
Note that both types of embryo show closely similar patterns of GFP expression (compare A and B). 
However, subsequent analysis by in situ hybridisation reveals dramatically increased expression of 
p21 along the midline in p21-electroporated embryos, corresponding to the GFP positive region (A-
A’). Embryos electroporated with GFP do not show ectopic p21 expression (B-B’). Section through 
the PNP of an embryo electroporated with p21+GFP shows p21-expressing cells throughout the 
middle part of the neural plate, and not restricted to the MHP (A’’). The level of section A’’ is 
indicated on A’. Scale bars = 500 μm (A-B) and 50 μm (C). 
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Figure 6.8 - Overexpression of CIP/KIP genes does not affect apparent MHP morphology at E8.5 
Embryos electroporated at E7.5 with GFP control (A), or expression plasmids for p21 and p57 (B-C) or 
p21, p27 and p57 (D) have normal MHPs. Note the amount of wedge shaped cells in the MHP of a 
control embryo (A’-A’’; arrows). Not all cells electroporated with p21 and p57 are basal (B-B’’; 
arrows) but an embryo with a group of cells strongly expressing p21 and p57 shows a distinct 
indentation in the lateral neural plate (C-C’’; arrows). Triple overexpression does not lead to any 
alteration in MHP appearance (D-D’’). Scale bars = 30 μm. 
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Figure 6.9 - A cluster of p21/p57 overexpressing cells coincides with indentation of neural plate 
High density of EGFP indicative of p21 and p57 overexpression coincides with a region of relatively 
basal nuclei in the lateral neural plate, leading to indentation (inside white dotted box). Scale bars = 
30 μm. 
Nuclear position was quantified in embryos electroporated with plasmids 
expressing both p21 and p57; p21, p27 and p57, or GFP control. A region of at least 
10 cells (GFP +ve and –ve) in the MHP and in the right and left lateral non-bending 
region was selected and the distance from the centre of the nucleus to the basal 
neuroepithelium was measured and presented as a proportion of total 
neuroepithelial distance (Figure 6.10, top). As in non-electroporated embryos, the 
MHP has significantly more basal nuclei than lateral regions (Figure 6.10, top). 
Embryos electroporated with p21 and p57 have significantly more basal nuclei in 
the MHP compared to embryos electroporated with p21/p27/p57, but not GFP 
only. In the lateral neural tube there is no difference between treatments. 
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However, the number of electroporated cells in the neural plate was generally low 
in this experiment (Table 6.1). Hence, the overexpressing plasmids were perhaps 
not expressed at high enough levels to cause an overall effect on nuclear 
localisation in either MHP or lateral regions.  
Next, nuclear localisation was quantified in GFP positive (i.e. electroporated) cells 
only. I expected there to be a trend towards overexpressing cells having more basal 
nuclei, as the CIP/KIPs are able to inhibit the cell cycle in late G1-/S-/early- G2 phase 
when nuclei are mostly basal. While MHP cells have significantly more basal nuclei 
than lateral cells, there is no significant difference in nuclear localisation between 
the treatments in the MHP or in the lateral neural plate (Figure 6.10, bottom). Triple 
overexpression in the MHP is, however, again associated with more apical nuclei 
than double overexpression, suggesting that p27 might serve to counteract the 
effect of p21 and p57 in inducing a basal nuclear position. p21, p27 and p57 have all 
been shown to inhibit the cell cycle in G1 phase when they are overexpressed (Fero 
et al., 1996; Harper et al., 1995; Lee et al., 1995). It is possible that they could have 
this effect in electroporated embryos, and so inhibit the cell cycle in G1-phase, 
when nuclei might have a relatively apical position.  
In order to examine whether GFP-positive nuclei were more likely to be basal 
compared to GFP-negative nuclei in the same region, basal nuclear distance of GFP-
positive cells was compared to GFP-negative cells in the MHP and lateral regions for 
each treatment group. No significant difference was found in nuclear position for 
GFP-positive double overexpressing nuclei or triple overexpression nuclei compared 
to GFP-negative cells not overexpressing the CIP/KIP genes in the MHP or lateral 
regions (Table 6.2). Surprisingly, GFP-positive cells in the control group (empty GFP 
plasmid) were significantly more basal than GFP-negative cells (p=0.003). The 
reason for this result is unknown. However, as the control plasmid was not 
sequenced for verification upon arrival, there is a possibility that the plasmid is not 
empty.  
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Table 6.1 - Quantification of the number of cells analysed for nuclear position at E8.5 
The total number of cells analysed per treatment is shown with the number of GFP +ve cells in 
parentheses. Note that on average, 2.6-5.4 GFP+ve cells were observed in the MHP while the 
number of GFP+ve cells was very small in the lateral regions analysed.  
 
  Cells analysed (GFP+) Cells per section 
 #Sections MHP lat MHP lat 
p21 and p57 15 171 (39) 197 (22.5) 11.4 (2.6) 13.1 (1.5) 
p21, p27, p57 9 133 (47) 111 (0) 14.8 (5.2) 12.3 (0) 
GFP control 14 174 (75) 171 (13) 12.4 (5.4) 12.2 (0.9) 
  
221 
 
All cells (GFP +ve and -ve)
p21/p57 p21/p27/p57 GFP p21/p57 p21/p27/p57 GFP
A
p
ic
o
-b
a
s
a
l 
a
x
is
 (
0
=
b
a
s
a
l,
 1
=
a
p
ic
a
l)
0.0
0.2
0.4
0.6
**
MHP Lateral region
 
GFP +ve cells
p21/p57 p21/p27/p57 GFP p21/p57 p21/p27/p57 GFP
A
p
ic
o
-b
a
s
a
l 
a
x
is
 (
0
=
b
a
s
a
l,
 1
=
a
p
ic
a
l)
0.0
0.2
0.4
0.6
MHP Lateral region
47-75 cells
  
  
222 
 
Figure 6.10 – Effect of overexpressing CIP/KIP genes on nuclear position in the neural plate 
Embryos electroporated with p21/p57, p21/p27/p57, or GFP control at E7.5 and cultured for 24 
hours were analysed for average nuclear position. Basal nuclear distance was measured in >10 cells 
in the MHP and in right and left lateral non-bending regions regardless of GFP status (top), or only in 
GFP positive cells (bottom). Top: Embryos electroporated with p21/p57 have significantly more basal 
nuclei than triple overexpression (p<0.001; Two way ANOVA). Comparisons of p21/p57 vs GFP and 
p21/p27/p57 vs GFP are not significant (Two way ANOVA). There is a significant difference between 
nuclear position in the MHP and lateral region (p<0.001) but not between treatments in the lateral 
region (Two way ANOVA). Bottom: there is no significant difference between treatments in either 
region while nuclear position between the MHP and the lateral regions is significantly different 
(p=0.02; Two way ANOVA). Error bars are +/-SEM. 
 
 GFP +ve (mean +/-SEM) GFP-ve (mean +/-SEM) 
 MHP lateral MHP lateral 
p21 and p57 0.31 (0.06) 0.44 (0.05) 0.31 (0.01) 0.46 (0.01) 
p21, p27, p57 0.39 (0.02) - 0.36 (0.01) 0.45 (0.01) 
GFP control* 0.30 (0.04) 0.34 (0.05) 0.37 (0.02) 0.45 (0.01) 
Table 6.2 - Basal nuclear distance (mean +/-SEM) for GFP +ve and GFP -ve nuclei 
Mean basal nuclear distance of GFP +ve and GFP –ve nuclei measured on 9-15 sections from at least 
3 embryos per treatment. Difference between basal nuclear distance is not significant between 
GFP+ve and GFP-ve cells for p21/p57 (p=0.57; Two-way ANOVA) or p21/p27/p57 (p=0.24; t-test). 
GFP+ve cells are significantly more basal than GFP–ve cells in the control group (p=0.003; Two way 
ANOVA). Cells of the MHP are more basal than lateral cells in all treatment groups. This difference is 
significant for p21 and p57 treated embryos (p<0.001).  
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6.2.4 p57 knock-down in a p21-/- background 
Under the experimental conditions I used, overexpression of the CIP/KIP genes was 
not found to be sufficient to induce increased ‘MHP-like’ bending of the neural 
plate. To test whether CIP/KIP genes are necessary for MHP bending, I 
electroporated a p57 siRNA into the neural plate of p21+/+ and p21-/- embryos to 
achieve double knock-down of p21 and p57. A tagged oligo was used together with 
p57 siRNA or the GC-matched siRNA control that could be visualised in the midline 
of successfully electroporated embryos after 24 hours of culture (Figure 6.11, B; 
arrow). Only embryos where the tagged oligo could be visualised in the neural tube 
were analysed. A cross section through an embryo with siRNA in the midline reveals 
that most of the siRNA is targeted to and around the MHP (Figure 6.11, D). 
In order to validate knock-down by the p57 siRNA, CD1 embryos were 
electroporated with p57 siRNA or siRNA control together with the tagged oligo. 
After 24 hours of culture, embryos that were labelled in the midline with the tagged 
oligo were processed for in situ hybridisation with a probe against p57 mRNA. None 
of the five embryos electroporated with the p57 siRNA display p57 mRNA in the 
neuroepithelium or the notochord (*) although expression is maintained in the 
hindgut (arrow) (Figure 6.12, A-C’). In contrast, all 4 embryos electroporated with 
the control siRNA show the presence of p57 mRNA in the neuroepithelium and 
notochord as well as in the hindgut (Figure 6.12, D-F’). The loss of p57 mRNA in the 
neuroepithelium was very consistent between embryos as shown in Figure 6.13. 
The complete loss of p57 is astonishing considering the low efficiency of GFP 
electroporated cells shown in Figure 6.8 and the extent of siRNA speckles shown in 
Figure 6.11. It is possible that the loss of p57 from the neural plate is a secondary 
effect resulting from the initial knock-down of p57 in the node which could affect 
several pathways that, in turn, could result in complete loss of p57 in some tissues, 
e.g. the neural plate. 
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Figure 6.11 - siRNA is targeted to the neural plate midline 
Electroporating a tagged siRNA through the node at E7.5 labels the neural plate midline after 24 
hours of culture (B; arrow). This uptake can be visualised in cross-sections (D; arrow).  
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Figure 6.12 - siRNA mediated knockdown of p57 abolishes mRNA in the neuroepithelium at E8.5 
Embryos were collected at E7.5 and electroporated with p57 siRNA or a GC control siRNA and 
cultured for 24 hours. Embryos with midline expression of the tagged oligo were processed for 
whole mount in situ hybridisation for p57 and sectioned. 5/5 embryos electroporated with p57 
siRNA have lost the expression of p57 in the neuroepithelium (inside dotted lines) and the notochord 
(*), whereas staining is retained in the ventral hindgut (arrow) (A-C’). All 4 controls have retained 
staining in the neuroepithelium, notochord and hindgut. Scale bars = 500 μm (A-F) and 50 μm (C’ and 
F’). 
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Figure 6.13 - Consistent loss of p57 mRNA upon siRNA treatment 
Sections through 5 different embryos (A-E) electroporated with p57 siRNA at E7.5 all show loss of 
expression of p57 in the neuroepithelium (inside dotted lines) and in the notochord (*) at E8.5 (A-E). 
Hindgut expression (arrow) is seen in all siRNA-treated embryos. In contrast, sections through 4 
different control embryos show p57 mRNA in the neuroepithelium, notochord, and hindgut (F-I). 
Scale bars 50 = μm. 
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In order to quantify the knock-down by p57 siRNA, neural tube midlines were 
dissected from E8.5 CD1 embryos using tungsten needles (Figure 6.14, A; along 
white dashed lines). The tagged oligo is detected in isolated midlines and is localised 
to the neural tube rather than the notochord which was not removed from the 
neural tube (Figure 6.14, B-D; arrows). 
6-7 isolated neural midlines were pooled per sample and the level of p57 mRNA as 
well as p21 and p27 was quantified by qRT-PCR (Figure 6.15). p57 mRNA is reduced 
following electroporation of p57 siRNA compared to siRNA control, although the 
reduction does not reach statistical significance (Figure 6.15). p21 and p27 
expression in the same midlines is slightly increased although the three replicate 
samples vary somewhat. Thus, taking together both the embryo in situ hybridisation 
and qRT-PCR studies of isolated midlines, I can conclude that p57 expression is 
consistently and specifically reduced in the neural plate of embryos electroporated 
with p57 siRNA. 
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Figure 6.14 - Isolated neural plate midlines specifically express a tagged siRNA 
Neural midlines were isolated from embryos at E8.5, 24 hours after electroporation with a tagged 
siRNA together with p57 siRNA or control siRNA. Embryos were digested in 2% pancreatin before the 
midline was dissected out with tungsten needles along the indicated lines, taking care not to collect 
somites (dotted squares) (A). Neural plate midlines were collected along with the most caudal flat 
neural plate (B; arrows). The tagged siRNA can be visualised specifically along the length of the 
dissected neural midlines. Note that the strongest expression domain is in the neural tube and not in 
the underlying region containing the notochord (B-C; arrowhead). 6-7 midlines were pooled per 
sample. Samples were subsequently quantified for CIP/KIP mRNA by qRT-PCR. 
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Figure 6.15 - p57 mRNA is reduced in siRNA treated isolated CD1 neural midlines 
CD1 embryos at E7.5 were electroporated with CIP/KIP siRNAs or control siRNA followed by a 24 
hour culture. CIP/KIP mRNA levels were assayed in three samples of 6-7 pooled midlines from each 
treatment group. Gene expression was determined by qPCR relative to expression in control siRNA 
samples. p57 mRNA levels were reduced following p57 siRNA treatment although not statistically 
significant. p-values, as determined by Student’s t-test, are shown on the graph.  
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I have shown that the p57 siRNA is efficient in abolishing p57 mRNA in the neural 
plate of mouse embryos. To examine the requirement for CIP/KIP function in 
midline bending, a few embryos that were wild-type or deficient for p21 were 
electroporated with p57 siRNA to achieve double knock-down in the mutant 
embryos. The number of embryos in this analysis is very small and this is therefore a 
very preliminary result. 
p21-/- embryos electroporated with p57 siRNA do not display abnormal MHP 
bending (Figure 6.16, A-B) compared to p21-/- embryos treated with the control 
siRNA (Figure 6.16, C-E) although the ‘double mutant’ MHP looks blunted (especially 
Figure 6.16, B). p57 knock-down on a p21 deficient background was further 
examined by measuring the nuclear position of cells in the MHP. There was no 
statistically significant difference between the nuclear position in the MHP of p21-/- 
or p21+/+ embryos treated with p57 siRNA or control siRNA (Figure 6.17), although 
one p57 siRNA treated p21-/- embryo had an average nuclear position higher than 
controls (Figure 6.17).  
  
232 
 
 
Figure 6.16 - p21/p57 knockout does not abolish the MHP 
p21
-/-
 embryos were electroporated with p57 siRNA at E7.5 and cultured for 24 hours. One out of 
two p21
-/-
 p57 siRNA treated embryos has a blunted MHP (B) compared to the sharp, typical bend in 
C-E, suggesting that MHP formation might be altered in the absence of p21 and p57. Scale bars = 30 
μm. 
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Figure 6.17 – Nuclear position following siRNA mediated knock-down of p57 
p21
-/-
 and p21
+/+
 embryos electroporated at E7.5 with p57 siRNA or a control siRNA were analysed 
for average nuclear position in the MHP after a 24 hour culture. Each point represents an embryo 
with +/-SEM for each embryo. The difference in the mean values between treatments is not 
significant after accounting for genotype (p=0.84; Two way ANOVA). 
6.3 Discussion 
In this chapter I attempted to test the significance of MHP expression of p21, p27 
and p57 by testing whether these genes are necessary or sufficient for MHP 
formation. I used a whole embryo culture system to manipulate CIP/KIP levels in the 
neural plate of intact mouse embryos. Electroporation of the mouse neural plate 
was reproducible and reliable, with evident results on p21 and p57 gene expression.  
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6.3.1 Overexpression of CIP/KIPs 
In all overexpressing experiments the number of electroporated cells in the neural 
tube was sparse as revealed by the number of cells with ectopic expression of p21 
(in situ hybridisation), as well as the number of GFP positive nuclei indicating 
overexpressing CIP/KIP cells.  
Overexpression of the CIP/KIP genes did not affect overall MHP morphology. It is 
difficult to say whether this is due to the low number of GFP-positive cells observed. 
It is clear, however, that if indentation of the neural plate is the result of 
simultaneous basal expansion of a group of cells, due to basal nuclear position, then 
2-5 scattered overexpressing cells would be unlikely to be sufficient to cause 
bending. The lack of effect on the apico-basal position of nuclei (GFP +ve and –ve) in 
the MHP is in line with the low occurrence of overexpressing cells. It is, however, 
surprising that basal position of GFP-positive nuclei is so similar to that of the total 
number of nuclei in the MHP or lateral regions, and suggests that overexpression of 
the CIP/KIP genes is not sufficient to induce basal expansion. In fact, p21 and p57 
overexpressing nuclei were particularly apical in one embryo analysed. There was, 
however, one embryo with a high density of the p21 and p57 overexpressing 
plasmids that had an ectopic indentation in the lateral neural plate. This suggests 
that, at high densities, p21 and p57 might be able to induce an ectopic hinge point. 
The only expression plasmid that had an effect on nuclear position in the MHP was 
the GFP control plasmid that should not express additional genes. The difference 
between basal distance of GFP +ve and GFP –ve nuclei of control embryos was 
statistically significant, suggesting that the plasmid induced basal expansion in the 
MHP and in the lateral region. The plasmid has not been sequenced for verification. 
In light of these experiments, that would be important to do. 
Electroporated embryos that overexpressed the CIP/KIP genes had a tendency to 
form premature DLHPs at E8.5. In the mouse, Bmp2 expression in the dorsal neural 
folds inhibits DLHPs during early neurulation when the neural plate is V-shaped 
(Ybot-Gonzalez et al., 2007a). As neural tube closure proceeds in the caudal 
direction, Noggin expressed from the notochord inhibits Bmp2 and DLHPs form 
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(Ybot-Gonzalez et al., 2007a). In neural stem cells, p21 directly represses Bmp2 at 
the transcriptional level and loss of p21 leads to upregulation of Bmp2 mRNA and 
protein (Porlan et al., 2013). Addition of p21 or Noggin prevents Bmp2 upregulation 
(Porlan et al., 2013). Thus, in p21 overexpressing embryos, Bmp2 in the dorsal 
neural folds might be inhibited, allowing premature DLHPs to form. 
A lot of time was spent on optimising the electroporation technique in order to 
achieve the maximum number of electroporated cells. In order to target the neural 
plate midline, the node was electroporated. Because the node lays down cells of 
the midline, the original population of electroporated cells goes through many 
rounds of cell division, and, judging by the GFP-positive cells observed on sections, 
leaves behind between 2.6 and 5.4 cells in the MHP at any one axial level. Hence, 
although the neural plate midline can be targeted by electroporation, it will be hard 
to achieve a higher density of GFP-positive cells in the MHP using the current 
method. The aim was to overexpress the CIP/KIP genes in the lateral neural folds by 
electroporating this region in E8.5 embryos. This could have led to a concentrated 
population of overexpressing cells. Unfortunately, this method did not work well. 
In the chick midbrain, Noggin overexpression has been shown to cause ectopic 
hinge point formation even with low electroporation efficiency (Eom et al., 2012). 
Furthermore, the plasmid concentrations used in that study (0.02-5 μg/μl) (Eom et 
al., 2012) correspond to the concentrations I have used (3.2 μg/μl). Thus, it is 
possible that my experiment worked but gave a negative result. 
6.3.2 Double CIP/KIP deficiency in the neural plate 
Although the number of GFP-positive cells in the overexpressing experiments was 
very scarce in the neuroepithelium, siRNA knock-down of p57 by the same method 
resulted in consistent and total abolition of p57 mRNA in the neuroepithelium. The 
siRNA result is curious, suggesting that the whole neural plate and notochord are 
targeted, in contrast to what is indicated by the GFP expression in the 
overexpressing experiments. It could be speculated that the siRNA is smaller and 
enters cells more easily than the larger plasmids during electroporation. I have, 
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however, accounted for this: in experiments where the GFP plasmid and the tagged 
oligo were electroporated together, I found that 94% of cells labelled with the 
siRNA had also taken up the GFP plasmid. It is more likely that the complete loss of 
p57 from the neural plate is secondary as a result of p57 knock-down in the node. 
Importantly, the p57 in situ hybridisation data following knock-down suggests that 
p21-/- p57 siRNA treated embryos are in fact double null in the neural plate. The 
MHP looks blunted in one of the ‘double null’ embryos, and the other embryo has 
an average nuclear distance from the basal surface greater than that of p21-/- 
embryos electroporated with a control siRNA. As the knock-down effect of the p57 
siRNA is very striking, it would be very important to repeat these experiments in 
p21-/- embryos in order to analyse nuclear position and MHP shape in a larger 
number of embryos. 
Interestingly, the embryos electroporated with the p21 and p57 expression 
plasmids have an average distance from the basal surface of the neural plate of 
between 3 and 3.2 whereas the two p21-/- embryos electroporated with p57 siRNA 
have values of 3.6 and 4.3. An interpretation of these results could be that 
overexpression makes the nuclei more basal and double knock-down more apical. It 
is, however, worth keeping in mind that CD1 mice were used for the overexpression 
experiments and p21 mice for the knock-down. Furthermore, the differences 
observed in apico-basal position are quite small. 
6.3.3 Role of p27 in basal expansion? 
p27 is expressed in G1 phase and the expression has been suggested to keep cells 
from entering S-phase. Consequently, p27 levels have to fall for cells to enter S-
phase (Moran and Rice, 1976). Thus, it could be that overexpression of p27 
prevents the cells from entering S-phase, thereby inhibiting basal expansion and 
abolishing the effect p21 and p57 seem to have on nuclear position. Furthermore, 
loss of p57 is associated with increased S-phase entry in cortical precursors (Mairet-
Coello et al., 2012) and overexpression leads to G1-phase arrest (Lee et al., 1995; 
Matsuoka et al., 1995) suggesting that p57 might be preventing cells from entering 
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S-phase in some systems. On the other hand, G1- and S-phase length was reduced 
in ventricular zone precursors in the absence of p57, suggesting a role for p57 in 
regulation of S-phase length (Mairet-Coello et al., 2012) although the effect was 
much more pronounced on G1-phase length. p21 overexpression has also been 
found to inhibit the cell cycle in G1-phase (Harper et al., 1995) whereas RNA 
mediated knock-down was suggested to be permissive of S-phase entry (Nakanishi 
et al., 1995). It could therefore be that a high level of the CIP/KIP genes in general 
prevents S-phase entry. Thus, high levels of p21, p27 and p57 specifically in the 
MHP could block cells at the G1/S-phase transition when cells are not necessarily 
basal. 
6.3.4 Analysing the cell cycle in the embryo culture system 
The aim was to use thymidine analogues with pHH3 to analyse changes in the cell 
cycle following overexpression and knock-down of CIP/KIP genes, similar to the 
analysis in Section 5.2.2. Many attempts were made to make use of thymidine 
analogues in the embryo culture system. EdU was tested extensively while IdU and 
BrdU labelling was attempted once. As previously found in our laboratory, BrdU 
labelling in culture resulted in poor tissue penetrance. The same was found for IdU. 
EdU worked very well on a couple of occasions, but failed to work in the final 
experiments despite changing the reagents one by one and re-testing on positive 
samples. An alternative could have been Ki67 which is expressed in all phases of the 
cell cycle and is useful as a tool to assign cells to individual phases based on the 
staining pattern (Braun et al., 1988). 
In conclusion, overexpression of CIP/KIP genes does not lead to an exaggerated 
MHP. Whether this is due to low transfection efficiency or because CIP/KIP 
overexpression causes G1-phase arrest is unknown. Thymidine labelling would have 
revealed whether the cells were blocked prior to S-phase. p57 knock-down in a  
p21-/- background results in a p21/p57 deficient neural plate but does not prevent 
MHP formation. Further studies are required to assess whether MHP formation is 
affected in these ‘double mutant’ neural plates.  
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Chapter 7 - General discussion 
In this thesis I have shown that the cyclin-dependent kinase inhibitor family CIP/KIP 
is expressed in the MHP during mouse neurulation, in a spatial and temporal 
pattern that fits with formation of the MHP. p21 was shown to be strongly 
implicated in being responsible for the prolongation of S-phase that accompanies 
midline furrowing and the transition of the medial neural plate into a wedge shaped 
population. In the absence of p21, S-phase in the MHP and lateral region was 
essentially the same, which is contrary to the wild-type setting where S-phase is 
prolonged by roughly 30%. Importantly, MHP formation is apparently normal in 
p21-/- embryos, showing that a prolonged S-phase is not necessary for MHP 
formation. Overexpression of the CIP/KIPs did not lead to exaggerated bending but 
rather caused ectopic DLHPs, possibly through p21 mediated inhibition of Bmp2 in 
the dorsal neural folds. Knock-down of p57 in the neural plate in a p21-/- 
background did not abolish MHP formation but in a small sample number there 
seemed to be an effect on the ‘sharpness’ of the MHP. 
7.1 Mechanisms of MHP formation 
There has been a lot of focus on basal expansion and cell cycle prolongation 
regarding MHP formation in the mouse and chick neural plate. I have shown that 
loss of p21 is sufficient to abolish the regional differences in S-phase length in the 
MHP. Importantly, a prolonged S-phase in the MHP is not necessary for MHP 
formation. This is evident in p21-/- neural plates which are morphologically 
indistinguishable from wild-type embryos.  
There is some evidence that cell wedging might precede neural plate bending as 
discussed in Chapter 3 (McShane et al., 2015; Smith and Schoenwolf, 1987; Smith 
and Schoenwolf, 1988). However, in light of the findings of this thesis it seems 
possible that cell cycle driven cell wedging is not responsible for MHP formation. On 
the other hand it seems unlikely that bending of the neural plate causes cell 
wedging by compression of the cells by crowding. Firstly because cell wedging has 
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been reported in neural plate midlines that have been separated from lateral 
tissues (Alvarez and Schoenwolf, 1992; Schoenwolf, 1988), and secondly, because 
the high proportion of wedge shaped cells in the MHP is observed in the relatively 
flat neural plate before a proper bend is found in the midline (Schoenwolf and 
Franks, 1984). So what other mechanisms could be responsible for MHP formation? 
7.1.1 CIP/KIPs as cytoskeletal regulators of MHP formation 
As introduced in Chapter 1, all three CIP/KIP genes act on the Rho pathway to 
regulate actin stress fibre formation. p27 inhibits RhoA, p21 inhibits ROCK, and p57 
translocates LIMK from the cytoplasm to the nucleus where it can no longer 
phosphorylate and inactivate cofilin (Besson et al., 2008). The Rho GTPases are a 
family of small GTPases that are regulators of actin and microtubule dynamics and, 
importantly, control cell shape and motility (Etienne-Manneville and Hall, 2002). 
Thus, the CIP/KIP genes in the neural plate could be involved in cell shape 
regulation independently of their cell cycle role. In support of this, Rho, F-actin and 
pMLC, a downstream target of Rho, seem to localise to the forming MHP in chick 
embryos (Haigo et al., 2003). Furthermore, inhibition of actin, myosin II, Rho or 
ROCK affects neural tube closure in the chick (Kinoshita et al., 2008). In Drosophila, 
the inhibition of ROCK perturbs apical migration, suggesting that ROCK might be an 
upstream activator of actomyosin contraction during IKNM (Meyer et al., 2011). 
Thus, the CIP/KIP genes could be directly involved in IKNM by regulating the Rho 
pathway. Interestingly, p57 has been found to be expressed in all the tissues 
reported to exhibit IKNM in Table 1.1. p21 and p27 have also been reported to be 
expressed in some of the tissues, as described in Chapter 3. CIP/KIP analysis with 
antibodies would have revealed whether the proteins are cytoplasmic and thereby 
possibly involved in regulation of the cytoskeleton. 
There are, however, some indications that actomyosin might not be required for 
MHP formation. First, actin is not localised specifically to the MHP in the mouse but 
is present in apices in all of the neural plate (Ybot-Gonzalez and Copp, 1999) 
suggesting that actin is not responsible for regional changes in cell shape. The study 
in the mouse did, however, not look at the forming MHP region equivalent to the 
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region in the chick that was enriched for Rho and actin. Furthermore, disruption of 
actin-microfilaments with Cytochalasin D does not prevent cell wedging and MHP 
formation in the mouse or chick embryo, suggesting that MHP formation and cell 
wedging is actin independent (Schoenwolf et al., 1988; Ybot-Gonzalez and Copp, 
1999). Even though the early events of neural plate bending, i.e. MHP formation 
and neural fold elevation, proceed unaffected following Cytochalasin D treatment, 
embryos consistently fail to complete closure (Schoenwolf et al., 1988). In 
conclusion, the CIP/KIP proteins can regulate the Rho –ROCK pathway that might be 
important for IKNM. However, the fact that MHP formation is unperturbed in the 
absence of actin goes against this theory.  
Interestingly, initiation of closure 1 is sensitive to Cytochalasin D treatment (Ybot-
Gonzalez and Copp, 1999), suggesting that the force required for the initial point of 
closure requires actin microfilaments. Considering that this is probably the event 
that requires the most force as the flat neuroepithelium bends to make a tube, it 
could be that the subsequent closure of the PNP is a more passive event, unaffected 
by the loss of microfilaments. This would suggest that the force generated within 
the closed neural tube drives bending and neural tube closure in the PNP. 
Interestingly, preliminary data has suggested that disruption of the integrity of the 
closed neural tube by making an incision some distance rostrally from the closure 
point halts PNP closure (A.J.Copp, unpublished). 
7.1.2 Notochord pulling 
If the cytoskeleton is not responsible for MHP formation, and a prolonged cell cycle 
in dispensable for bending, then what is necessary for MHP formation? It has been 
argued that forces generated by lateral tissues are important for neural tube 
closure. However, isolation of the neural tube and plate from lateral tissues does 
not prevent PNP closure (van Straaten et al., 1993) suggesting that the forces 
required for spinal neurulation are intrinsic to the neural plate.  
The MHP does not form in the absence of the notochord (Smith and Schoenwolf, 
1989). This could be due to factors expressed in the notochord that are necessary 
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for induction of genes with a role in MHP formation, or because of physical 
attachment of the notochord to the midline that functions as a hinge. In order for 
the hinge to be effective, there would have to be some sort of downwards pulling of 
the midline, otherwise the midline would just attach to the notochord and stay in 
the same formation. In other words, imagine a sheet of paper with a piece of gum 
attached in a line across the middle of the paper. If there was no pulling at the gum 
it would just be a flat sheet of paper with the gum attached to it. If I started pulling 
the gum, then the sheet of paper would become narrow at the point of attachment. 
Furthermore, if the gum was broad, then the sheet of paper would have a larger 
bending area than if there was a thin line of pulling gum. Thus, a scenario where a 
narrow, attached notochord pulls the midline down seems possible. It could be just 
as likely that the neural plate was pulled away from the notochord, as when the 
gum is stuck to the table and the paper is pulled. However, the fact that lateral 
tissues are not necessary for neural plate bending and elevation makes this scenario 
less likely.  
How would the notochord pull on the neural plate in the scenario above? One 
possibility would be through the very slow proliferative rate in the notochord 
(McShane et al., 2015). It has been shown in the curly tail mouse, which has a 
grainyhead-like-3 mutation, that a proliferative defect in the hindgut leads to a 
growth imbalance between the dorsal and ventral tissues, causing spina bifida 
through excessive curvature of the PNP (Copp et al., 1988). In the neural plate, the 
attachment of the notochord, which has a slower proliferative rate than MHP cells 
(Copp et al., 1988; McShane et al., 2015), could pull on the neural plate by the same 
mechanism, thereby creating an effective hinge. This would also account for the 
MHP like characteristics observed in cells of the lateral neural tube that are in 
contact with transplanted notochordal fragments (Smith and Schoenwolf, 1989). 
Whether this pulling of the midline would affect the cell cycle, or make the cells 
basal, is hard to predict. 
In PCP mouse mutants, craniorachischisis is observed due to a lack of convergent 
extension along the body axis, resulting in a broad neural plate midline that is not 
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permissive of neural fold closure as the neural folds are spaced to wide apart 
(reviewed by Copp et al., 2003a). It is possible that the broad neural plate arises 
because of defective convergent extension in the mesoderm underlying the midline, 
resulting in a broad notochord that no longer functions as an efficient hinge (Copp 
et al., 2003a). The broad midline resulting from a broad notochord would fit with 
the theory of notochord pulling described above. In line with this, disruptive MHP 
formation could be secondary to the primary problem which was a broad 
notochord. In the notochordal pulling scenario, basal cell expansion regulated by 
p21 could lead to more efficient midline bending without being necessary. 
7.1.3 BMP antagonism in MHP formation 
BMP blockade is capable of prolonging the cell cycle at ectopic hinge points in the 
developing chick neural tube and increase the time cells spend with basal nuclei 
(Eom et al., 2013). Furthermore, Noggin overexpression in the chick MHP 
exaggerates bending while BMP overexpression prevents MHP formation (Eom et 
al., 2012). This suggests that BMP antagonists such as Chordin and Noggin which are 
expressed in the mouse notochord (Ybot-Gonzalez et al., 2007a) could play a role in 
MHP formation. p21 has been shown to repress Bmp2 at the transcriptional level in 
neural stem cells (Burnside, 1971). Furthermore, p21 can be transcriptionally 
activated by the BMP antagonist Drm/Gremlin in tumour derived cell lines, and 
Drm/Gremlin, in turn, can be activated by Shh (Chen et al., 2002; Farin et al., 2013). 
Thus, it could be that p21 in the MHP acts as a BMP antagonist to allow MHP 
bending. Conversely, a study in keratinocytes has suggested that BMP2 regulates 
transcription of p57, and upregulates p21 (Gosselet et al., 2007) and in the mouse 
enamel knot, during tooth development, p21 is induced by BMP4 (Jernvall et al., 
1998).   
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7.2 How does p21 prolong S-phase in the MHP? 
p21 interacts directly with PCNA and at low molar ratios p21 is suggested to 
interfere with the rate of synthesis by polymerase β, possibly interfering with the 
sliding of the polymerase along the DNA whereby p21 can alter the rates of DNA 
synthesis (Flores-Rozas et al., 1994). This setting would fit with the long S-phase in 
p21 expressing MHP cells and is distinct from the G1 arrest caused by DNA damage 
in which the p53 dependent checkpoint is activated (Flores-Rozas et al., 1994). In 
other studies it has been suggested that the p21 binding site on PCNA overlaps with 
the DNA polymerase δ and replication factor C, suggesting that p21 binding to PCNA 
blocks DNA synthesis by preventing association between PCNA, polδ, and the 
replication factor (reviewed by Jung et al., 2010). The best known role of p21 is to 
inhibit DNA replication (Moldovan et al., 2007). My analysis with thymidine 
analogues shows that DNA synthesis is not blocked in the MHP where p21 
expression is high, as most cells incorporate BrdU or IdU. Thus, it is more likely that 
p21 inhibits the CDK1-cyclin A and/or CDK2-cyclin A complexes that are required for 
S to G2 transition, keeping the nuclei basal in late S-phase (Deng et al., 1995). 
In conclusion, p21 prolongs S-phase in MHP cells. The best known functions of p21 
are to inhibit the cell cycle in G1-phase, S-phase or inhibiting S- to G2-phase 
transition. The number of cells undergoing DNA synthesis in the MHP suggests that 
the role of p21 is to prolong S-phase or inhibit the transition into G2. Further 
experiments are required to unravel the mechanism of S-phase prolongation.  
The normal MHP morphology of p21-/- embryos suggests that S-phase prolongation 
is not necessary for MHP formation. It is possible that there is redundancy between 
CIP/KIP genes in the MHP but S-phase regulation is dependent on p21. Thus, it 
seems that other mechanisms besides basal expansion are required for MHP 
formation. The prolongation of S-phase and the basal nuclei could provide a 
favourable environment for midline bending, but are not required. 
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Appendix I 
p21 -/- Lateral combined
Single/double S-phase length Single/double S-phase length Single/double S-phase length
#B14 A2 I 3/8 5.33 7/3 0.86 3/9 6.00
#B14 A2 II 6/5 1.67 3/4 2.67 4/4 2.00
#B14 A2 III 6/6 2.00 5/7 2.80  5/7 2.80
#B14 A2 IV 4/7 3.50 7/6 1.71 7/11 3.14
#B14 B1 I 4/6 3.00 12/6 1.00 4/4 2.00
#B14 B1 II 3/8 5.33 4/10 5.00 4/5 2.50
#B14 B1 III 4/6 3.00 5/8 3.20 4/4 2.00
#B14 B1 IV 4/7 3.50 6/6 2.00  2/7 7.00
#B14 B1 V 2/9 9.00 8/6 1.50 5/8 3.20
#B14 B1 VI 7/4 1.14 4/8 4.00 6/8 2.67
#B14 B1 VII 5/8 3.20 6/5 1.67 6/8 2.67
#B14 B1 VIII 5/9 3.60 11/4 0.73 8/7 1.75
53/83 3.13 78/73 1.87 58/82 2.83 2.35
MHP Left lateral Right lateral 
 
Example of the analysis of S-phase length for one embryo (12 sections). Single and double labelled nuclei were counted in the MHP and in two lateral regions for each 
section, and the total number of single and double labelled nuclei was combined to calculate mean S-phase length per embryo. The lateral regions were combined for the 
graph while SEM values were calculated on data from both regions. 
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Appendix II 
Basal  dis t. MHP basa l  dis t. Basa l  dis t.
#B3 B1 I 0.484 G2 0.455 G2 0.860 late S
0.743 G2 0.577 G2 0.498 G2
0.274 early/mid S 0.256 G2 0.850 M
0.239 G2 0.403 G2 0.504 G2
0.581 G2 0.487 G2 0.396 G2
0.793 late S 0.246 early/mid S 0.165 G2
0.759 G2 0.233 G2 0.792 late S
0.494 G2 0.741 late S 0.397 G2
0.641 early/mid S 0.358 G2 0.473 G2
0.241 early/mid S 0.304 G2 0.695 G2
0.872 M 0.773 M
0.769 G2 0.295 G2
0.369 G2 0.795 late S
#B3 B1 II 0.362 G2 0.729 S 0.797 M
0.751 G2 0.439 S 0.503 late S
0.252 early/mid S 0.312 early/mid S 0.292 G2
0.468 G2 0.464 G2 0.560 late S
0.655 G2 0.390 early/mid S 0.883 M
0.856 late S 0.245 early/mid S 0.548 late S
0.364 G2 0.622 late S 0.601 G2
0.364 G2 0.591 G2 0.330 G2
0.804 late S 0.406 late S 0.881 M
0.634 G2 0.814 late S 0.447 G2
#B3 B1 II I 0.659 G2 0.584 late S 0.660 late G2/M
0.844 M 0.345 early/mid S 0.381 early/mid S
0.299 early/mid S 0.567 early/mid S 0.306 early/mid S
0.831 M 0.445 G2 0.785 M
0.523 early/mid S 0.344 G2 0.516 mid/late S
0.307 G2 0.407 late S 0.354 G2
0.849 late S 0.264 late S 0.710 G2
0.691 G2 0.662 G2 0.609 G2
0.277 early/mid S 0.518 G2 0.279 G2
0.770 G2 0.330 late S 0.269 G2
0.653 G2
0.330 G2
0.700 G2
#B3 B1 IV 0.304 G2 0.718 late S 0.385 G2
0.844 M 0.418 G2 0.372 G2
0.570 late S 0.395 G2 0.827 M
0.882 M 0.429 mid S 0.258 G2
0.608 late S 0.288 early/mid S 0.610 late S
0.651 mid/late S 0.731 G2 0.789 M
0.619 early/mid S 0.327 late S 0.338 G2
0.751 mid/late S 0.681 G2 0.431 G2
0.450 early/mid S 0.236 early/mid S 0.739 G2
 0.786 M
0.498 G2
Average 0.582 0.455 0.551 0.566
SE 0.031 0.026 0.031
% Left # % MHP # % Right #
S 24.444 11 28.205 11 6.818 3 15.631
late S 13.333 6 25.641 10 15.909 7 14.621
G2 51.111 23 46.154 18 54.545 24 52.828
M 11.111 5 0.000 0 20.455 9 15.783
late G2/M 0.000 0 0.000 0 2.273 1 1.136
LateG2/M+M 11.111 5 0.000 0 22.727 10 16.919
Total cells 100 45 100 39 100 44  
Example of basal nuclear distances in the left-, MHP- and right regions of 4 sections from one 
embryo. Each nucleus was assigned to a cell cycle phase based on IdU and pHH3 staining. Mean 
basal distance and cell cycle distribution is shown at the bottom. 
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